Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3016543	li-leuk	E6/l (e6/l)	5907	8749	0.00%
3016543	li-leuk	— (—)	2886	3980	100.00%	Distribution not available
3016543	li-leuk	10E6/l (e6/l)	1415	1827	11.33%
3016543	li-leuk-3	E6/l (e6/l)	226	242	0.00%
3016543	li-leuk	E6/L (e6/l)	211	230	0.00%
3016543	li-leuk	E6/l______ (e6/l)	136	147	0.00%
3016543	li-leuk	E06/L (e6/l)	134	150	0.00%
3016543	li-leukosyytit,likvor	— (—)	59	63	100.00%	Distribution not available
3016543	li-leukosyytit,likvor	10E6/l (e6/l)	41	49	0.00%
3016543	li-leuk-3	— (—)	8	9	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Focal epilepsy, strict definition

790

1791

4.72

322.83

1.6

28.07

25.22

e6/l

0.13

611

1291

Polyneuropathies and other disorders of the peripheral nervous system

813

1888

4.59

322.03

1.7

1.4

27.17

28.13

e6/l

0.02

612

1388

Stroke, including SAH

1645

4088

2.98

321.73

1.9

1.3

55.12

29.03

e6/l

1.48

1258

3020

Abnormal findings on diagnostic imaging of central nervous system

392

453

10.36

320.99

1.4

1.7

94.92

32.04

e6/l

0.69

288

337

Cerebral cysts

378

417

10.47

318.60

1.6

1.3

9.41

32.38

e6/l

0.94

295

309

Anxiety disorders, excluding more controls

2004

4892

2.68

315.02

1.5

1.4

35.76

38.20

e6/l

0.08

1445

3615

Meningitis

372

417

10.68

311.70

1.9

1.4

417.39

22.81

e6/l

5.28

284

306

Implicit bacterial Sepsis, including avohilmo

1246

3176

3.38

311.70

1.6

1.4

29.75

25.42

e6/l

0.14

930

2407

Degenerative diseases of the nervous system

1137

1889

4.54

307.65

1.2

1.4

8.34

28.26

e6/l

2.55

815

1436

Dementia

1320

2047

4.62

307.65

1.2

1.4

12.80

42.00

e6/l

2.30

975

1525

Other degenerative diseases of the nervous system

1792

577

25.31

307.65

1.2

24.08

11.21

e6/l

0.64

1303

422

Episodal and paroxysmal disorders

2788

5379

2.69

307.65

1.4

1.5

25.35

37.57

e6/l

0.98

2083

3943

Organic, including symptomatic, mental disorders

1885

2732

5.13

307.65

1.3

1.4

19.50

35.85

e6/l

0.98

1387

2032

Convulsions, not elsewhere classified

907

1538

6.17

307.65

1.6

1.3

30.34

17.52

e6/l

0.38

654

1119

Other mental disorders due to brain damage and dysfunction and to physical disease

528

738

7.83

307.65

1.3

1.4

3.55

38.00

e6/l

2.35

400

544

MS-disease / Multiple Sclerosis

626

621

12.29

307.65

1.1

1.4

33.40

23.34

e6/l

0.18

472

452

Migraine

1561

3733

3.37

307.65

1.4

1.5

21.91

39.77

e6/l

1.12

1178

2716

Other encephalitis

362

218

24.08

307.65

1.7

1.4

84.36

8.54

e6/l

1.49

257

159

Dizziness and giddiness

1933

5079

3.04

307.65

1.4

1.5

20.55

41.78

e6/l

1.83

1476

3836

Demyelinating diseases of the central nervous system

760

12.25

307.65

1.2

1.4

43.65

33.58

e6/l

0.16

573

541

Abnormalities of gait and mobility

574

863

7.33

307.65

1.6

1.5

11.61

33.25

e6/l

1.18

431

609

Delirium, not induced by alcohol and other psychoactive substances

489

696

7.55

307.65

1.3

1.4

41.00

39.97

e6/l

0.01

351

511

Alzheimer’s disease (Late onset), excluding more controls

479

158

20.88

307.65

1.2

6.20

17.34

e6/l

0.86

346

119

Condition for Implicit Sepsis (Organ dysfunction codes)

2933

5591

3.79

307.65

1.4

20.05

35.05

e6/l

1.36

2070

4225

Other symptoms and signs involving the nervous and musculoskeletal systems

1825

3880

5.02

307.65

1.4

1.5

22.27

38.02

e6/l

0.86

1498

2789

Alzheimer’s disease (Early onset), excluding more controls

274

70.47

307.65

1.1

2.17

16.72

e6/l

0.60

196

Concussion

1189

1364

6.97

307.65

1.5

1.4

19.86

15.50

e6/l

0.26

890

974

Other demyelinating diseases of the central nervous system

402

314

16.93

307.65

1.2

1.5

38.40

15.78

e6/l

0.35

289

239

Cerebrovascular diseases

2120

4774

3.19

307.65

1.8

1.3

47.14

27.44

e6/l

1.33

1600

3532

Intracranial trauma

1417

1378

7.17

307.65

1.5

1.4

21.76

15.45

e6/l

0.44

1044

982

Other neurological diseases

2957

4951

4.90

307.65

1.7

1.3

25.08

36.54

e6/l

0.88

2277

3622

Any dementia, excluding more controls

1168

1639

5.15

307.65

1.2

1.4

7.81

39.42

e6/l

3.42

862

1239

Any mental disorder

2658

5228

2.60

307.65

1.4

1.5

29.18

38.90

e6/l

0.53

1948

3870

Neurological diseases

2652

1906

7.27

307.65

1.5

24.75

21.64

e6/l

0.25

1979

1349

Cerebrovascular diseases (FINNGEN)

1300

1945

4.98

307.65

1.9

1.3

44.31

19.57

e6/l

1.88

971

1411

Dementia, including avohilmo

1424

2366

4.30

307.65

1.3

1.4

12.43

39.08

e6/l

2.38

1041

1765

Encephalitis

376

231

23.29

307.65

1.7

1.4

84.12

32.17

e6/l

0.68

269

168

Implicit Sepsis, including avohilmo

2794

5649

3.68

307.65

1.4

20.81

34.18

e6/l

1.11

1990

4244

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3049

5791

3.69

307.65

1.4

20.01

34.96

e6/l

1.42

2159

4346

Visual disturbances

1561

5165

3.15

307.65

1.4

1.5

29.28

35.99

e6/l

0.24

1176

3819

Neurological diseases, wide definition

979

413

12.44

307.65

1.7

1.5

21.29

10.91

e6/l

1.26

734

281

Fever of other and unknown origin

1577

3608

3.91

307.65

1.8

1.4

50.29

28.59

e6/l

1.05

1206

2644

Headache

2963

3961

6.13

307.65

1.4

32.78

27.83

e6/l

0.26

2265

2881

Malaise and fatigue

1611

2976

4.43

307.65

1.4

20.27

30.47

e6/l

0.70

1187

2203

Disorders of optic nerve and visual pathways

549

870

7.11

307.65

1.4

1.6

17.13

33.94

e6/l

0.83

409

627

Inflammatory diseases of the central nervous system

746

719

12.79

307.65

1.8

1.4

245.92

17.54

e6/l

6.21

555

526

Symptoms and signs involving the nervous and musculoskeletal systems

2556

5575

4.88

307.65

1.5

20.07

35.11

e6/l

1.24

2037

4038

Normal-pressure hydrocephalus

702

261

42.11

307.65

1.9

1.2

6.25

71.52

e6/l

1.26

569

191

Mood disorders, excluding more controls

2403

5136

2.82

307.65

1.4

29.17

39.12

e6/l

0.61

1763

3807

Unspecific neurodegenerative disorder

1180

2125

3.96

307.65

1.2

1.4

11.33

38.06

e6/l

2.19

867

1601

Other symptoms and signs involving cognitive functions and awareness

2381

3020

7.58

307.65

1.3

1.4

21.34

37.16

e6/l

1.08

1657

2303

Any dementia

1185

1996

4.29

307.65

1.2

1.4

7.72

42.47

e6/l

3.27

875

1499

Hydrocephalus

1037

454

33.15

307.65

2.4

1.4

19.39

37.29

e6/l

0.48

827

328

Implicit Sepsis

2443

5422

3.45

307.65

1.4

23.23

32.57

e6/l

0.60

1786

4022

Focal epilepsy

840

1955

4.58

307.65

1.6

26.89

24.95

e6/l

0.09

647

1411

Viral infections of the central nervous system, including avohilmo

559

702

9.33

307.65

1.5

1.4

68.67

36.41

e6/l

1.57

434

510

Epilepsy

1192

2474

5.09

307.65

1.7

1.6

27.89

37.40

e6/l

0.44

908

1807

Other headache syndromes

1295

3625

3.70

307.65

1.4

23.98

39.96

e6/l

0.83

951

2635

Implicit viral Sepsis, including avohilmo

1031

2548

4.24

307.65

1.5

1.4

33.88

26.57

e6/l

0.22

759

1925

Alzheimer disease, excluding more controls

794

203

27.47

307.65

1.2

9.76

15.89

e6/l

0.38

569

152

Postprocedural disorders of nervous system

597

566

12.71

307.65

1.3

1.2

16.99

34.75

e6/l

0.73

469

412

General symptoms and signs

3193

4252

3.89

307.65

1.4

34.71

28.13

e6/l

0.40

2383

3107

Disturbances of skin sensation

1122

2877

4.14

307.65

1.2

1.4

8.44

28.99

e6/l

3.48

824

2120

Viral infections of the central nervous system

534

654

9.64

307.65

1.5

1.4

70.79

38.94

e6/l

1.38

419

472

Visual disturbances and blindness

1632

5538

3.06

307.65

1.5

1.4

28.32

35.63

e6/l

0.29

1227

4098

STROKE

1706

3640

3.28

307.65

1.8

1.3

38.29

32.84

e6/l

0.24

1274

2628

Symptoms and signs involving cognition, perception, emotional state and behaviour

3662

6009

4.26

307.65

1.3

1.5

17.43

41.47

e6/l

3.47

2648

4503

Psychiatric diseases

2226

4384

2.60

306.51

1.4

1.5

26.32

41.16

e6/l

0.93

1614

3243

Alzheimer disease, including avohilmo

1020

1842

3.99

305.11

1.2

1.4

12.38

27.79

e6/l

1.38

755

1395

Focal epilepsy, mode (most common among epilepsy diagnosis)

746

1695

4.70

303.97

1.6

29.75

24.31

e6/l

0.27

575

1226

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

745

653

5.86

298.16

1.5

30.45

44.33

e6/l

0.49

538

469

Mood [affective] disorders

2598

7409

2.30

295.66

1.4

27.45

35.40

e6/l

0.52

1894

5508

Traumatic subdural haemorrhage

315

259

11.87

294.84

1.7

1.1

33.78

11.77

e6/l

1.00

237

192

Mood disorders

2599

7410

2.29

294.61

1.4

27.43

35.39

e6/l

0.52

1896

5509

Pain, not elsewhere classified

794

1930

4.28

293.57

1.4

1.3

13.58

25.90

e6/l

1.00

609

1422

Other and unspecified hydrocephalus

227

129

25.27

292.96

3.0

1.3

24.03

12.98

e6/l

0.59

183

Viral Sepsis

726

1662

4.61

291.89

1.6

1.4

25.97

20.77

e6/l

0.26

561

1239

Implicit viral Sepsis

722

1656

4.60

289.57

1.6

1.4

26.13

20.82

e6/l

0.26

557

1234

Benign intracranial hypertension

188

46.29

289.11

1.4

8.75

13.26

e6/l

0.19

146

Depression

2449

7230

2.32

287.37

1.4

28.03

34.51

e6/l

0.38

1789

5364

Alzheimer’s disease, strict definition

739

1331

4.68

284.72

1.2

1.3

4.82

28.65

e6/l

3.12

530

1011

Use of anticholinesterases

940

1942

3.88

281.33

1.2

1.4

8.40

32.68

e6/l

2.77

688

1473

N06DA Anticholinesterases

940

1942

3.88

281.33

1.2

1.4

8.40

32.68

e6/l

2.77

688

1473

Alzheimer disease

893

1623

4.09

279.62

1.2

1.3

9.00

25.33

e6/l

1.65

654

1236

Infections, IBD-co-morbidities

365

242

10.99

277.57

1.9

1.5

33.27

6.99

e6/l

0.82

268

155

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

229

148

21.22

276.24

1.7

1.4

49.44

10.84

e6/l

3.88

190

106

Viral encephalitis, not elsewhere classified/unspecified

225

146

21.17

270.92

1.7

1.4

49.69

10.84

e6/l

3.90

189

106

Aneurysms, operations, SAH

599

1253

5.10

270.02

2.4

1.3

77.74

27.87

e6/l

1.86

473

925

Alzheimer’s disease (Early onset)

274

242

12.83

268.90

1.1

1.3

2.17

31.82

e6/l

1.43

196

187

Other antidepressants

2380

5308

2.33

264.91

1.3

1.4

18.08

37.32

e6/l

2.56

1739

3930

Implicit bacterial Sepsis

1092

2941

3.29

264.72

1.6

1.4

29.08

25.24

e6/l

0.12

829

2229

Communicating hydrocephalus

222

150

19.91

261.11

3.7

1.6

33.48

10.98

e6/l

1.31

166

104

Depression or dysthymia

1442

2742

2.94

255.33

1.4

1.5

20.14

43.40

e6/l

1.91

1061

2020

Bacterial Sepsis

1194

3324

3.06

254.77

1.6

1.4

53.95

25.88

e6/l

1.02

910

2509

Other and unspecified polyneuropathies, also in other diseases

662

1593

4.41

250.20

1.4

32.11

27.13

e6/l

0.11

500

1166

Nontraumatic intracranial haemmorrhage

615

1399

4.62

248.84

2.7

1.3

107.02

29.83

e6/l

2.31

487

1044

Syncope and collapse

1014

2667

3.26

242.03

1.6

1.3

31.16

24.98

e6/l

0.18

750

1995

Migraine without aura

663

1715

4.05

225.95

1.4

1.5

31.42

40.86

e6/l

0.19

492

1241

Stroke, excluding SAH

1399

3906

2.65

222.76

1.7

1.4

39.46

30.93

e6/l

0.34

1066

2893

Other meningitis

191

134

19.93

221.05

2.0

1.2

471.73

5.75

e6/l

3.55

151

100

Care involving use of rehabilitation procedures

1639

6362

2.37

217.27

1.5

28.81

31.00

e6/l

0.09

1315

4645

Parkinson's disease, excluding more controls

238

204

11.08

212.27

1.4

1.2

4.05

12.59

e6/l

1.24

189

155

Subarachnoid haemorrhage

403

744

5.84

210.00

2.9

1.3

106.65

34.05

e6/l

1.84

324

552

Anxiety disorders

2181

7193

2.12

209.15

1.4

33.22

32.65

e6/l

0.02

1575

5315

Neurotic, stress-related and somatoform disorders

2161

7164

2.12

206.88

1.4

27.29

34.59

e6/l

0.41

1562

5289

Migraine with aura

726

2120

3.56

206.32

1.3

1.4

28.01

44.24

e6/l

0.42

554

1555

Obstructive hydrocephalus

162

23.39

205.76

2.6

1.8

34.47

13.55

e6/l

0.83

125

Diplopia

494

1109

4.76

204.73

1.4

39.87

30.68

e6/l

0.15

377

810

Dorsalgia

2249

5698

2.13

204.34

1.3

1.4

23.66

36.45

e6/l

1.05

1716

4140

Recurrent or chronic depression

932

2095

3.17

201.66

1.4

28.21

39.78

e6/l

0.48

678

1528

Optic neuritis

271

352

8.94

200.97

1.3

1.5

8.88

14.42

e6/l

0.79

197

272

General examination and investigation of persons without complaint and reported diagnosis

1446

2982

2.57

197.88

1.4

23.18

36.95

e6/l

0.93

1162

2102

Low back pain

1805

5556

2.24

196.72

1.3

1.4

25.14

36.89

e6/l

0.78

1369

4043

Symptoms and signs involving the skin and subcutaneous tissue

1771

7803

2.19

196.28

1.4

1.5

20.95

32.47

e6/l

0.95

1309

5788

Persons encountering health services for specific procedures and health care

2475

7503

1.98

190.94

1.5

1.4

29.32

31.43

e6/l

0.13

1875

5474

Parkinson's disease, strict definition, excluding more controls

212

189

10.79

187.26

1.4

1.2

4.35

13.33

e6/l

1.19

169

144

Anxiety (asthma-related co-morbidities)

1510

5020

2.34

187.21

1.4

26.99

37.83

e6/l

0.48

1063

3722

Other soft tissue disorders, not elsewhere classified

2171

6076

2.07

186.89

1.5

23.22

34.98

e6/l

0.81

1628

4463

Disorders of thyroid, IBD co-morbidities

309

274

7.91

186.37

1.5

1.3

68.35

11.41

e6/l

0.85

228

187

Autoimmune diseases excluding thyroid diseases

2380

6546

2.00

185.90

1.3

1.5

30.65

34.30

e6/l

0.16

1765

4816

Status epilepticus

211

219

10.99

185.72

1.7

1.8

20.48

79.66

e6/l

0.89

178

166

Other dorsopathies, not elsewhere classified

2229

5714

2.06

185.53

1.3

1.4

19.70

36.34

e6/l

2.48

1703

4155

Papilloedema, unspecified

196

194

12.53

180.97

1.5

1.3

21.40

15.07

e6/l

0.22

150

147

Autoimmune diseases excluding thyroid diseases, strict definition

2296

6321

2.01

180.82

1.3

1.5

28.26

29.75

e6/l

0.06

1700

4658

Viral meningitis, including avohilmo

249

334

8.67

179.83

1.4

106.36

10.19

e6/l

11.84

204

243

ILD medications: immunosuppressive drugs

1583

6608

2.22

179.62

1.9

1.4

42.03

27.62

e6/l

0.52

1185

4845

Autoimmune diseases related-to ILD

1983

8283

2.04

178.11

1.3

1.4

42.10

30.08

e6/l

0.50

1490

6124

Viral meningitis

241

317

8.88

177.10

1.4

109.54

8.19

e6/l

12.58

198

230

Motor neuron disease ALS

103

51.10

176.87

1.1

7.74

38.20

e6/l

0.55

Sequelae of cerebrovascular disease

824

2385

3.04

175.67

2.0

1.3

48.70

32.58

e6/l

0.53

645

1791

Lower back pain or/and sciatica

2416

7908

1.93

175.55

1.4

22.48

35.59

e6/l

1.26

1850

5798

Cerebral palsy and other paralytic syndromes

431

985

4.68

174.83

1.6

14.98

31.67

e6/l

0.95

303

722

Malignant neoplasm of brain, including Hilmo

273

418

7.34

173.80

2.0

1.3

53.62

33.21

e6/l

0.39

210

325

Alzheimer’s disease (Atypical or mixed), excluding more controls

181

15.58

172.36

1.3

1.1

21.93

26.27

e6/l

0.08

153

Motor neuron disease (with DMD)

104

43.76

172.20

1.1

1.8

7.71

35.00

e6/l

0.56

Pain in limb

1909

5942

2.08

171.11

1.5

25.43

35.10

e6/l

0.53

1427

4367

Bacterial infection, other or unspecified

1266

4547

2.41

171.03

1.9

1.4

48.64

22.77

e6/l

1.19

963

3359

Anaemias

560

902

4.10

170.65

1.9

1.2

12.78

10.73

e6/l

0.30

406

685

Bacterial infection, other or unspecified, including avohilmo

1372

4965

2.32

169.19

1.8

1.4

46.28

23.26

e6/l

1.13

1049

3666

Other disorders of optic [2nd] nerve and visual pathways

317

578

6.08

168.91

1.6

1.7

23.25

39.51

e6/l

0.46

240

426

Ischaemic Stroke, excluding all haemorrhages

1209

3689

2.47

167.70

1.5

1.4

25.10

35.55

e6/l

0.62

923

2751

Nerve, nerve root and plexus disorders

2337

7425

1.92

166.21

1.3

1.4

40.83

29.66

e6/l

0.53

1800

5443

Certain infectious and parasitic diseases

2052

5122

2.04

164.77

1.6

1.4

43.18

22.15

e6/l

1.61

1514

3751

All anxiety disorders

1547

5616

2.18

163.93

1.4

26.53

37.14

e6/l

0.49

1092

4147

ILD medications

2481

7185

1.89

163.82

1.7

1.4

46.41

26.76

e6/l

1.02

1860

5270

Use of donepezil

507

1294

3.88

162.24

1.2

1.3

3.46

30.60

e6/l

3.43

386

976

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

313

592

5.77

159.56

1.9

1.3

48.92

26.38

e6/l

0.57

239

448

Subjective visual disturbances

722

2466

3.04

158.63

1.4

12.15

35.16

e6/l

2.30

538

1798

Medical observation and evaluation for suspected diseases and conditions

1362

2982

2.38

158.53

1.5

1.4

14.56

36.95

e6/l

2.21

1045

2102

Malignant neoplasm of brain

215

283

8.73

157.44

2.0

1.4

61.70

42.74

e6/l

0.25

166

221

Dementia in Alzheimer disease

396

727

4.71

157.33

1.3

14.46

37.91

e6/l

0.94

335

543

Bleeding

1798

6329

2.03

154.32

1.9

1.4

45.44

28.06

e6/l

1.28

1351

4669

Provisional assignment of new diseases of uncertain etiology

1286

5802

2.25

153.55

1.6

1.4

19.89

34.35

e6/l

1.20

918

4346

Codes for special purposes

1286

5809

2.25

153.06

1.6

1.4

19.89

34.32

e6/l

1.20

918

4352

Other anxiety disorders

1200

4470

2.34

152.56

1.4

25.57

39.69

e6/l

0.53

847

3293

Primary_lymphoid and hematopoietic malignant neoplasms

646

2119

3.17

152.44

3.1

1.3

35.22

22.86

e6/l

0.43

490

1576

Covid-19 confirmed case

928

3682

2.59

151.49

1.7

1.4

23.62

26.90

e6/l

0.14

657

2764

Selective serotonin reuptake inhibitors

2004

5354

1.97

149.33

1.4

20.42

37.06

e6/l

2.15

1488

3960

Depression medications

664

982

3.48

148.76

1.4

1.2

14.18

10.79

e6/l

0.51

476

750

Alzheimer’s disease (Late onset)

513

1180

3.69

147.37

1.2

1.4

6.30

30.39

e6/l

2.53

374

900

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

671

2259

3.02

146.68

1.3

1.4

15.60

32.02

e6/l

2.02

484

1685

Substance abuse, excluding more controls

1110

3999

2.36

144.99

1.4

42.27

41.91

e6/l

0.01

819

2974

Use of rivastigmine

400

988

4.21

144.65

1.2

1.3

16.24

27.92

e6/l

0.43

285

752

Pain (limb, back, neck, head abdominally)

1407

3185

2.25

144.34

1.6

1.5

17.12

44.68

e6/l

2.72

1057

2321

Dorsopathies

2143

5766

1.91

144.03

1.3

1.5

21.53

36.31

e6/l

1.81

1627

4192

Guillain-Barre syndrome

142

123

14.68

143.71

1.4

1.3

9.36

15.95

e6/l

0.35

105

Other bacterial diseases

2021

7162

1.90

142.11

1.9

1.4

54.72

26.59

e6/l

1.78

1529

5262

Examination and observation for other reasons

1214

2969

2.35

141.94

1.5

1.4

30.21

37.05

e6/l

0.21

918

2092

Malignant neoplasm of eye, brain and central nervous system

232

371

6.99

141.62

2.0

1.4

58.36

33.88

e6/l

0.41

177

285

Used for control exclusion in common control thyroid runs

2213

6032

1.88

141.06

1.4

1.5

17.45

30.68

e6/l

2.28

1633

4436

Benzodiazepine use

2182

8110

1.84

140.71

1.4

31.28

32.74

e6/l

0.05

1597

6026

Extrapyramidal and movement disorders

902

3690

2.51

138.39

1.3

1.4

7.64

31.53

e6/l

4.62

643

2758

Intracranial injury

1344

6008

2.13

138.38

1.6

1.5

22.67

33.62

e6/l

0.84

987

4468

Abnormal involuntary movements

406

1054

4.05

138.29

1.6

1.4

10.12

36.31

e6/l

2.01

301

756

Sciatica+with lumbago

1163

4653

2.26

138.03

1.4

14.88

40.54

e6/l

3.45

906

3349

Other special examinations and investigations of persons without complaint or reported diagnosis

1309

2982

2.26

136.29

1.5

1.4

27.60

36.95

e6/l

0.43

1006

2102

Opioids

2049

5655

1.90

136.11

1.3

1.4

25.70

31.45

e6/l

0.32

1505

4197

Pain in joint

1156

3105

2.33

135.69

1.2

1.4

20.63

45.78

e6/l

2.04

841

2258

Secondary parkinsonism, excluding more controls

30.57

135.25

1.3

4.30

22.17

e6/l

0.50

Nausea and vomiting

688

2436

2.84

133.73

1.8

1.6

19.07

34.51

e6/l

1.14

509

1789

Migraine without aura and triptan purchases

532

1690

3.29

132.94

1.4

35.51

28.25

e6/l

0.13

399

1240

Other disorders of urethra and urinary system

1520

5280

2.04

132.30

1.5

1.4

32.78

29.12

e6/l

0.12

1103

3956

Cardiovascular diseases (excluding rheumatic etc)

1467

4074

2.10

131.41

1.6

1.4

31.25

23.45

e6/l

0.47

1091

2954

Metabolic disorders

1989

6469

1.87

131.36

1.4

1.5

40.24

32.82

e6/l

0.29

1424

4839

Bell's palsy

387

1012

4.04

130.78

1.5

1.4

42.70

21.92

e6/l

0.75

283

726

Viral hepatitis, IBD co-morbidity

125

13.31

130.41

1.8

1.2

27.40

7.33

e6/l

1.33

Tramadol

1649

5075

1.98

129.28

1.4

30.90

32.65

e6/l

0.06

1201

3779

Parasetamol

1494

3670

2.09

128.64

1.5

1.4

22.97

30.40

e6/l

0.52

1106

2655

Memory loss

279

576

5.15

127.94

1.3

14.50

40.93

e6/l

0.84

163

429

Liquid cancers

732

2666

2.68

126.38

2.9

1.4

34.71

26.06

e6/l

0.30

547

2035

Use of memantine

575

1528

3.11

126.36

1.2

1.3

5.77

28.05

e6/l

2.94

455

1163

Use of other anti-dementia drugs

575

1528

3.11

126.36

1.2

1.3

5.77

28.05

e6/l

2.94

455

1163

Autoimmune diseases

2289

6580

1.79

125.95

1.3

1.5

19.90

34.15

e6/l

2.12

1695

4840

Nonorganic sleeping disorders, excluding more controls

514

1656

3.20

124.70

1.3

1.4

12.91

31.03

e6/l

1.58

357

1255

Circumscribed brain atrophy

135

133

11.88

123.91

1.2

1.3

2.63

75.79

e6/l

0.92

100

Cardiovascular diseases

1384

3543

2.11

123.50

1.6

1.4

21.36

23.23

e6/l

0.10

1015

2576

Explicit Sepsis, including avohilmo

923

3603

2.37

123.31

2.2

1.4

79.45

25.25

e6/l

1.80

719

2710

Codeine

1901

5579

1.87

121.75

1.3

1.4

36.16

31.37

e6/l

0.15

1389

4140

Non-invasive ventilation

583

1729

2.99

121.74

1.6

1.4

46.83

18.13

e6/l

1.26

508

1267

Other intervertebral disc disorders

1644

5114

1.94

121.72

1.3

1.4

25.36

38.42

e6/l

0.76

1312

3720

Personality disorders, excluding more controls

597

2114

2.90

121.70

1.3

1.4

7.75

33.73

e6/l

5.75

431

1580

Pain in throat and chest

1802

5750

1.88

120.83

1.3

1.5

21.60

39.82

e6/l

2.06

1340

4205

Other bacterial diseases, including avohilmo

2113

7496

1.78

120.79

1.8

1.4

57.22

23.60

e6/l

2.13

1578

5497

Schizophrenia or delusion, excluding more controls

649

2385

2.75

120.41

1.3

1.4

46.89

39.71

e6/l

0.11

463

1784

First line medication for Crohn's disease

2289

7103

1.76

120.12

1.8

1.3

50.55

23.96

e6/l

1.60

1713

5208

Any gastric operation

1609

4133

1.98

120.10

1.8

1.2

25.40

36.31

e6/l

0.68

1191

3059

GASTRO-related operations

1609

4133

1.98

120.10

1.8

1.2

25.40

36.31

e6/l

0.68

1191

3059

Explicit Sepsis

899

3540

2.36

119.15

2.2

1.4

66.24

24.65

e6/l

1.66

700

2665

Other disorders of fluid, electrolyte and acid-base balance

703

2570

2.64

118.86

1.5

1.4

34.44

28.80

e6/l

0.11

554

1976

Spirochaetal infections, other/unspecified

329

825

4.27

118.54

1.3

1.4

35.02

34.24

e6/l

0.02

221

608

Injuries to the head

2330

8100

1.73

118.34

1.5

1.4

27.39

33.61

e6/l

0.39

1723

5999

Diseases of the eye and adnexa

1660

4364

1.93

115.71

1.5

1.4

29.94

36.37

e6/l

0.34

1237

3213

Any reimbursement code in KELA

1250

2959

2.15

115.66

1.7

1.3

24.54

30.08

e6/l

0.30

919

2134

ILD medications: prednisolone, methylprednisolone, prednisone

2194

7051

1.75

115.10

1.5

1.4

45.23

26.92

e6/l

0.91

1643

5174

Unspecified dementia

248

440

5.23

114.21

1.2

1.3

3.29

51.33

e6/l

1.86

206

335

Migraine with aura and triptan purchases

489

1620

3.14

113.77

1.3

1.4

34.09

28.85

e6/l

0.08

371

1177

Other reaction to severe stress, and adjustment disorders

888

3936

2.31

113.31

1.5

1.4

18.30

38.85

e6/l

1.50

661

2894

Hypothyroidism (congenital or acquired)

527

925

3.26

112.05

1.4

1.2

30.14

10.61

e6/l

1.11

398

709

Paralytic strabismus

260

572

4.89

111.02

1.6

1.5

68.87

37.06

e6/l

0.31

200

422

Influenza and pneumonia

2195

7972

1.72

110.69

1.6

1.4

34.17

32.07

e6/l

0.10

1659

5831

Speech disturbances, not elsewhere classified

299

737

4.30

109.87

1.3

27.17

33.48

e6/l

0.13

211

548

Abnormalities of breathing

1841

5882

1.81

109.37

1.4

1.5

22.80

39.28

e6/l

1.17

1408

4299

Hypothyroidism and >3 levothyroxin purchases

521

925

3.23

109.07

1.4

1.2

29.25

10.61

e6/l

1.03

393

709

Hypothyroidism, levothyroxine purchases

521

925

3.23

109.07

1.4

1.2

29.25

10.61

e6/l

1.03

393

709

Diffuse large B-cell lymphoma, helper endpoint

206

381

5.92

107.94

1.6

1.3

16.89

30.20

e6/l

0.37

171

298

Diffuse large B-cell lymphoma

206

381

5.92

107.94

1.6

1.3

16.89

30.20

e6/l

0.37

171

298

Diffuse large B-cell lymphoma, including Hilmo

206

381

5.92

107.94

1.6

1.3

16.89

30.20

e6/l

0.37

171

298

Spondylopathies

1503

4684

1.92

107.88

1.4

30.30

40.53

e6/l

0.60

1165

3390

Non-Hodgkin lymphoma, all, including Hilmo

383

1132

3.55

107.82

1.8

1.3

51.42

27.19

e6/l

0.55

300

848

Non-follicular lymphoma

299

755

4.20

106.37

1.9

1.4

39.36

25.35

e6/l

0.29

244

557

1786

5843

1.81

105.94

1.6

1.4

37.81

28.31

e6/l

0.56

1338

4260

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1786

5843

1.81

105.94

1.6

1.4

37.81

28.31

e6/l

0.56

1338

4260

Neuromuscular dysfunction of bladder

288

711

4.28

105.50

1.5

1.4

20.96

28.16

e6/l

0.26

218

525

Disorders of ocular muscles, binocular movement, accommodation and refraction

1117

5552

2.04

103.49

1.6

1.5

42.95

31.99

e6/l

0.29

843

4065

Benign neoplasm: Cerebral meninges

303

794

4.05

102.44

1.5

1.3

117.68

30.44

e6/l

1.15

214

578

Benign neoplasm of meninges

319

867

3.89

102.23

1.6

1.3

112.52

28.95

e6/l

1.17

226

629

Cerebral aneurysm, nonruptured

276

679

4.31

101.71

1.8

1.3

30.55

39.14

e6/l

0.23

219

497

Lumbar disc prolapse

1279

4909

1.96

101.64

1.3

1.4

23.58

39.15

e6/l

0.77

1016

3559

Tick-borne viral encephalitis, including avohilmo

24.70

99.32

1.1

1.2

93.11

4.94

e6/l

3.51

Hard cardiovascular diseases

1662

5515

1.81

98.02

1.6

1.5

26.40

36.25

e6/l

0.70

1281

3976

Other diseases of urinary system

1942

6392

1.73

97.34

1.4

32.07

29.65

e6/l

0.08

1415

4782

Complications of surgical and medical care, not elsewhere classified

2000

7974

1.69

97.05

1.6

1.4

42.94

30.61

e6/l

0.61

1493

5902

Oedema, not elsewhere classified

569

2158

2.63

96.59

1.3

23.27

30.41

e6/l

0.26

413

1605

Asthma (mode)

1483

4217

1.87

95.39

1.4

43.85

26.10

e6/l

0.62

1102

3058

Persons encountering health services in other circumstances, wide

2239

7010

1.66

95.38

1.5

25.01

35.29

e6/l

0.97

1602

5270

Hypo-osmolality and hyponatraemia

409

1341

3.12

95.04

1.5

22.94

37.30

e6/l

0.51

327

1025

Symptoms and signs involving the digestive system and abdomen

1922

5632

1.73

94.62

1.5

19.41

40.41

e6/l

2.80

1430

4155

Traumatic subarachnoid haemorrhage

14.58

94.32

1.6

1.3

25.92

12.55

e6/l

0.45

Liquid cancers, including Hilmo

795

3175

2.26

94.23

2.7

1.4

32.85

26.45

e6/l

0.23

597

2412

Asthma, excluding more controls

1460

4046

1.88

94.20

1.4

1.3

43.33

26.12

e6/l

0.58

1081

2935

Other and unspecified degenerative diseases of nervous system

128

167

8.55

93.97

1.4

1.3

4.01

61.20

e6/l

0.90

126

Spondylosis

1047

4081

2.04

93.90

1.4

30.02

38.41

e6/l

0.27

805

2955

Strabismus

659

2794

2.42

93.27

1.6

36.13

23.63

e6/l

0.32

504

2043

Symptoms and signs involving the circulatory and respiratory systems

1984

5904

1.70

92.44

1.4

1.5

29.92

39.17

e6/l

0.42

1501

4314

Asthma

1485

4189

1.85

92.08

1.4

42.70

25.71

e6/l

0.58

1100

3039

Other/unspecified dorsalgia

772

3472

2.24

92.06

1.3

1.4

12.74

38.80

e6/l

3.52

567

2511

Enlarged lymph nodes

335

1001

3.45

92.00

1.5

1.4

16.55

14.35

e6/l

0.08

248

730

All pneumoniae

2049

8117

1.66

91.57

1.6

1.4

32.49

32.54

e6/l

0.00

1544

5943

Systemic atrophies primarily affecting the central nervous system

172

314

5.98

91.39

1.6

1.5

6.19

58.69

e6/l

1.27

128

239

Bacterial meningitis

163

286

6.34

90.74

1.9

1.4

651.88

8.28

e6/l

3.77

126

209

Pneumonias (Asthma/COPD co-morbidities)

2033

8103

1.66

90.66

1.6

1.4

32.72

32.45

e6/l

0.01

1532

5932

Codeine or tramadol medication

2201

7389

1.64

89.75

1.3

1.4

40.73

28.92

e6/l

0.47

1617

5499

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1950

7981

1.67

89.25

1.8

1.4

35.65

32.47

e6/l

0.11

1455

5900

Inflammatory bowel disease treatment related agents

2257

7822

1.62

88.50

1.7

1.4

41.69

28.03

e6/l

0.72

1711

5723

Hypertension, essential

1531

4879

1.80

88.24

1.4

55.00

31.48

e6/l

0.85

1115

3616

Intracerebral haemorrhage

293

828

3.67

87.95

2.5

1.4

93.22

36.73

e6/l

0.72

227

612

Tick-borne viral encephalitis

26.67

87.95

1.1

1.2

88.50

5.62

e6/l

2.83

Hypertensive diseases (excluding secondary)

1065

3111

2.02

87.81

1.4

41.22

24.42

e6/l

0.57

778

2257

Septicaemia

847

3697

2.13

87.62

2.3

1.4

55.78

21.16

e6/l

1.96

664

2751

Soft tissue disorders

1983

6127

1.68

87.61

1.5

28.93

34.89

e6/l

0.30

1469

4503

Undefined dementia

248

567

4.16

87.50

1.3

3.29

39.83

e6/l

1.86

206

441

Oral corticosteroids

2089

7552

1.64

87.47

1.4

39.66

28.36

e6/l

0.53

1603

5528

Persons encountering health services for examination and investigation

1161

2982

1.98

86.79

1.5

1.4

24.16

36.95

e6/l

0.65

865

2102

Other extrapyramidal and movement disorders in other diseases

568

2337

2.50

86.52

1.3

1.4

9.92

37.60

e6/l

2.94

389

1732

Other septicaemia, including avohilmo

779

3415

2.18

86.43

2.3

1.4

56.89

21.57

e6/l

1.15

613

2550

Small fibre neuropathy

144

237

6.80

85.65

1.3

1.4

5.46

48.95

e6/l

0.91

112

168

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1978

8109

1.64

85.57

1.6

1.4

32.85

32.39

e6/l

0.02

1493

5936

Symptoms and signs involving speech and voice

726

3338

2.23

85.16

1.3

1.4

25.80

35.38

e6/l

0.36

517

2471

Other and unspecified visual disturbances

312

943

3.47

84.95

1.3

1.4

54.96

32.48

e6/l

0.23

221

682

Transient ischemic attack

937

3716

2.04

84.87

1.4

11.64

34.94

e6/l

3.15

720

2761

Other disorders of central nervous system

12.72

84.48

1.7

1.3

343.00

13.75

e6/l

1.42

Dysphagia

547

2234

2.51

84.45

1.5

1.4

36.07

36.50

e6/l

0.01

403

1651

Other septicaemia

759

3347

2.18

84.04

2.3

1.4

40.48

21.39

e6/l

1.08

597

2500

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2119

7004

1.62

83.78

1.4

1.5

22.36

35.32

e6/l

1.57

1513

5265

Pneumonia, organism unspecified

1802

7481

1.67

83.77

1.6

1.4

34.73

33.22

e6/l

0.06

1364

5476

Asthma, unspecified (mode), excluding more controls

1026

3781

1.97

82.53

1.4

59.02

22.19

e6/l

1.05

746

2740

Certain infectious and parasitic diseases, including avohilmo

1314

3578

1.86

82.48

1.5

1.4

32.82

18.51

e6/l

1.01

954

2656

Asthma, unspecified (mode)

1040

3911

1.95

80.98

1.4

58.20

21.94

e6/l

1.05

757

2837

Complications of medical and surgical care

1452

7631

1.73

80.75

1.6

1.4

40.36

30.63

e6/l

0.55

1066

5673

Meningitis, viral

24.47

80.29

1.4

1.3

155.20

3.00

e6/l

4.80

Cervicobrachial syndrome

491

1956

2.58

80.03

1.3

1.4

12.37

44.51

e6/l

2.21

398

1387

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

190

420

4.75

79.95

1.4

1.3

41.54

46.53

e6/l

0.05

132

316

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1275

6270

1.79

79.61

1.4

39.13

32.73

e6/l

0.17

936

4660

Use of teriflunomide

11.99

79.31

1.1

1.3

145.70

16.52

e6/l

0.47

Implicit fungal Sepsis, including avohilmo

210

508

4.36

79.11

1.5

1.3

5.14

20.26

e6/l

1.46

149

384

Abdominal and pelvic pain

1842

5631

1.66

78.29

1.4

1.5

22.58

40.41

e6/l

2.03

1386

4154

Symptoms and signs involving the urinary system

1469

6502

1.73

78.29

1.5

1.4

32.14

35.15

e6/l

0.11

1095

4802

Cystitis

1589

5594

1.71

78.14

1.4

41.94

29.27

e6/l

0.48

1170

4192

Antihypertensive medication - note that there are other indications

1281

3699

1.83

77.41

1.5

23.61

30.62

e6/l

0.41

931

2719

L04AA Selective immunosuppressants

545

2327

2.41

76.68

1.7

1.5

46.42

30.92

e6/l

0.26

415

1676

Disorders of lipoprotein metabolism and other lipidaemias

1508

5385

1.72

76.66

1.3

1.4

29.64

33.48

e6/l

0.20

1031

4031

Hemiplegia

177

386

4.90

76.40

1.6

1.4

7.67

34.68

e6/l

0.97

131

289

L04AX Other immunosuppressants

1161

6507

1.81

76.39

2.1

1.4

28.48

33.53

e6/l

0.18

869

4801

Second line medication for Crohn's disease

1193

6746

1.80

76.01

2.1

1.4

37.96

33.92

e6/l

0.11

896

4976

Other general symptoms and signs

152

288

5.50

75.77

1.8

1.7

10.58

14.90

e6/l

0.36

101

209

Asthma (only as main-diagnosis), excluding more controls

1302

4046

1.80

75.39

1.4

1.3

37.54

26.12

e6/l

0.39

998

2935

Other disorders of eye and adnexa

388

1422

2.83

75.30

1.4

1.5

16.11

29.86

e6/l

1.01

274

1025

Somatoform disorder

401

1498

2.76

74.78

1.3

1.4

16.70

31.90

e6/l

1.04

304

1113

Asthma (only as main-diagnosis)

1321

4189

1.78

74.37

1.4

37.02

25.71

e6/l

0.40

1015

3039

Triptan medication for migraine, single purchase ok

1542

6266

1.69

74.32

1.4

35.28

33.95

e6/l

0.04

1138

4580

Migraine, single triptan purchase ok & required. ICD-code if available is included

1542

6266

1.69

74.32

1.4

35.28

33.95

e6/l

0.04

1138

4580

Invasive ventilation

232

640

3.84

73.01

2.0

1.7

87.09

36.09

e6/l

0.82

181

477

COPD/asthma related infections

1872

5843

1.62

72.63

1.5

1.4

48.97

28.31

e6/l

0.99

1395

4260

COPD/asthma/ILD related infections

1872

5843

1.62

72.63

1.5

1.4

48.97

28.31

e6/l

0.99

1395

4260

Other lack of coordination

106

9.67

72.15

1.4

7.68

22.31

e6/l

0.79

Hypertension

1506

5058

1.70

71.70

1.4

1.5

45.13

30.65

e6/l

0.54

1103

3743

Fall on same level

2199

7641

1.55

71.44

1.4

1.5

27.92

34.26

e6/l

0.35

1610

5663

Hypertensive diseases

1506

5065

1.70

71.39

1.4

1.5

45.44

30.62

e6/l

0.56

1103

3747

Dental caries

558

2327

2.31

71.28

2.2

1.4

47.43

28.14

e6/l

0.37

419

1729

Pure hypercholesterolaemia

1347

4982

1.74

71.27

1.3

1.4

29.60

31.39

e6/l

0.09

931

3729

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

132

143

6.59

69.86

1.2

1.5

30.56

8.78

e6/l

0.72

101

Bipolar affective disorders

438

1767

2.55

69.71

1.3

1.4

15.25

26.91

e6/l

0.63

323

1320

Endovascular or surgical operations to intracerebral aneurysms

186

455

4.33

69.26

2.0

1.2

49.15

47.37

e6/l

0.03

157

332

Symptoms and signs concerning food and fluid intake

223

623

3.69

67.90

1.7

1.4

39.34

14.30

e6/l

0.58

181

447

Unspecified mental disorder

848

4478

1.93

67.84

1.2

1.4

45.64

34.61

e6/l

0.23

615

3303

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

671

3284

2.09

67.08

1.3

1.4

15.60

24.47

e6/l

1.06

484

2429

Exclusions for E4_PCOS_BROAD

442

1831

2.49

66.56

1.5

1.7

61.64

24.02

e6/l

0.61

329

1336

364

1376

2.73

66.43

1.7

1.4

23.72

29.54

e6/l

0.23

249

1026

Somnolence, stupor and coma

134

260

5.47

66.20

1.7

1.6

10.55

65.55

e6/l

1.01

107

197

Caries of dentine

493

2068

2.35

65.72

1.8

1.4

50.98

29.56

e6/l

0.37

375

1526

Diseases of the musculoskeletal system and connective tissue

1035

2817

1.87

65.51

1.7

1.6

25.66

36.25

e6/l

0.51

764

2039

All kidney diseases

1875

8147

1.56

65.33

1.5

1.4

43.69

29.37

e6/l

0.59

1384

6012

Other diseases of spinal cord

112

187

6.50

65.24

2.4

1.1

43.21

40.04

e6/l

0.03

135

Use of hypnotics and sedatives

1992

7440

1.55

65.03

1.4

28.56

33.56

e6/l

0.24

1490

5508

Acute lymphocytic leukaemia, including Hilmo

13.32

64.86

12.6

1.3

8.44

16.50

e6/l

0.32

Acute lymphocytic leukaemia

13.32

64.86

12.6

1.3

8.44

16.50

e6/l

0.32

Acute lymphocytic leukaemia, helper endpoint

13.32

64.86

12.6

1.3

8.44

16.50

e6/l

0.32

2073

6897

1.54

64.57

1.5

1.4

43.16

29.19

e6/l

0.71

1584

5065

Cervicalgia

429

1776

2.47

64.46

1.3

1.4

9.27

34.91

e6/l

1.89

325

1263

Viral infections characterized by skin and mucous membrane lesions

873

4749

1.87

63.53

1.7

1.5

39.61

27.06

e6/l

0.78

660

3493

Diarrhoea and gastroenteritis of presumed infectious origin

1371

7511

1.65

63.53

1.4

1.5

28.36

32.45

e6/l

0.15

1028

5535

Acute upper respiratory infections of multiple and unspecified sites

1470

6661

1.63

62.65

1.5

1.4

17.44

27.89

e6/l

1.48

1118

4861

Endocrine, nutritional and metabolic diseases

1502

4646

1.65

62.57

1.5

22.39

32.91

e6/l

0.83

1091

3453

Non-selective monoamine reuptake inhibitors

631

2962

2.08

62.32

1.4

12.20

38.95

e6/l

3.67

464

2191

Other functional intestinal disorders

915

4593

1.84

62.31

1.4

1.6

12.92

34.13

e6/l

3.84

673

3413

COPD differential diagnosis

1397

4218

1.68

61.91

1.5

1.4

26.35

26.10

e6/l

0.01

1037

3059

Retention of urine

631

2474

2.10

61.90

1.5

1.4

21.23

30.34

e6/l

0.45

486

1875

Intestinal infectious diseases

1795

8714

1.55

61.85

1.5

1.4

27.46

31.93

e6/l

0.22

1352

6424

Bronchitis

2033

8111

1.52

61.72

1.5

1.4

24.95

34.22

e6/l

0.77

1546

5968

Radiculopathy

323

1192

2.78

61.57

1.4

26.24

35.96

e6/l

0.19

249

855

ILD differential diagnosis

1395

4217

1.67

61.53

1.5

1.4

26.39

26.10

e6/l

0.01

1035

3058

Other pulmonary diagnosis

1399

4233

1.67

61.49

1.4

25.52

25.60

e6/l

0.00

1037

3075

Excluding asthma or asthma-COPD overlap

1396

4233

1.67

60.86

1.5

1.4

26.60

25.60

e6/l

0.05

1037

3075

Complications of procedures, not elsewhere classified

1510

7701

1.60

60.51

1.6

1.4

40.80

30.62

e6/l

0.45

1115

5698

Other specific joint derangements/joint disorders

1452

5613

1.63

60.47

1.3

1.5

18.71

30.82

e6/l

1.42

1072

4121

Speech and linguistic disorders, excluding more controls

216

597

3.52

60.11

2.0

2.1

19.23

30.58

e6/l

0.64

162

448

Exposure to unspecified factor

1924

8709

1.52

59.72

1.4

1.5

33.93

31.51

e6/l

0.09

1322

6548

Progressive vascular leukoencephalopathy

113

207

5.79

59.48

1.2

1.3

3.34

77.93

e6/l

1.19

159

Other sleep disorders

246

798

3.18

59.39

1.2

1.4

27.24

33.73

e6/l

0.14

196

583

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1140

6692

1.69

59.16

1.7

1.3

46.26

29.53

e6/l

0.92

846

4988

Non-Hodgkin lymphoma, all

138

303

4.84

59.08

1.7

1.3

74.39

34.20

e6/l

0.42

103

249

Behavioural syndromes associated with physiological disturbances and physical factors

1784

7925

1.54

59.02

1.4

35.37

32.18

e6/l

0.12

1295

5869

All influenza

537

2535

2.16

59.00

1.6

1.5

25.85

22.21

e6/l

0.13

418

1859

Poisoning by medicine

509

2361

2.21

58.79

1.3

1.4

10.90

25.48

e6/l

2.33

359

1734

Diagnoses used for exclusion with ILD

500

2301

2.22

58.69

1.6

1.4

48.33

24.82

e6/l

0.42

380

1722

Renal tubulo-interstitial diseases

1613

7634

1.56

58.29

1.5

1.4

45.60

28.80

e6/l

0.62

1200

5622

Myalgia

509

2366

2.20

58.27

1.3

1.4

16.60

43.37

e6/l

2.18

382

1738

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1894

8081

1.52

58.26

1.4

32.63

31.46

e6/l

0.04

1400

5973

Acute upper respiratory infections

1897

7549

1.52

58.11

1.5

1.4

38.76

29.71

e6/l

0.40

1452

5541

Mental and behavioural disorders due to psychoactive substance use

1139

6269

1.69

57.69

1.4

41.33

34.36

e6/l

0.17

839

4641

Substance abuse

1110

6160

1.70

57.65

1.4

42.27

34.24

e6/l

0.20

819

4561

Nonorganic sleeping disorders

514

2413

2.18

57.59

1.3

1.5

12.91

25.39

e6/l

1.07

357

1783

Spinal stenosis

837

3361

1.86

57.34

1.4

16.83

40.72

e6/l

2.30

650

2438

Focal brain injury

135

6.83

57.33

2.0

1.1

31.27

9.84

e6/l

1.19

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1721

8830

1.53

57.32

1.5

1.4

37.93

30.98

e6/l

0.35

1284

6522

Kela-code for severe mental illness

739

3954

1.90

56.97

1.2

1.4

42.32

29.93

e6/l

0.25

533

2911

Poisoning by drugs, medicaments and biological substances

543

2614

2.13

56.93

1.3

1.4

12.48

24.15

e6/l

1.75

387

1920

Third [oculomotor] nerve palsy

143

7.16

56.80

1.4

1.3

14.79

15.71

e6/l

0.04

107

Shoulder lesions

1341

4958

1.64

56.60

1.4

19.04

38.45

e6/l

2.19

1042

3654

Sleep disorders

1714

7763

1.54

56.50

1.3

1.4

36.18

32.47

e6/l

0.14

1244

5750

Asthma-related infections

1135

6697

1.67

56.45

1.4

1.5

40.92

29.00

e6/l

0.33

865

4942

Asthma, hospital admission 2, infections

1135

6697

1.67

56.45

1.4

1.5

40.92

29.00

e6/l

0.33

865

4942

Brain meningioma, including Hilmo

167

440

4.03

56.37

1.8

1.3

99.41

19.23

e6/l

1.31

129

333

Cluster headache, strict

113

218

5.50

56.25

1.4

1.2

4.04

14.29

e6/l

1.47

165

Constipation

1627

7185

1.55

55.70

1.5

35.82

31.46

e6/l

0.14

1180

5345

Intestinal infectious diseases, including avohilmo, including avohilmo

2102

7984

1.48

55.67

1.4

33.82

32.57

e6/l

0.05

1551

5912

Ocular pain

245

827

3.09

55.66

1.4

1.6

15.96

28.31

e6/l

0.61

178

608

Brain meningioma

163

429

4.04

55.13

1.8

1.3

102.13

19.76

e6/l

1.30

125

323

Disorders of adult personality and behaviour

632

3258

1.98

54.69

1.3

1.4

7.61

28.33

e6/l

5.62

456

2410

Benign neoplasm of brain and other parts of central nervous system

190

558

3.59

54.51

2.0

1.5

45.64

40.45

e6/l

0.08

140

406

Hypothyroidism, drug reimbursement

251

572

3.13

54.20

1.4

1.2

84.43

8.52

e6/l

0.94

183

450

Narcolepsy and cataplexy

17.52

54.09

1.1

1.5

2.26

11.30

e6/l

0.56

Herpesviral [herpes simplex] infections

291

1097

2.75

53.61

1.6

1.5

69.98

24.19

e6/l

1.42

230

801

Acute sinusitis

1023

5541

1.70

53.52

1.4

57.79

29.81

e6/l

0.85

775

4033

Post-traumatic stress disorder

236

797

3.07

53.40

1.3

1.4

32.81

22.68

e6/l

0.16

168

591

Fibromyalgia

233

782

3.09

53.27

1.2

1.3

7.50

35.15

e6/l

2.09

171

566

Other disorders of lacrimal gland

723

3928

1.87

53.15

1.4

28.86

35.90

e6/l

0.28

559

2887

Acute tubulo-interstitial nephritis

1163

6038

1.64

53.08

1.5

46.90

28.12

e6/l

0.62

880

4482

Follow-up examination after treatment for conditions other than malignant neoplasms

723

2550

1.91

52.93

1.3

1.4

19.89

33.38

e6/l

0.97

502

1799

Disorders of other endocrine glands

859

4840

1.77

52.74

1.5

40.23

30.62

e6/l

0.24

630

3576

severe traumatic brain injury, does not include concussion

423

1902

2.27

52.62

1.7

1.3

28.43

25.70

e6/l

0.09

306

1415

Personality disorders

597

3060

1.99

52.58

1.3

1.4

7.75

28.44

e6/l

5.07

431

2262

Sixth [abducent] nerve palsy

123

272

4.88

52.56

1.5

1.6

125.21

67.50

e6/l

0.26

202

Other diseases of intestines

1970

7482

1.48

52.36

1.4

1.5

26.37

35.03

e6/l

0.47

1430

5568

Schizophrenia, schizotypal and delusional disorders

652

3446

1.93

52.30

1.3

1.4

46.70

29.79

e6/l

0.31

465

2535

Psychotic depression

133

311

4.43

52.23

1.4

1.5

6.24

48.52

e6/l

1.29

237

Certain disorders involving the immune mechanism

413

1850

2.29

52.11

2.5

1.5

71.48

25.20

e6/l

0.57

310

1355

Other CVD (FINNGEN)

249

644

3.04

52.04

1.7

1.3

48.44

14.54

e6/l

0.62

188

474

Cluster headache, wide

115

241

5.04

52.04

1.4

1.2

4.63

13.78

e6/l

1.36

182

Factors influencing health status and contact with health services

479

1065

2.29

51.90

1.5

1.3

30.17

30.18

e6/l

0.00

353

758

Schizophrenia or delusion

649

3437

1.92

51.76

1.3

1.4

46.89

29.90

e6/l

0.31

463

2525

Persons encountering health services in other circumstances

788

4379

1.81

51.68

1.5

22.54

38.81

e6/l

1.24

569

3281

884

5097

1.75

51.50

1.5

48.18

29.34

e6/l

0.44

684

3737

Rare circulating lymphoid malignancy, including Hilmo

113

237

5.17

51.49

9.9

1.3

10.18

41.72

e6/l

0.69

194

Sleep disorders (combined)

1955

6956

1.48

51.49

1.4

30.94

33.34

e6/l

0.10

1438

5181

Visual field defects

209

673

3.23

51.43

1.7

1.4

74.50

32.68

e6/l

0.37

168

504

Dementia in other diseases classified elsewhere

119

259

4.83

51.37

1.2

1.3

2.68

75.62

e6/l

1.47

189

Urinary track infection

1099

3280

1.70

51.08

1.4

49.92

29.61

e6/l

0.56

804

2448

Alcohol abuse, main dg, excluding more controls

284

1083

2.69

50.83

1.3

1.4

53.86

35.23

e6/l

0.16

208

825

Other and unspecified nonorganic psychotic disorders

445

2075

2.20

50.80

1.2

1.4

45.09

27.11

e6/l

0.25

318

1539

Dissociative [conversion] disorders

130

309

4.47

50.46

1.2

1.6

13.51

12.79

e6/l

0.03

101

226

Triptan medication for migraine, min. 3 purchases

1133

5222

1.64

50.30

1.4

34.88

32.51

e6/l

0.05

847

3811

Mental and behavioural disorders due to alcohol

949

5381

1.70

50.24

1.3

1.4

30.98

32.47

e6/l

0.04

704

3987

Dyspnoea

1626

7854

1.51

49.81

1.4

1.5

23.67

33.15

e6/l

0.53

1258

5750

Complications of other internal prosthetic devices, implants and grafts

133

325

4.35

49.79

2.9

1.4

15.76

41.33

e6/l

0.62

105

246

Falls/tendency to fall

1917

6550

1.48

49.72

1.4

1.5

28.99

34.91

e6/l

0.28

1400

4865

Disorders of eyelid, lacrimal system and orbit

1564

7623

1.52

49.48

1.5

1.4

24.91

33.45

e6/l

0.69

1154

5650

Other heart diseases

860

3191

1.77

49.40

1.4

1.5

60.56

25.21

e6/l

1.07

640

2323

Other medical care

847

4102

1.76

49.18

1.6

1.4

46.51

25.42

e6/l

0.94

617

3016

Brain glioblastoma and astrocytoma

138

6.67

48.91

1.8

1.2

49.66

34.45

e6/l

0.21

107

Other viral diseases, including avohilmo

791

4480

1.78

48.90

1.7

1.5

31.46

30.23

e6/l

0.04

574

3286

Specific personality disorders

519

2603

2.04

48.73

1.3

1.4

8.50

26.00

e6/l

4.20

382

1917

Any operation in hilmo

20.82

48.71

1.3

1.0

20.98

61.33

e6/l

—

Hyperkinetic disorders, excluding more controls

288

1047

2.63

48.67

1.4

1.7

11.01

23.07

e6/l

2.04

201

786

Other acute disseminated demyelination

8.79

48.66

1.3

1.2

153.03

14.67

e6/l

0.47

Alzheimer’s disease (Atypical or mixed)

184

557

3.34

48.54

1.3

21.79

40.31

e6/l

0.37

154

433

Mental and behavioural disorders due to alcohol, excluding acute intoxication

821

4718

1.75

48.31

1.3

1.4

34.90

32.33

e6/l

0.06

611

3467

Systemic connective tissue disorders

646

3492

1.88

48.30

1.3

1.4

31.45

31.58

e6/l

0.00

480

2590

Diseases of the myoneural junction and muscle

276

1068

2.67

48.26

1.7

1.5

12.50

26.80

e6/l

0.90

219

786

Neoplasms

1468

5011

1.55

48.23

2.0

1.3

30.41

25.96

e6/l

0.23

1066

3752

Cervical disc disorders

615

3277

1.91

47.99

1.5

1.4

26.55

37.40

e6/l

0.43

486

2352

Asthma (diagnoses ohter than nonallergic)

1599

8713

1.50

47.99

1.4

1.5

44.43

28.03

e6/l

0.62

1193

6439

Alcohol use disorder, Swedish definition

996

5513

1.66

47.98

1.3

1.4

31.28

32.91

e6/l

0.04

739

4075

Oxycodone

691

3247

1.84

47.55

1.6

1.4

20.81

33.75

e6/l

0.96

536

2431

Cervicocranial syndrome

238

862

2.84

47.30

1.3

1.4

11.26

25.10

e6/l

0.85

184

615

Paraplegia, diplegia of upper limbs

164

5.94

47.05

1.9

1.5

31.38

15.11

e6/l

0.43

121

Other diseases of blood and blood-forming organs, wide

444

2139

2.12

46.57

2.3

1.5

37.08

26.60

e6/l

0.15

350

1559

1098

6001

1.61

46.25

1.3

1.4

28.74

34.76

e6/l

0.19

813

4454

Pain in thoracic spine

309

1285

2.46

46.20

1.3

1.4

11.48

34.66

e6/l

1.18

246

909

Frontotemporal dementia, wide, incl. Pick's disease

13.90

46.06

1.1

1.2

1.97

21.10

e6/l

0.53

1049

5836

1.62

46.00

1.3

1.4

29.32

32.31

e6/l

0.08

773

4334

Other complications of surgical and medical care, not elsewhere classified

241

897

2.78

45.64

1.5

1.4

33.07

27.37

e6/l

0.14

190

663

Unknown and unspecified causes of morbidity

139

373

3.84

45.26

1.3

1.4

22.70

11.62

e6/l

0.47

113

274

Unspecified fall

939

5631

1.66

45.24

1.4

1.5

23.69

32.20

e6/l

0.48

677

4181

Encephalopathy

9.78

45.00

1.8

1.6

3.31

19.49

e6/l

0.87

Insomnia

1632

7755

1.48

44.98

1.3

1.4

37.81

32.60

e6/l

0.20

1178

5746

Any death

1074

4687

1.62

44.98

1.7

1.4

56.41

29.57

e6/l

1.02

838

3419

Benign neoplasm: Pituitary gland, craniopharyngeal duct

159

473

3.55

44.86

1.5

1.4

140.88

44.43

e6/l

0.53

116

353

Other viral diseases

611

3318

1.87

44.61

1.8

1.5

31.71

24.01

e6/l

0.28

456

2425

Suicide or other Intentional self-harm

512

2639

1.98

44.47

1.3

1.4

12.00

24.04

e6/l

1.87

356

1944

Disorders of lacrimal system

813

4732

1.71

44.41

1.5

1.4

28.99

36.15

e6/l

0.33

630

3500

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1017

6370

1.61

43.94

1.7

1.4

50.06

29.86

e6/l

1.05

756

4746

Disorders of vestibular function (Vertigo)

819

4742

1.70

43.88

1.3

1.4

27.56

36.58

e6/l

0.36

616

3505

Alcohol use disorder, ICD-based

754

4396

1.74

43.66

1.3

1.4

35.81

29.87

e6/l

0.13

557

3218

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

586

3136

1.88

43.64

2.4

1.4

12.65

33.28

e6/l

2.43

433

2316

Zoster [herpes zoster]

362

1654

2.24

43.50

1.8

1.4

18.49

23.04

e6/l

0.33

271

1228

Frontotemporal dementia

14.39

43.48

1.1

1.2

2.07

21.86

e6/l

0.53

Gastrointestinal diseases

1097

3419

1.62

43.31

1.7

1.4

19.04

38.90

e6/l

1.68

811

2554

Secondary parkinsonism+Parkinsonism in other disease

185

5.27

42.91

1.3

1.2

4.24

60.27

e6/l

0.99

139

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

650

3656

1.81

42.80

1.5

80.30

27.20

e6/l

1.12

472

2684

Secondary parkinsonism

185

5.21

41.92

1.3

4.30

60.92

e6/l

1.00

138

Diseases of oesophagus, stomach and duodenum

1876

7832

1.42

41.68

1.3

1.5

32.67

33.87

e6/l

0.04

1395

5793

Generalized anxiety disorder

358

1657

2.21

41.52

1.2

1.4

13.85

32.17

e6/l

1.94

254

1228

Rotator cuff syndrome

1038

4511

1.60

41.28

1.3

1.4

31.12

37.64

e6/l

0.20

810

3336

Herpesviral [herpes simplex] infections, including avohilmo

531

2852

1.90

40.73

1.5

1.4

50.45

24.63

e6/l

1.25

408

2110

Other joint disorders

1593

5716

1.46

40.06

1.3

1.5

24.58

30.60

e6/l

0.28

1194

4200

Hypotension

301

1318

2.33

40.03

1.6

1.4

40.01

29.15

e6/l

0.19

232

981

Asthma, including avohilmo

2087

8320

1.39

39.90

1.4

1.5

41.45

29.55

e6/l

0.48

1540

6155

Injuries to the abdomen, lower back, lumbar spine and pelvis

731

4268

1.71

39.83

1.5

1.4

18.00

29.81

e6/l

1.00

533

3178

Other intracranial haemorrhages

181

5.08

39.79

2.4

1.3

44.72

62.08

e6/l

0.16

133

Diseases of the ear and mastoid process

2024

7287

1.40

39.77

1.4

49.79

27.12

e6/l

1.13

1500

5367

Brachial plexus disorders

221

845

2.70

39.74

1.2

1.4

11.02

28.21

e6/l

1.01

175

602

Superficial injury of head

452

2317

1.98

39.69

1.6

1.5

15.90

26.94

e6/l

1.05

325

1727

Use of levodopa decarboxylase inhibitor

258

1065

2.48

39.36

1.4

1.3

3.95

32.55

e6/l

2.69

203

786

Diseases of inner ear

919

5534

1.61

39.13

1.3

1.4

27.27

34.67

e6/l

0.33

691

4087

Finngen Rheumatological endpoints

1718

6858

1.43

39.11

1.4

34.05

31.69

e6/l

0.09

1256

5066

Panic disorder

319

1451

2.25

38.86

1.3

1.4

15.19

28.54

e6/l

0.79

232

1083

Accidents

1380

4643

1.50

38.85

1.4

1.5

22.30

37.00

e6/l

1.20

988

3484

Use of galantamine

154

490

3.24

38.63

1.2

1.3

3.53

41.81

e6/l

1.58

105

379

Lymphoid leukaemia

143

437

3.43

38.60

8.2

1.4

47.32

34.28

e6/l

0.12

112

324

Other external causes of accidental injury

1378

4643

1.50

38.53

1.4

1.5

22.36

37.00

e6/l

1.19

989

3484

Osteopathies and chondropathies

986

5779

1.58

38.49

1.6

1.4

21.54

35.14

e6/l

1.27

733

4273

Use of peginterferon beta-1a

13.99

38.35

1.1

13.33

20.36

e6/l

0.15

Other acute lower respiratory infections

946

5737

1.59

38.28

1.5

27.45

32.89

e6/l

0.24

715

4248

Polyuria

402

2013

2.03

37.97

1.4

32.00

26.06

e6/l

0.14

300

1507

Hypopituitarism

198

735

2.80

37.91

1.6

2.1

49.09

24.07

e6/l

0.42

162

535

Other disorders of binocular movement

194

4.91

37.89

1.6

172.14

18.19

e6/l

0.50

140

Other symptoms and signs involving general sensations and perceptions

103

255

4.22

37.79

1.2

1.6

17.18

66.36

e6/l

0.80

189

Asthma, hospital admissions 3, pneumonia

628

3627

1.75

37.19

1.6

1.5

18.91

27.17

e6/l

0.72

474

2702

Asthma-related pneumonia or sepsis

628

3627

1.75

37.19

1.6

1.5

18.91

27.17

e6/l

0.72

474

2702

Postviral fatigue syndrome

8.82

37.12

1.2

1.8

1.03

16.52

e6/l

0.79

Asthma-related pneumonia

626

3619

1.75

36.95

1.6

1.5

18.95

27.23

e6/l

0.72

473

2695

Diseases of the respiratory system

1073

3460

1.57

36.81

1.5

1.4

33.81

24.96

e6/l

0.41

794

2509

Sequelae of external causes of morbidity and mortality

472

2530

1.90

36.47

1.6

1.4

75.55

32.19

e6/l

0.61

338

1855

Fungal Sepsis

110

294

3.92

36.38

1.7

1.3

3.87

22.88

e6/l

1.00

227

Vascular dementia

139

415

3.29

35.97

1.4

1.3

6.35

49.58

e6/l

1.46

100

322

Persistent mood disorders

349

1696

2.10

35.82

1.3

1.4

25.20

34.84

e6/l

0.29

244

1272

Other CVD

332

1584

2.13

35.73

1.6

1.4

38.94

27.45

e6/l

0.22

253

1187

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

210

826

2.63

35.72

1.4

8.41

25.23

e6/l

1.12

156

621

Other spirochaetal diseases, including avohilmo

621

3635

1.73

35.65

1.2

1.4

36.24

38.86

e6/l

0.09

429

2675

Other spirochaetal diseases

615

3593

1.74

35.56

1.3

1.4

36.54

39.25

e6/l

0.09

424

2646

Spirochaetal infections, other/unspecified, including avohilmo

612

3576

1.74

35.37

1.2

1.4

35.82

38.93

e6/l

0.11

422

2632

Lyme disease

609

3559

1.74

35.19

1.3

1.4

36.05

39.05

e6/l

0.10

419

2621

Lyme disease, including avohilmo

609

3559

1.74

35.19

1.3

1.4

36.05

39.05

e6/l

0.10

419

2621

Genitourinary diseases

984

3147

1.58

35.16

1.6

36.36

31.19

e6/l

0.16

727

2348

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

357

1766

2.07

35.09

1.3

1.4

11.31

27.24

e6/l

1.76

244

1307

Other strabismus

440

2328

1.92

35.03

1.6

15.71

24.89

e6/l

0.92

336

1700

Phobic anxiety disorders

287

1303

2.25

34.96

1.4

1.5

13.89

32.10

e6/l

1.45

212

965

Panhypopituitarism

129

5.75

34.88

1.9

1.6

39.24

47.91

e6/l

0.07

Sarcoidosis

274

1227

2.29

34.86

1.6

1.4

57.91

29.29

e6/l

0.27

206

903

External causes of morbidity and mortality

1105

3639

1.53

34.56

1.5

1.4

26.77

39.28

e6/l

0.68

777

2714

Other viral diseases, not elsewhere classified, including avohilmo

540

3047

1.79

34.54

1.8

1.6

28.62

26.43

e6/l

0.08

389

2248

Agranulocytosis

240

1020

2.42

34.54

2.6

1.4

59.64

33.58

e6/l

0.22

194

745

ILD medications: azathioprine

296

1372

2.21

34.49

1.6

1.4

54.28

28.33

e6/l

0.29

223

998

Other and unspecified mood [affective] disorders

168

602

2.88

34.29

1.5

27.37

23.04

e6/l

0.14

115

454

Abnormalities of heart beat

616

3524

1.72

34.07

1.3

1.4

11.70

41.33

e6/l

4.30

466

2590

Sleep apnoea

1604

7239

1.41

33.78

1.4

23.25

35.98

e6/l

1.45

1192

5332

Other disorders of bladder

219

901

2.49

33.74

1.4

1.3

14.05

27.84

e6/l

0.73

172

672

Open wound of head

907

5529

1.56

33.73

1.5

17.59

32.15

e6/l

1.68

668

4126

Hypokalaemia

228

956

2.44

33.67

1.7

1.4

66.28

27.80

e6/l

0.31

174

732

Implicit fungal Sepsis

103

278

3.89

33.64

1.6

1.3

3.83

23.77

e6/l

1.00

217

Other degenerative diseases of the basal ganglia

141

5.42

33.64

1.3

2.18

71.29

e6/l

0.93

107

Brain glioblastoma

105

6.29

33.61

1.7

1.2

43.11

39.16

e6/l

0.04

Chronic lower respiratory diseases

2101

8238

1.35

33.51

1.4

1.5

34.53

31.47

e6/l

0.11

1559

6078

Other systemic involvement of connective tissue (FG)

451

2403

1.87

33.37

1.3

1.4

14.02

32.28

e6/l

1.45

329

1789

Persons encountering health services for specific procedures, not carried out

197

777

2.61

33.31

1.3

1.5

33.39

18.59

e6/l

0.30

118

560

Abnormal findings on examination of blood, without diagnosis

778

4425

1.61

33.20

1.4

59.52

25.67

e6/l

0.82

564

3298

Injuries to the neck

456

2495

1.86

33.11

1.3

1.4

11.36

24.61

e6/l

2.03

355

1835

Other disorders of nervous system

141

468

3.12

33.08

1.8

1.2

15.71

37.83

e6/l

0.57

101

336

Benign neoplasm of other and unspecified endocrine glands

270

1229

2.25

33.03

1.4

91.22

27.56

e6/l

0.57

184

897

Undetermined asthma, excluding more controls

247

1081

2.33

32.96

1.5

1.3

71.21

20.39

e6/l

0.47

183

779

Other and unspecified nerve root and plexus disorders, also in other diseases

385

1999

1.96

32.86

1.3

1.4

46.65

28.30

e6/l

0.25

307

1427

Emotionally unstable personality disorder

281

1303

2.21

32.84

1.2

1.4

10.12

20.59

e6/l

2.07

201

954

Cardiac arrhythmias

997

4204

1.53

32.73

1.3

1.4

39.91

32.48

e6/l

0.25

738

3034

Abnormal findings in cerebrospinal fluid

15.13

32.67

1.8

1.3

506.38

22.80

e6/l

0.72

Pneumonitis due to solids and liquids

167

612

2.81

32.64

1.5

37.18

35.94

e6/l

0.02

130

465

Injuries to the thorax

768

4851

1.60

32.48

1.3

1.4

20.58

29.27

e6/l

0.48

571

3599

Undetermined asthma

247

1088

2.32

32.48

1.5

1.3

71.21

20.26

e6/l

0.47

183

792

Hypothyroidism, strict autoimmune

1144

5094

1.48

32.44

1.3

1.4

17.36

31.64

e6/l

2.36

857

3750

Use of glatiramer acetate

142

5.32

32.39

1.2

1.6

8.08

9.60

e6/l

0.12

105

Other necrotizing vasculopathies (FG)

135

443

3.16

32.36

1.3

1.4

100.05

24.38

e6/l

0.42

100

328

Brain glioblastoma, helper endpoint

109

6.06

32.34

1.7

1.2

43.11

13.36

e6/l

0.67

Bacterial pneumonia, not elsewhere classified

631

3327

1.68

32.18

1.7

1.4

24.45

24.82

e6/l

0.02

474

2463

Speech and linguistic disorders

225

922

2.41

31.76

2.0

2.1

18.78

20.31

e6/l

0.08

166

663

Sleep apnoea, including avohilmo

1688

7442

1.38

31.66

1.4

32.59

33.15

e6/l

0.02

1265

5494

Obesity related asthma

621

3754

1.68

31.64

1.4

75.79

29.95

e6/l

0.78

484

2768

Parkinson's disease, including avohilmo

269

1247

2.20

31.35

1.4

1.3

3.92

30.53

e6/l

2.95

213

909

Other viral diseases, not elsewhere classified

376

1963

1.95

31.34

2.0

1.6

26.65

21.15

e6/l

0.21

279

1443

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

716

2778

1.64

31.18

1.5

1.3

29.80

21.11

e6/l

0.34

540

2017

Other and unspecified types of non-Hodgkin lymphoma, hilmo

107

313

3.59

31.07

1.7

1.3

13.91

56.35

e6/l

0.89

234

Asthma, hospital admissions , main diagnosis only

1408

8780

1.41

31.02

1.4

1.5

35.25

31.09

e6/l

0.13

1087

6436

Disorders of sclera, cornea, iris and ciliary body

955

6399

1.51

31.02

1.4

34.85

29.64

e6/l

0.23

720

4729

Other and unspecified anaemias

669

3874

1.64

31.02

1.8

1.4

49.34

27.21

e6/l

0.41

485

2910

Arthropathies

1577

5738

1.40

30.84

1.4

1.5

24.66

30.56

e6/l

0.42

1151

4213

Diffuse brain injury

6.58

30.80

2.0

1.2

19.09

13.53

e6/l

0.21

Other and unspecified drugs and medicaments

193

785

2.54

30.70

1.4

1.5

8.86

36.06

e6/l

1.49

145

572

Dental pulpitis, including avohilmo

1631

7628

1.38

30.68

1.3

1.4

28.55

32.75

e6/l

0.17

1175

5635

Optic atrophy

137

5.23

30.61

1.9

1.8

21.83

17.38

e6/l

0.10

103

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

459

2233

1.82

30.57

1.7

16.83

19.34

e6/l

0.24

335

1638

Other anaemias

672

3902

1.63

30.44

1.8

1.4

49.19

27.08

e6/l

0.41

487

2930

Bacterial pneumoniae

660

3572

1.64

30.39

1.7

1.4

25.34

25.63

e6/l

0.01

496

2629

Other symptoms and signs involving the urinary system

211

897

2.42

30.36

1.7

1.5

23.77

23.58

e6/l

0.01

154

665

Dementia due to Parkinsons disease, excluding more controls

11.82

30.15

1.3

1.1

1.74

25.89

e6/l

0.58

Optic atrophy, wide definition

139

5.13

30.07

1.9

1.8

21.83

16.64

e6/l

0.12

107

Persons with potential health hazards related to communicable diseases

710

4467

1.59

29.58

1.6

1.5

38.41

27.22

e6/l

0.27

493

3288

Disorders of psychological development

277

1229

2.14

29.49

1.8

1.9

16.17

20.36

e6/l

0.32

206

888

Chronic sinusitis

743

4768

1.57

29.36

1.4

46.07

34.99

e6/l

0.24

537

3487

Acute bronchitis

684

4229

1.60

29.24

1.5

29.02

27.45

e6/l

0.05

513

3137

Any event in cancer register

1574

6709

1.38

29.23

2.0

1.3

61.12

24.45

e6/l

1.59

1116

5028

Azathioprine

296

1464

2.07

29.18

1.6

1.4

54.28

23.62

e6/l

0.36

223

1063

Aplastic and other anaemias

714

4152

1.59

29.16

1.7

1.4

46.80

25.78

e6/l

0.42

521

3110

Other systemic involvement of connective tissue

459

2616

1.78

29.08

1.3

1.4

13.79

32.64

e6/l

1.60

335

1935

Viral pneumonia

251

1168

2.20

29.06

1.5

48.51

16.73

e6/l

0.72

201

845

Trigeminal neuralgia

138

488

2.93

29.03

1.4

111.27

26.15

e6/l

0.47

348

Coagulation defects, purpura and other haemorrhagic conditions

360

1907

1.92

29.03

2.1

1.5

36.60

24.73

e6/l

0.26

278

1393

Type 2 diabetes, wide definition

1294

5785

1.42

28.97

1.4

36.80

37.17

e6/l

0.01

963

4281

Other bacterial intestinal infections, including avohilmo

403

2213

1.85

28.93

1.6

1.4

19.01

24.61

e6/l

0.27

284

1633

Vocal cord dysfunction

229

895

2.29

28.85

1.4

40.06

25.83

e6/l

0.23

165

669

Other infectious diseases, including avohilmo

186

765

2.50

28.85

1.5

1.4

13.59

33.47

e6/l

0.92

141

571

Other and unspecified myopathies

175

700

2.57

28.80

1.8

1.5

12.75

34.37

e6/l

0.97

142

523

Other metabolic disorders

258

1220

2.16

28.68

1.6

1.4

81.79

28.02

e6/l

0.61

192

921

Injury, poisoning and certain other consequences of external causes

872

2849

1.55

28.44

1.5

1.4

28.65

43.50

e6/l

0.64

627

2066

Volume depletion

168

663

2.59

28.32

1.5

27.67

23.54

e6/l

0.07

133

512

Cluster headache, strict, including avohilmo

129

447

3.01

28.25

1.4

3.63

14.68

e6/l

2.39

332

Bacterial pneumonia (organism specified)

710

4112

1.58

28.19

1.7

1.4

33.54

29.91

e6/l

0.12

536

3050

Neuralgia and neuritis, unspecified

123

415

3.08

28.18

1.7

1.4

9.00

50.07

e6/l

1.25

306

Dermatitis

1068

7285

1.45

28.09

1.5

1.4

25.01

31.32

e6/l

0.45

803

5371

Other bacterial intestinal infections

311

1589

1.99

27.90

1.7

1.4

21.60

25.81

e6/l

0.15

228

1166

Benign paroxysmal vertigo

482

2827

1.73

27.61

1.4

28.47

32.55

e6/l

0.10

368

2080

Benign neoplasm: Brain, supratentorial

126

5.17

27.50

2.2

1.7

15.32

16.33

e6/l

0.03

Infections of the skin and subcutaneous tissue

1023

6995

1.45

27.49

1.8

1.4

32.41

34.27

e6/l

0.05

769

5137

Other and unspecified dermatitis

905

6149

1.49

27.48

1.5

1.4

23.93

31.55

e6/l

0.55

674

4531

Polyarthropathies

1111

4975

1.45

27.41

1.4

1.5

35.10

32.64

e6/l

0.07

824

3655

Transport accidents

789

4314

1.54

27.41

1.3

1.4

14.65

36.38

e6/l

2.74

589

3233

Zoster [herpes zoster], including avohilmo

838

5412

1.51

27.28

1.5

1.4

21.99

32.98

e6/l

0.90

616

4004

Cramp and spasm

125

435

3.00

27.22

1.5

12.77

34.81

e6/l

0.75

322

Secondary and unspecified malignant neoplasm of lymph nodes

175

720

2.50

27.18

1.8

1.3

80.95

27.35

e6/l

0.55

125

536

Other and unspecified effects of external causes

518

3112

1.69

27.16

1.3

1.6

15.60

23.42

e6/l

0.89

373

2284

Hyperlipidaemia, other/unspecified

572

3157

1.65

26.93

1.3

1.4

31.16

31.51

e6/l

0.01

420

2407

Hypothyreosis and Thyroxine purchase for inclusion criteria

1518

7336

1.36

26.91

1.4

43.59

28.35

e6/l

0.63

1132

5414

Other necrotizing vasculopathies

151

583

2.68

26.84

1.3

1.4

93.17

37.37

e6/l

0.32

110

427

Other/unspecified cytomegaloviral diseases

157

4.59

26.80

2.4

1.3

3.64

15.26

e6/l

1.08

114

Other infectious diseases

156

616

2.61

26.45

1.5

15.52

37.14

e6/l

0.78

118

460

Intracranial and intraspinal abscess and granuloma

6.38

26.27

2.7

1.2

569.60

13.05

e6/l

1.26

Rheumatism, unspecified

238

1130

2.15

26.21

1.3

1.4

19.33

46.12

e6/l

1.08

174

818

Cluster headache, wide,, including avohilmo

131

477

2.85

26.20

1.4

4.14

17.41

e6/l

2.76

352

Irritable bowel syndrome

492

2944

1.69

26.19

1.2

1.4

11.36

34.56

e6/l

2.84

356

2182

Cough

672

4036

1.57

26.13

1.7

1.5

16.71

39.12

e6/l

2.70

499

2947

Substance use, excluding alcohol

371

2055

1.84

26.03

1.5

1.4

60.05

26.82

e6/l

0.47

256

1517

Hypothyroidism, other/unspecified

1461

7089

1.36

25.90

1.3

1.4

44.55

28.89

e6/l

0.62

1089

5221

Coxibs

425

1239

1.82

25.71

1.3

1.5

12.99

50.32

e6/l

2.67

305

946

Other problems related to primary support group, including family circumstances

248

1172

2.11

25.68

4.0

1.5

12.48

23.25

e6/l

0.87

193

845

Functional dyspepsia

467

2773

1.71

25.61

1.4

12.13

26.76

e6/l

2.26

350

2060

Other disorders of ear

1520

7306

1.35

25.55

1.5

1.4

54.21

29.10

e6/l

0.97

1150

5370

Other and unspecified paralytic syndromes

103

5.47

25.46

1.3

1.2

4.75

12.96

e6/l

0.58

Injuries to the ankle and foot

1277

7960

1.38

25.36

1.4

43.98

31.19

e6/l

0.38

926

5867

Sequelae with surgical and medical care as external cause

348

1907

1.86

25.30

1.7

1.4

92.66

26.35

e6/l

0.75

254

1401

Cytomegalovirus infection, IBD co-morbidity

177

4.21

25.28

2.4

1.2

80.35

13.78

e6/l

0.41

129

Specific development disorders of speech and language

155

601

2.57

25.21

1.9

2.4

23.20

13.94

e6/l

0.49

112

422

Drug-induced neutropenia

158

645

2.53

25.09

2.1

1.4

12.83

39.17

e6/l

1.09

134

460

Irregular menses

864

4417

1.48

25.01

1.4

36.06

30.08

e6/l

0.16

650

3221

Dislocation, sprain and strain of joints and ligaments at neck level

313

1668

1.91

24.94

1.3

1.4

12.36

27.20

e6/l

1.45

248

1226

Thrombocytopenia, unspecified

154

623

2.55

24.88

2.7

1.5

53.04

36.60

e6/l

0.14

120

461

Other shoulder lesions

188

830

2.32

24.87

1.4

21.30

39.87

e6/l

0.73

137

600

Unspecified/other endometriosis

200

887

2.26

24.82

1.3

9.95

16.46

e6/l

0.75

140

671

Diabetes insipidus

6.38

24.79

1.9

1.2

317.03

15.33

e6/l

0.48

Disorders of the thyroid gland

1548

7532

1.34

24.61

1.3

1.4

43.24

30.14

e6/l

0.52

1163

5551

Dermatitis and eczema

1877

8554

1.31

24.43

1.4

33.39

32.04

e6/l

0.06

1396

6326

Cytomegaloviral disease

182

4.08

24.32

2.4

1.3

80.35

12.33

e6/l

0.42

133

Leukaemia of unspecified cell type

6.68

24.32

7.6

1.3

1.52

15.04

e6/l

0.70

Fracture of rib(s), sternum and thoracic spine

489

2980

1.66

24.28

1.4

15.40

28.55

e6/l

0.96

372

2214

Cytomegaloviral disease, including avohilmo

187

4.03

24.23

2.3

1.5

79.05

12.21

e6/l

0.42

136

Temporomandibular joint disorders, including avohilmo

808

5332

1.48

24.19

1.4

35.80

31.32

e6/l

0.10

601

3929

Chronic apical periodontitis

1853

7986

1.31

24.17

1.4

48.84

27.58

e6/l

0.89

1329

5968

Monoplegia

124

4.88

24.11

1.3

5.51

16.61

e6/l

0.75

Lesion of lateral popliteal nerve

113

399

2.94

23.95

1.2

1.4

58.77

26.11

e6/l

0.29

292

Other arthritis (FG)

522

3246

1.63

23.91

1.3

1.4

69.73

36.03

e6/l

0.50

383

2401

Voice disturbances

445

2662

1.70

23.80

1.3

1.4

24.03

34.28

e6/l

0.30

318

1950

Fracture of skull and facial bones

375

2142

1.78

23.73

1.5

1.4

22.30

31.27

e6/l

0.61

260

1590

199

3.87

23.70

1.4

1.5

18.55

14.90

e6/l

0.11

148

Restless leg syndrome

267

1375

1.98

23.61

1.3

1.4

9.05

31.58

e6/l

2.48

182

1021

Other specified/unspecified arthritis

461

2789

1.67

23.59

1.3

1.5

77.13

37.17

e6/l

0.54

340

2055

Other nutritional deficiencies

1151

7657

1.38

23.44

1.3

1.4

65.70

27.44

e6/l

1.18

841

5630

Inflammatory diseases of female pelvic organs

1050

5121

1.41

23.35

1.3

1.4

18.72

37.59

e6/l

1.64

771

3772

Fall on and from stairs and steps

453

2746

1.67

23.05

1.3

1.5

29.91

30.96

e6/l

0.03

315

2042

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

102

349

3.03

22.88

1.4

1.3

73.84

33.64

e6/l

0.28

265

Immunodeficiency with predominantly antibody defects

219

3.67

22.77

2.5

1.6

17.80

17.76

e6/l

0.00

161

Postprocedural endocrine and metabolic disorders, not elsewhere classified

227

1118

2.07

22.77

1.6

1.3

91.12

29.73

e6/l

0.60

166

848

Osteoporosis

398

2140

1.73

22.76

1.7

1.4

27.76

33.51

e6/l

0.17

291

1605

Iridocyclitis

384

2237

1.74

22.70

1.3

1.4

28.61

19.29

e6/l

0.27

283

1623

Diseases of pulp and periapical tissues, including avohilmo

1696

6708

1.31

22.65

1.4

1.5

18.92

29.42

e6/l

1.47

1235

5019

Lung diseases due to external agents

218

1059

2.09

22.63

1.6

1.4

31.28

27.18

e6/l

0.08

165

794

Fracture of lumbar spine and pelvis

343

1932

1.79

22.55

1.5

1.4

22.16

28.40

e6/l

0.22

249

1451

Sequelae of injuries, of poisoning and of other consequences of external causes

413

2462

1.70

22.45

1.6

1.4

49.98

28.24

e6/l

0.34

311

1793

Vascular dementia (subcortical)

151

4.17

22.44

1.4

1.3

2.80

68.91

e6/l

0.96

114

Covid-19 suspected case

394

2320

1.72

22.42

1.3

1.5

9.87

24.00

e6/l

2.40

291

1716

Disorders of synovium and tendon

850

5016

1.45

22.35

1.4

26.28

35.99

e6/l

0.60

635

3670

Parkinson's disease

238

1200

2.02

22.33

1.4

1.3

4.05

31.38

e6/l

2.89

189

876

Emotional disorders starting during childhood or adolecense, excluding more controls

100

331

3.02

22.27

3.1

2.3

21.24

24.48

e6/l

0.10

240

Congenital malformations of the nervous system

228

3.59

22.23

2.0

3.3

52.53

10.77

e6/l

1.05

160

Statin medication

1108

4504

1.39

22.03

1.4

19.19

38.34

e6/l

1.90

804

3349

Exposure to other specified factors

1371

8878

1.33

22.00

1.4

36.42

30.58

e6/l

0.21

966

6604

Allergic asthma (mode), excluding more controls

378

2154

1.73

21.98

1.4

1.3

19.25

21.78

e6/l

0.10

293

1556

Allergic asthma (mode)

378

2155

1.73

21.95

1.4

1.3

19.25

21.94

e6/l

0.10

293

1561

Disorders of speech understanding and production

119

444

2.74

21.91

1.9

2.8

26.67

12.90

e6/l

0.63

304

Exclusions for E4_PCOS_CONSORTIUM

1217

5592

1.37

21.91

1.4

1.5

39.62

30.00

e6/l

0.28

900

4123

Purpura and other haemorrhagic conditions

243

1245

1.99

21.83

2.3

1.5

38.88

28.50

e6/l

0.14

186

917

Disturbance of activity and attention

281

1473

1.90

21.82

1.4

1.8

12.05

21.42

e6/l

1.34

200

1078

Adrenocortical insufficiency

306

3.14

21.80

1.5

1.6

24.06

51.78

e6/l

0.46

221

Bacterial intestinal infections, IBD co-morbidities

301

1656

1.85

21.67

1.7

1.4

19.84

24.94

e6/l

0.19

217

1217

Injuries to the shoulder and upper arm

1400

8173

1.33

21.64

1.4

31.46

34.38

e6/l

0.10

1053

6051

Malignant neoplasm, wide definition

1449

6373

1.33

21.64

2.1

1.4

50.45

29.94

e6/l

0.77

1020

4770

Disorders of refraction and accommodation

505

3185

1.60

21.52

1.6

24.13

24.88

e6/l

0.04

378

2316

Injuries to the wrist and hand

1696

8713

1.30

21.50

1.3

1.5

26.27

33.55

e6/l

0.37

1238

6467

Enthesopathies of lower limb, excluding foot

358

2077

1.75

21.46

1.3

1.5

22.37

45.56

e6/l

1.29

267

1475

Benign neoplasms

1624

6784

1.31

21.36

1.4

36.88

29.19

e6/l

0.37

1205

5043

Other and unspecified tonsillitis

601

3273

1.54

21.36

1.4

61.02

28.49

e6/l

0.57

443

2396

Gastro-oesophageal reflux disease

1100

6800

1.37

21.36

1.3

1.5

28.61

33.56

e6/l

0.16

817

5041

Supplementary factors related to causes of morbidity and mortality classified elsewhere

535

3450

1.57

21.07

1.6

1.4

31.63

30.27

e6/l

0.04

419

2537

Malignant neoplasm, including Hilmo

1441

6371

1.33

20.86

2.1

1.4

50.82

29.92

e6/l

0.78

1012

4770

Heterophoria

172

791

2.23

20.78

1.6

1.8

13.92

29.32

e6/l

0.77

137

576

Acute alcohol intoxication

409

2482

1.67

20.76

1.3

1.4

40.44

27.71

e6/l

0.16

297

1832

Retrobulbar neuritis in diseases classified elsewhere

9.21

20.76

1.1

1.3

7.50

20.36

e6/l

0.32

Visual impairment including blindness (binocular or monocular)

126

506

2.55

20.69

1.7

1.5

6.50

40.16

e6/l

1.29

376

Dentofacial anomalies [including malocclusion]

1207

7048

1.35

20.65

1.5

1.4

31.59

32.95

e6/l

0.04

893

5191

Hypersomnia

107

4.82

20.50

1.2

2.70

13.51

e6/l

0.95

Urticaria and erythema

628

4220

1.50

20.39

1.6

1.5

57.08

31.45

e6/l

0.49

473

3093

Other heart diseases, wide

1571

7335

1.30

20.34

1.4

1.5

44.07

30.53

e6/l

0.57

1173

5372

Malignant neoplasm

1398

6215

1.33

20.30

2.1

1.4

51.79

30.31

e6/l

0.77

978

4647

Monoamine oxidase A inhibitors

180

849

2.16

20.27

1.2

1.4

12.23

33.09

e6/l

1.22

128

632

Problems related to lifestyle

200

983

2.08

20.25

1.5

1.4

37.35

24.83

e6/l

0.17

148

738

Unspecified acute lower respiratory infection

272

1484

1.86

20.20

1.5

26.02

24.24

e6/l

0.05

210

1104

Malignant neoplasm

1395

6209

1.32

20.08

2.1

1.4

51.74

30.32

e6/l

0.77

974

4645

Paracetamol or NSAID medication

253

647

1.99

20.06

1.9

2.0

15.83

59.99

e6/l

1.60

186

493

Malignant immunoproliferative diseases

6.03

20.04

1.4

1.3

8.04

20.02

e6/l

0.45

Type of accident

493

3159

1.58

20.01

1.6

1.4

33.30

31.30

e6/l

0.05

394

2327

Alcohol dependence

419

2585

1.64

19.95

1.3

1.4

12.03

26.98

e6/l

2.13

313

1913

Early lumbar disc prolapse, operated

178

843

2.15

19.88

1.3

1.4

20.88

21.31

e6/l

0.02

141

609

Social phobias

167

772

2.21

19.83

1.6

1.5

10.17

20.49

e6/l

1.69

120

571

Mixed and other personality disorders

164

756

2.23

19.72

1.2

1.4

5.04

20.23

e6/l

2.98

113

544

Alcohol abuse, main dg

284

1585

1.82

19.63

1.3

1.4

53.86

28.95

e6/l

0.23

208

1173

Autonomic disorders

149

4.00

19.62

1.4

1.1

28.83

11.29

e6/l

0.40

106

Inflammatory disease of uterus

264

1443

1.86

19.55

1.2

1.4

9.07

23.78

e6/l

2.26

196

1071

Hyperkinetic disorders

293

1610

1.81

19.53

1.4

1.8

11.92

20.63

e6/l

1.28

204

1182

Secondary uncertain malignant neoplasm

221

1140

1.97

19.51

1.7

1.3

64.64

24.62

e6/l

0.56

169

855

Deforming dorsopathies

418

2590

1.63

19.49

1.4

1.5

8.99

38.89

e6/l

3.08

321

1853

Haemorrhage from respiratory passages

509

2914

1.56

19.39

1.5

28.90

38.08

e6/l

0.31

380

2169

Diseases of the skin and subcutaneous tissue

1600

6221

1.30

19.37

1.5

1.4

30.06

31.04

e6/l

0.04

1198

4600

Diaphragmatic hernia

539

3550

1.53

19.30

1.3

1.4

11.40

28.58

e6/l

2.98

389

2664

Erysipelas, including avohilmo

1081

5932

1.36

19.29

1.4

1.3

47.61

27.37

e6/l

0.77

806

4372

Acute alcohol intoxication, ICD10

352

2103

1.70

19.09

1.3

1.4

44.43

29.83

e6/l

0.15

254

1548

Fasciculation

5.09

19.08

1.4

1.2

1.40

18.16

e6/l

0.92

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

151

683

2.27

19.06

1.9

1.5

34.16

17.91

e6/l

0.75

102

506

KRA_PSY_EATING, excluding more controls

146

644

2.29

18.97

1.3

1.5

12.84

26.10

e6/l

1.15

113

482

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

114

4.50

18.93

1.4

1.2

23.95

4.98

e6/l

1.82

Superficial injury of abdomen, lower back and pelvis

282

1589

1.80

18.87

1.4

1.5

13.40

26.53

e6/l

1.17

207

1178

Erysipelas

801

4909

1.42

18.82

1.4

1.3

53.63

24.97

e6/l

0.88

608

3605

Mycoses, including avohilmo

1514

8994

1.29

18.66

1.4

30.61

32.33

e6/l

0.06

1095

6689

Manic episode

212

3.38

18.66

1.1

1.3

51.21

17.35

e6/l

0.31

156

Disorders of muscles

179

871

2.09

18.65

1.2

1.4

7.47

34.66

e6/l

1.89

133

634

Parkinson's disease, strict definition

212

1096

1.97

18.61

1.4

1.3

4.35

31.93

e6/l

2.62

169

808

Somnolence

4.85

18.57

2.0

1.8

3.97

15.57

e6/l

0.81

Appendectomy

1059

7531

1.35

18.54

1.3

1.4

30.40

32.81

e6/l

0.07

792

5535

Nystagmus and other irregular eye movements

121

4.34

18.40

1.9

2.3

15.78

12.67

e6/l

0.12

Vascular syndromes of brain in cerebrovascular disorders

244

3.16

18.39

1.5

1.3

7.42

75.75

e6/l

1.23

179

Explicit bacterial Sepsis

163

769

2.16

18.38

2.1

1.4

195.72

21.56

e6/l

1.39

129

575

Schizoaffective disorder

157

733

2.20

18.34

1.2

1.5

13.39

22.50

e6/l

0.41

108

533

Cerebral amyloid angiopathy

8.57

18.28

1.2

2.32

24.21

e6/l

0.49

Mental and behavioural disorders due to opioids

355

2.78

18.25

2.0

1.5

154.52

15.31

e6/l

0.52

272

Explicit bacterial Sepsis, including avohilmo

166

793

2.13

18.13

2.1

1.4

193.03

21.27

e6/l

1.39

131

592

Other disorders of adrenal gland

104

410

2.63

17.94

1.5

1.7

28.04

49.26

e6/l

0.40

293

L04AD Calcineurin inhibitors

212

1114

1.95

17.87

2.7

1.8

19.44

28.20

e6/l

0.34

146

807

Disorders of brain, other and unspecified

5.94

17.76

2.1

1.2

28.62

5.24

e6/l

1.03

Non-allergic asthma (mode)

282

1601

1.77

17.73

1.3

1.4

20.00

18.10

e6/l

0.09

214

1165

All influenza (not pneumonia)

255

1422

1.82

17.69

1.5

41.01

18.01

e6/l

0.52

193

1032

Hypermobility syndrome

121

517

2.41

17.54

1.3

1.6

23.85

19.10

e6/l

0.12

375

Non-allergic asthma (mode), excluding more controls

282

1607

1.76

17.51

1.3

1.4

20.00

18.59

e6/l

0.07

214

1169

Superficial injury of lower leg

439

2829

1.57

17.46

1.3

1.5

42.86

25.62

e6/l

0.25

321

2097

Atypical facial pain

106

427

2.56

17.45

1.3

1.4

18.15

26.38

e6/l

0.16

307

Transplanted organ and tissue status

191

979

1.99

17.33

3.4

1.6

15.79

29.87

e6/l

0.64

136

707

Diseases of male genital organs

758

2689

1.43

17.15

1.4

1.6

38.22

31.59

e6/l

0.18

551

1999

Other facial nerve disorders

229

3.19

17.15

1.2

1.4

33.87

14.13

e6/l

0.38

164

Pain and other conditions associated with female genital organs and menstrual cycle

371

1917

1.64

17.14

1.3

1.4

11.94

29.47

e6/l

1.60

275

1419

Agoraphobia

255

3.05

17.13

1.2

1.4

21.80

22.26

e6/l

0.01

191

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

832

5852

1.38

17.11

1.4

25.62

33.83

e6/l

0.41

645

4294

Need for other prophylactic measures

123

536

2.36

17.06

2.5

1.7

12.09

42.31

e6/l

1.07

391

Other disorders of peripheral nervous system

6.58

16.94

1.2

1.1

1.50

7.22

e6/l

1.00

Tetraplegia

6.10

16.90

3.5

2.8

44.79

3.64

e6/l

0.61

Speech therapy

394

2497

1.60

16.89

1.4

16.54

29.75

e6/l

0.90

309

1837

Cauda equina syndrome

107

4.40

16.88

1.3

1.2

3.91

13.31

e6/l

0.77

Use of pramipexole

326

1973

1.67

16.87

1.3

1.4

11.35

33.35

e6/l

1.66

238

1459

Carpal tunnel syndrome

902

5776

1.36

16.82

1.3

1.4

69.12

27.21

e6/l

1.07

717

4189

Congenital malformations, deformations and chromosomal abnormalities

969

6878

1.34

16.78

1.5

1.4

32.70

33.11

e6/l

0.02

732

5053

Candidiasis, including avohilmo

504

3376

1.51

16.77

1.4

37.83

27.81

e6/l

0.15

366

2483

Other/unspecified disorders of vestibular function

336

2.74

16.76

1.3

1.4

71.34

57.75

e6/l

0.09

252

Nonpyogenic thrombosis of intracranial venous system

5.34

16.76

1.6

1.2

11.50

16.53

e6/l

0.16

Anterior Iridocyclitis

329

2000

1.67

16.76

1.3

1.4

30.89

22.83

e6/l

0.19

248

1465

Viral infections of central nervous system, not elsewhere classified/unspecified

4.74

16.73

1.5

1.3

28.70

5.72

e6/l

1.79

Dental caries, including avohilmo

1080

4148

1.34

16.69

1.6

1.4

31.60

29.70

e6/l

0.08

785

3112

Lesion of ulnar nerve

225

1231

1.86

16.67

1.3

1.4

20.19

23.43

e6/l

0.12

182

886

Protozoal diseases, including avohilmo

249

3.06

16.66

1.6

1.3

79.71

49.39

e6/l

0.15

183

Missing teeth due to accident, extraction or parodontitis

931

6190

1.35

16.64

1.4

32.00

35.72

e6/l

0.10

695

4590

Sleep disorders, other/unspecified

315

2.79

16.60

1.2

1.5

5.18

14.39

e6/l

1.37

238

Disorders of conjunctiva

1371

8316

1.28

16.59

1.5

1.4

23.11

34.20

e6/l

1.17

977

6163

Other disorders of bone

330

2014

1.66

16.56

1.5

1.4

24.28

26.43

e6/l

0.08

246

1485

Other and unspecified iron deficiency

514

3458

1.50

16.53

1.5

1.4

38.53

26.28

e6/l

0.20

377

2576

Mental disorders, not otherwise specified

166

824

2.06

16.53

1.2

1.4

47.03

22.72

e6/l

0.30

119

603

Chorioretinal inflammation

245

3.07

16.52

1.4

10.55

52.36

e6/l

0.86

183

Special screening examination for other diseases and disorders

175

883

2.01

16.45

1.5

1.4

17.44

29.60

e6/l

0.75

142

614

Enterocolitis due to Clostridium difficile

172

865

2.02

16.43

1.9

1.5

18.66

29.57

e6/l

0.27

125

641

Hyperosmolality and hypernatraemia

4.61

16.41

1.5

1.4

2.34

3.59

e6/l

0.52

Dystonia

113

483

2.41

16.39

1.4

1.5

3.39

41.11

e6/l

1.52

350

Other diseases of upper respiratory tract

1716

7144

1.26

16.38

1.4

1.5

29.11

32.39

e6/l

0.18

1284

5252

Diseases of the digestive system

669

4711

1.42

16.34

1.4

1.5

33.08

30.04

e6/l

0.07

502

3495

Conjunctivitis

1256

7852

1.29

16.32

1.5

1.4

24.12

34.03

e6/l

0.90

892

5820

Sequelae of injuries of head

111

472

2.42

16.29

1.8

1.4

6.57

34.75

e6/l

1.33

346

Ptosis of eyelid

185

958

1.97

16.28

1.6

1.4

22.01

22.86

e6/l

0.02

145

696

Mental and behavioural disorders due to sedatives or hypnotics

140

656

2.19

16.27

1.3

1.4

11.97

28.87

e6/l

0.93

489

Other disorders of glucose regulation and pancreatic internal secretion

158

775

2.08

16.24

1.7

1.8

18.76

35.91

e6/l

0.62

128

564

Acetic acid derivatives and related substances

380

1208

1.64

16.23

1.3

1.5

20.61

49.85

e6/l

1.61

270

915

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

661

4632

1.42

16.13

1.3

1.5

30.40

33.19

e6/l

0.08

473

3402

Other disorders of optic disc

120

4.09

16.08

1.3

1.1

18.59

14.23

e6/l

0.10

Acute and subacute iridocyclitis

309

1871

1.67

16.02

1.3

1.4

31.63

18.36

e6/l

0.33

234

1369

Other enthesopathies

452

2991

1.53

15.92

1.3

1.4

17.05

39.66

e6/l

2.15

349

2193

Spondyloarthritis

273

1601

1.73

15.91

1.4

1.3

59.84

22.30

e6/l

0.90

213

1158

Intestinal stricture

443

2925

1.53

15.80

1.5

1.4

8.69

33.99

e6/l

3.65

336

2163

Other congenital malformations of circulatory system

220

3.14

15.73

2.5

1.3

63.41

27.46

e6/l

0.38

161

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1594

8052

1.26

15.71

1.8

1.4

28.60

31.46

e6/l

0.15

1171

5935

Hernia of abdominal wall, postoperative

263

1521

1.74

15.68

1.3

1.2

17.36

27.32

e6/l

0.38

191

1139

Contact with and exposure to communicable diseases

532

3636

1.47

15.65

1.4

1.5

45.84

28.12

e6/l

0.35

383

2684

Unspecified haematuria

584

3304

1.45

15.60

1.5

1.4

34.79

31.88

e6/l

0.05

443

2476

Injuries to the knee and lower leg

1914

8421

1.23

15.59

1.4

1.5

24.56

34.10

e6/l

0.59

1408

6256

Venous thromboembolism

766

5394

1.38

15.57

1.6

1.4

29.63

33.66

e6/l

0.18

587

4002

Pneumocystosis

146

3.69

15.56

1.8

1.2

113.60

10.40

e6/l

0.45

108

Pneumocystosis, including avohilmo

146

3.69

15.56

1.8

1.2

113.60

10.40

e6/l

0.45

108

Disorders of mineral metabolism

146

707

2.11

15.53

1.4

1.5

16.56

29.79

e6/l

0.51

107

537

Paralytic ileus and intestinal obstruction

369

2347

1.59

15.52

1.5

1.4

7.68

28.33

e6/l

3.42

286

1756

Amenorrhoea

140

668

2.14

15.51

1.3

129.22

21.89

e6/l

0.68

103

503

Varicella [chickenpox], including avohilmo

114

502

2.34

15.44

2.0

2.2

54.14

7.73

e6/l

1.71

368

Protozoal diseases

244

2.99

15.41

1.7

1.3

82.43

49.89

e6/l

0.16

181

Other specified disorders of muscle

186

3.28

15.35

1.2

1.4

3.71

57.43

e6/l

0.85

138

Kela reimbursement Agammaglobulinemia (D80-84)

5.35

15.33

3.6

1.5

4.84

19.81

e6/l

0.60

Acute appendicitis, no complications

898

6709

1.34

15.33

1.4

28.63

35.34

e6/l

0.20

673

4941

Arnold-Chiari syndrome

4.83

15.32

2.3

74.36

8.64

e6/l

0.99

Mouth breathing

614

4340

1.43

15.32

1.4

1.5

10.23

30.39

e6/l

4.05

471

3170

Nonhereditary hypogammaglobulinemia

4.68

15.30

1.4

1.2

2.59

14.49

e6/l

0.70

Thiamine deficiency

6.58

15.17

1.1

1.4

2.40

9.12

e6/l

0.51

Other diseases of hard tissues of teeth

806

3044

1.38

15.07

1.6

1.4

29.04

25.30

e6/l

0.13

589

2289

Heart failure, not strict

1093

5644

1.31

15.06

1.5

59.42

30.43

e6/l

0.93

831

4147

Other disorders of eyelid

619

4144

1.42

15.06

1.4

31.45

33.22

e6/l

0.06

452

3088

Symptoms and signs involving appearance and behaviour

5.68

14.94

1.7

1.3

4.95

19.33

e6/l

0.56

Attention to artificial openings

298

2.73

14.92

2.6

1.8

92.70

23.99

e6/l

0.83

217

Nutritional anaemias

720

5006

1.38

14.89

1.5

1.4

45.69

31.62

e6/l

0.26

537

3755

Hypoglycaemia, other or unspecified

131

622

2.16

14.75

1.7

1.9

14.72

37.08

e6/l

0.75

105

460

Hereditary ataxia

4.32

14.73

1.2

1.9

4.07

22.36

e6/l

1.08

Other specified/unspecified necrotizing vasculopathies

4.31

14.72

1.6

1.2

272.31

15.31

e6/l

0.47

Conjunctivitis (acute, non atopic)

476

3228

1.48

14.65

1.6

29.69

28.86

e6/l

0.03

347

2382

Other noninfective gastroenteritis and colitis

390

2548

1.55

14.63

1.4

1.6

24.57

27.55

e6/l

0.10

290

1867

Asthma and allergy, excluding more controls

212

1170

1.81

14.63

1.3

1.4

27.29

21.35

e6/l

0.14

174

837

Obesity

1025

7432

1.31

14.59

1.3

1.4

71.07

27.18

e6/l

1.26

762

5452

Obesity and other hyperalimentation

1030

7462

1.31

14.59

1.3

1.4

70.80

27.10

e6/l

1.26

765

5475

Soft tissue disorders related to use, overuse and pressure

405

2671

1.53

14.58

1.3

1.4

19.65

42.18

e6/l

1.15

301

1964

Other viral hepatitis, including avohilmo

133

639

2.13

14.55

1.7

1.4

26.02

17.68

e6/l

0.39

463

Propionic acid derivatives

410

1327

1.57

14.53

1.5

1.7

27.26

47.52

e6/l

0.60

300

1005

Spondylolisthesis/Spondylolysis

257

1522

1.71

14.51

1.2

1.4

8.50

43.24

e6/l

1.99

195

1084

Keratitis

562

3957

1.43

14.49

1.4

39.01

30.31

e6/l

0.31

429

2905

Myasthenia gravis

129

3.76

14.48

1.5

1.3

3.97

60.62

e6/l

0.71

Viral hepatitis, including avohilmo

149

749

2.03

14.41

1.7

1.5

30.77

29.43

e6/l

0.03

104

551

Adverse effects, not elsewhere classified

337

2143

1.59

14.37

1.3

1.6

17.79

26.62

e6/l

0.67

252

1571

Asthma and allergy

211

1169

1.80

14.37

1.3

1.4

27.45

21.86

e6/l

0.13

173

837

Diseases of oral cavity, salivary glands and jaws

805

3050

1.37

14.29

1.5

1.4

27.73

25.49

e6/l

0.08

582

2293

Abnormal weight loss

161

834

1.97

14.25

1.3

1.6

30.69

33.20

e6/l

0.04

126

612

Other disorders starting during childhood or adolecense, excluding more controls

351

2.50

14.24

3.2

2.6

12.68

24.41

e6/l

0.89

251

Chronic rhinitis, nasopharyngitis and pharyngitis

520

3622

1.45

14.22

1.4

1.5

19.79

37.19

e6/l

1.11

378

2635

Maternal care for other conditions predominantly related to pregnancy

355

2231

1.57

14.19

1.3

14.54

36.32

e6/l

1.31

246

1635

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1048

7399

1.30

14.17

1.5

1.4

31.94

32.97

e6/l

0.04

791

5437

Weight loss

174

927

1.91

14.15

1.7

1.6

28.37

32.02

e6/l

0.06

137

678

Immunodeficiencies

102

446

2.36

14.14

2.2

2.0

13.76

34.66

e6/l

0.61

323

Excessive vomiting in pregnancy

156

802

1.99

14.14

1.3

11.03

27.29

e6/l

0.99

107

591

Insulin, intermediate and long-acting

806

5821

1.34

14.14

1.5

1.4

36.72

32.53

e6/l

0.11

622

4340

Superficial injury of hip and thigh

230

1331

1.75

14.13

1.3

1.4

11.58

27.12

e6/l

1.08

177

977

Acute renal failure

316

1987

1.61

14.10

1.4

13.83

27.41

e6/l

1.29

229

1463

Alcohol withdrawal state with delirium

122

574

2.18

14.09

1.3

1.4

7.18

24.70

e6/l

0.88

100

425

Ovarian cyst

548

2172

1.46

14.08

1.3

26.24

28.93

e6/l

0.11

401

1626

Pulmonary embolism

409

2726

1.51

14.01

1.6

1.3

21.78

31.70

e6/l

0.51

311

2014

Pulmonary heart disease

409

2728

1.51

13.96

1.6

1.3

21.78

31.71

e6/l

0.51

311

2014

Paroxysmal tachycardia

323

1688

1.60

13.94

1.4

31.74

20.66

e6/l

0.27

246

1228

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

127

609

2.13

13.93

1.2

1.4

74.30

36.60

e6/l

0.52

100

457

GI-bleeding

435

2943

1.49

13.83

1.5

1.4

36.14

26.59

e6/l

0.16

326

2194

Behavioural disorders, excluding more controls

142

3.50

13.80

1.3

2.1

29.58

17.17

e6/l

0.33

105

Abnormal blood-pressure reading, without diagnosis

407

2.40

13.77

1.3

1.6

12.93

47.27

e6/l

1.09

299

Urticaria

498

3465

1.45

13.75

1.6

1.5

39.91

32.75

e6/l

0.12

366

2541

Caries of dentine, including avohilmo

1152

4584

1.29

13.73

1.5

30.05

28.72

e6/l

0.06

841

3416

Asthma/COPD (KELA code 203)

1522

8227

1.24

13.70

1.4

1.5

36.25

31.51

e6/l

0.16

1142

6069

Pneumonia due to other infectious organisms, not elsewhere classified

243

2.85

13.69

1.7

1.5

130.77

16.02

e6/l

0.70

184

Other symptoms and signs involving the circulatory and respiratory systems

120

567

2.16

13.68

1.4

1.5

103.58

33.08

e6/l

0.36

411

Algoneurodystrophy

289

2.69

13.68

1.3

1.4

17.35

11.71

e6/l

0.15

212

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

238

1407

1.72

13.61

1.6

1.3

60.89

24.77

e6/l

0.52

176

1054

Other congenital malformations of nervous system

4.35

13.59

2.3

2.6

74.36

15.86

e6/l

0.82

Anankastic personality disorder

361

2.49

13.58

1.5

1.4

8.70

20.84

e6/l

0.95

266

Other viral hepatitis

125

603

2.12

13.57

1.7

1.4

27.03

17.76

e6/l

0.43

437

Disorders of skin appendages

806

6046

1.34

13.55

1.4

30.61

32.32

e6/l

0.04

624

4434

Beningn neoplasm: Meninges, unspecified

116

3.82

13.54

1.8

1.2

267.88

12.49

e6/l

0.48

Varicella [chickenpox]

417

2.37

13.51

1.7

1.8

66.00

7.32

e6/l

1.79

311

Degeneration of the brain due to alcohol

150

3.41

13.46

1.2

1.4

13.27

69.63

e6/l

0.70

110

Acute and transient psychotic disorders

200

1131

1.80

13.43

1.3

1.4

32.76

30.81

e6/l

0.03

139

840

Obsessive-compulsive disorder

125

605

2.11

13.37

1.3

1.6

13.67

20.21

e6/l

0.27

457

Iron deficiency anaemia

617

4388

1.39

13.36

1.5

1.4

34.65

26.60

e6/l

0.15

453

3289

Special screening examination for infectious and parasitic diseases

341

1593

1.57

13.33

1.4

1.3

20.17

44.36

e6/l

1.08

212

1102

Viral hepatitis

140

709

2.02

13.30

1.7

1.4

32.16

30.22

e6/l

0.05

522

Noninfective enteritis and colitis

723

5376

1.35

13.28

1.4

1.5

34.57

33.81

e6/l

0.01

528

3969

Temporal arteritis

276

2.70

13.25

1.2

23.34

60.50

e6/l

0.56

208

Pulmonary heart disease, diseases of pulmonary circulation

432

2945

1.48

13.25

1.5

1.4

24.39

31.94

e6/l

0.37

327

2187

Other and unspecified injuries of head

131

648

2.06

13.24

1.5

1.6

9.60

38.72

e6/l

1.46

488

Anti-inflammatory and antirheumatic products, non-steroids

403

1328

1.54

13.24

1.4

1.7

27.06

47.47

e6/l

0.60

293

1006

Use of fingolimod

4.57

13.22

1.2

1.7

12.32

13.30

e6/l

0.04

Diseases of arteries, arterioles and capillaries (FINNGEN)

320

1394

1.60

13.19

1.5

1.2

69.29

19.85

e6/l

0.82

255

1011

Streptococcal septicaemia

139

704

2.01

13.13

2.2

1.4

139.23

12.32

e6/l

1.48

110

522

Acute pharyngitis

266

1617

1.65

13.13

1.7

1.4

9.16

25.85

e6/l

1.93

205

1169

Post-traumatic hydrocephalus, unspecified

13.24

13.12

2.1

1.1

3.27

10.33

e6/l

0.46

Fourth [trochlear] nerve palsy

168

3.23

13.11

1.9

1.2

21.29

34.42

e6/l

0.23

122

Diseases of pulp and periapical tissues and dental caries

945

3699

1.32

13.10

1.6

1.4

31.17

27.43

e6/l

0.14

689

2780

Other diseases of the digestive system

434

2970

1.47

13.07

1.4

36.82

27.53

e6/l

0.15

318

2212

Lagophthalmos

4.26

13.06

1.6

1.2

182.62

20.94

e6/l

0.87

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

166

895

1.89

13.06

1.8

1.4

11.81

32.51

e6/l

1.17

126

680

Diseases of appendix

1162

8241

1.27

13.01

1.4

27.12

31.77

e6/l

0.17

856

6103

Injuries to the hip and thigh

692

4594

1.36

12.97

1.4

22.12

30.16

e6/l

0.46

524

3410

Streptococcal septicaemia, including avohilmo

142

728

1.98

12.96

2.2

1.4

137.09

12.27

e6/l

1.48

112

541

Disorders of optic nerve, not elsewhere classified

154

3.33

12.94

1.4

1.2

3.30

15.19

e6/l

1.14

116

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

130

648

2.05

12.92

1.3

1.5

12.28

41.16

e6/l

1.30

481

Abnormal findings on diagnostic imaging of other body structures

227

1345

1.71

12.91

1.4

11.64

25.28

e6/l

1.28

156

1000

DVT of lower extremities and pulmonary embolism

567

4063

1.40

12.90

1.5

1.3

27.55

30.98

e6/l

0.12

437

3028

Dental operations

866

3366

1.33

12.90

1.5

1.4

31.71

26.38

e6/l

0.20

637

2473

Giant cell arteritis with polymyalgia rheumatica

280

2.66

12.89

1.2

23.34

60.50

e6/l

0.56

208

Acute appendicitis

1089

7971

1.27

12.88

1.4

26.83

32.66

e6/l

0.21

803

5882

Disorders of lens

967

4629

1.30

12.81

1.4

13.78

41.25

e6/l

4.16

710

3402

Conjunctivitis (acute, non atopic), including avohilmo

1600

7904

1.23

12.77

1.4

18.99

36.50

e6/l

2.81

1146

5909

Use of dimethyl fumarate

4.56

12.77

1.1

13.24

13.62

e6/l

0.01

Diseases of liver

511

3623

1.42

12.75

1.4

37.71

33.41

e6/l

0.07

363

2674

Appendicitis, broad definition

1151

8208

1.26

12.70

1.4

26.73

31.91

e6/l

0.19

849

6076

Adhesive capsulitis of shoulder

235

1411

1.69

12.68

1.4

22.70

38.57

e6/l

0.43

181

1027

Cutaneous abscess, furuncle and carbuncle

418

2861

1.48

12.65

1.5

1.4

18.89

27.01

e6/l

0.58

313

2105

Conductive and sensorineural hearing loss

1148

6030

1.27

12.62

1.5

1.4

52.85

27.49

e6/l

0.90

874

4429

Chronic gastritis

359

2384

1.52

12.58

1.2

1.4

10.79

25.13

e6/l

1.81

262

1793

Assault

237

1431

1.68

12.58

1.3

1.5

10.51

22.38

e6/l

1.40

157

1053

Giant cell arteritis

325

2.50

12.58

1.2

21.33

54.11

e6/l

0.56

239

Brain astrocytoma

6.20

12.51

1.9

1.1

68.06

19.43

e6/l

0.59

Brain astrocytoma, including Hilmo

6.20

12.51

1.9

1.1

68.06

19.43

e6/l

0.59

Assault by bodily force

149

788

1.93

12.48

1.2

1.5

9.19

16.97

e6/l

0.90

100

581

Infections with a predominantly sexual mode of transmission, including avohilmo

660

4472

1.36

12.45

1.4

1.3

23.57

31.42

e6/l

0.56

468

3315

Endometriosis

517

2114

1.43

12.38

1.3

1.4

13.51

29.01

e6/l

1.54

366

1591

Disorders of choroid and retina

1167

6498

1.26

12.38

1.5

1.4

27.84

34.09

e6/l

0.22

837

4845

Other disorders of skin and subcutaneous tissue

1083

7232

1.27

12.35

1.6

1.4

27.01

33.59

e6/l

0.45

791

5380

Faecal incontinence

138

713

1.97

12.34

1.9

1.4

9.38

65.52

e6/l

1.85

529

Insulin, combination of fast acting with intermediate-acting or long-acting

891

6249

1.30

12.33

1.5

1.4

33.69

31.42

e6/l

0.06

685

4657

Viral and other specified intestinal infections, including avohilmo

458

3081

1.44

12.30

1.5

22.97

24.19

e6/l

0.06

360

2279

Unspecified privation

176

986

1.81

12.25

1.1

1.4

17.78

31.90

e6/l

0.68

113

733

Diverticular disease of intestine

1008

4904

1.29

12.16

1.3

1.4

28.27

36.02

e6/l

0.23

729

3668

6-mercaptopurine

307

2.51

12.08

10.0

1.5

152.16

19.16

e6/l

0.44

235

Hypothyroidism, strict autoimmune, 3 medication purchases required

1260

6813

1.25

12.00

1.3

1.4

16.59

29.58

e6/l

2.53

951

5035

Oxicams

301

1079

1.60

12.00

1.3

1.5

9.31

53.21

e6/l

2.98

237

829

Panniculitis affecting regions of neck and back

267

2.62

11.94

1.4

27.71

45.59

e6/l

0.25

195

Myeloid leukaemia

200

2.90

11.86

2.9

1.3

8.02

58.41

e6/l

0.96

154

Arthrosis

1046

4503

1.28

11.84

1.3

1.4

30.56

34.14

e6/l

0.16

786

3306

Hyperplasia of prostate

468

1833

1.45

11.84

1.3

1.4

25.66

28.39

e6/l

0.07

349

1376

Insulin medication

890

5736

1.29

11.79

1.5

33.74

33.84

e6/l

0.00

684

4281

Obesity due to excess calories

759

5797

1.32

11.78

1.3

1.4

71.74

26.50

e6/l

1.15

578

4260

Other drug-induced secondary parkinsonism

4.45

11.77

1.3

1.67

13.07

e6/l

0.63

Oter anti-inflammatory and antirheumatic agents, non-steroids

282

966

1.62

11.76

1.3

1.5

20.94

57.31

e6/l

1.65

207

742

Other and unspecified immunodeficiencies with predominantly antibody defects

3.86

11.74

3.7

1.4

10.88

12.37

e6/l

0.06

Other postsurgical states

123

624

2.01

11.68

2.0

1.6

7.94

38.17

e6/l

1.45

101

463

Polycystic ovarian syndrome, consortium definition

1106

5035

1.27

11.65

1.4

45.26

31.84

e6/l

0.38

830

3694

Other respiratory disorders and diseases

272

1732

1.59

11.60

1.6

1.5

11.35

26.23

e6/l

1.50

203

1268

Other diseases of the respiratory system

272

1732

1.59

11.60

1.6

1.5

11.35

26.23

e6/l

1.50

203

1268

Trochanteric bursitis

212

1270

1.69

11.60

1.3

1.4

12.06

42.11

e6/l

1.75

160

928

Leisure time condition

286

1844

1.57

11.59

1.6

1.5

24.24

24.41

e6/l

0.00

228

1355

Fenamates

205

814

1.73

11.55

1.5

21.75

61.32

e6/l

1.52

149

612

Other obstetric conditions, not elsewhere classified

540

2454

1.40

11.53

1.3

24.74

27.97

e6/l

0.14

404

1819

Benign neoplasm: Brain, infratentorial

5.03

11.51

2.2

2.1

19.44

20.40

e6/l

0.02

Other and unspecified disorders of binocular movement

5.19

11.50

2.2

2.3

58.32

16.11

e6/l

0.43

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

529

2394

1.40

11.45

1.3

24.94

28.48

e6/l

0.15

399

1778

Symptoms and signs involving emotional state

215

2.78

11.43

1.2

2.1

24.41

14.49

e6/l

0.22

162

Other gastritis (incl. Duodenitis)

308

2025

1.54

11.40

1.4

7.12

28.26

e6/l

3.77

242

1501

Lack of expected normal physiological development

3.58

11.38

2.6

2.0

35.89

32.75

e6/l

0.03

Other specified and unspecified personality disorders

156

863

1.84

11.37

1.3

1.5

6.01

30.59

e6/l

2.30

112

634

Vitamin deficiency, wide

423

2.23

11.37

1.2

1.6

18.60

25.51

e6/l

0.19

316

Vitamin deficiency

423

2.23

11.37

1.2

1.6

18.60

25.51

e6/l

0.19

316

Fall on same level involving ice and snow

879

6872

1.29

11.35

1.4

35.18

33.89

e6/l

0.03

643

5097

Degeneration of nervous system due to alcohol

167

3.05

11.32

1.2

1.4

13.27

63.01

e6/l

0.68

122

Disorders of gallbladder, biliary tract and pancreas

1486

7611

1.22

11.31

1.4

43.71

30.16

e6/l

0.47

1080

5661

Maltreatment syndromes

104

503

2.12

11.29

1.2

1.6

7.24

20.30

e6/l

1.55

374

Hypermetropia

138

736

1.91

11.29

1.8

2.1

7.76

34.04

e6/l

1.41

100

523

SLE (Finngen)

251

2.62

11.29

1.3

1.7

17.06

41.60

e6/l

0.48

186

Hyperhidrosis

167

3.00

11.21

1.3

1.6

16.60

11.44

e6/l

0.14

123

Failure and rejection of transplanted organs and tissues

117

3.52

11.18

3.5

1.3

21.80

12.84

e6/l

0.19

Viral and other specified intestinal infections

338

2219

1.50

11.17

1.5

1.6

17.62

25.50

e6/l

0.53

271

1625

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

4.96

11.16

2.2

1.1

10.00

18.71

e6/l

0.28

Disorders of calcium metabolism

104

505

2.10

11.14

1.5

1.6

15.81

27.97

e6/l

0.32

377

Unspecified visual impairment (binocular)

117

3.49

11.14

1.3

1.6

3.27

5.00

e6/l

0.45

Chronic diseases of tonsils and adenoids

1235

6303

1.24

11.14

1.3

1.5

17.61

35.76

e6/l

2.38

922

4573

Sensorineural hearing loss

1062

5639

1.26

11.12

1.4

55.48

28.43

e6/l

0.88

806

4144

Nephropathy related operations

191

1129

1.72

11.07

1.7

1.6

16.10

27.23

e6/l

0.56

133

820

Heartburn

173

997

1.76

10.95

1.3

1.4

5.22

37.92

e6/l

2.94

123

726

Mycoses

424

2993

1.43

10.95

1.5

1.4

44.88

26.70

e6/l

0.26

323

2202

Generalized epilepsy

373

2.28

10.87

1.5

1.9

4.87

15.77

e6/l

1.95

275

Brain astrocytoma, helper endpoint

5.40

10.85

1.9

1.3

68.06

17.64

e6/l

0.63

All chronic kidney diseases

762

4682

1.30

10.73

1.4

1.5

40.91

26.87

e6/l

0.39

579

3486

Other maternal disorders predominantly related to pregnancy

863

4213

1.29

10.68

1.3

1.4

23.88

39.54

e6/l

1.24

650

3057

Disorders of acoustic nerve

230

2.66

10.61

1.7

1.2

100.68

54.85

e6/l

0.27

172

Drug-induced adrenocortical insufficiency

152

3.09

10.61

1.5

1.3

48.25

10.06

e6/l

0.84

109

Pain associated with micturition

187

1112

1.70

10.60

1.5

11.47

27.44

e6/l

1.33

136

813

Secondary hypertension

114

573

1.99

10.60

1.5

12.49

19.40

e6/l

0.29

413

Superficial injury of wrist and hand

344

2352

1.48

10.58

1.4

1.6

27.80

24.74

e6/l

0.07

253

1739

Disturbances of smell and taste

265

2.51

10.58

1.5

15.58

66.86

e6/l

0.87

195

Other or unspecified paralytic strabismus

4.87

10.47

2.1

1.3

4.53

17.48

e6/l

0.48

Insulin, fast-acting

526

3878

1.37

10.43

1.5

18.26

29.98

e6/l

1.09

400

2877

Diabetic neuropathy

159

904

1.78

10.41

1.5

1.4

30.54

18.76

e6/l

0.32

127

654

Internal derangement of knee

550

4046

1.35

10.37

1.3

1.4

14.21

32.33

e6/l

2.32

408

2972

Other or unspecified ileus, impaction or obstruction

253

1629

1.57

10.33

1.6

1.4

7.04

29.40

e6/l

3.11

197

1224

Transient global amnesia

122

645

1.92

10.28

1.2

1.4

13.33

40.16

e6/l

1.10

462

Other arthrosis

752

3890

1.30

10.22

1.4

37.31

31.43

e6/l

0.12

560

2865

Rash and other nonspecific skin eruption

148

834

1.80

10.19

1.9

1.5

12.65

28.20

e6/l

0.94

111

609

Osteoporosis with pathological fracture (FG)

101

502

2.05

10.18

1.6

1.4

39.44

29.98

e6/l

0.10

371

Scleritis and episcleritis

110

566

1.98

10.11

1.1

1.4

22.19

28.27

e6/l

0.12

414

Elevated blood glucose level

138

765

1.83

10.05

1.6

100.04

33.78

e6/l

0.34

563

Malnutrition

162

2.94

10.05

1.9

2.4

89.69

15.05

e6/l

0.41

118

Misadventures to patients during surgical and medical care

211

1313

1.63

10.03

1.7

1.3

21.21

24.65

e6/l

0.11

154

973

Gingivitis and periodontal diseases

1494

6415

1.21

10.00

1.5

1.4

31.18

29.67

e6/l

0.05

1072

4816

Chronic viral hepatitis

101

507

2.04

9.98

1.9

1.4

32.63

14.25

e6/l

0.89

374

Diseases of salivary glands

484

3553

1.37

9.95

1.3

1.4

33.58

31.35

e6/l

0.04

353

2636

Reimbursement for rheumatic diseases

828

6501

1.27

9.92

1.3

1.4

46.08

34.62

e6/l

0.30

611

4809

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

106

3.49

9.92

1.2

1.1

9.30

9.96

e6/l

0.02

Emotional disorders and disorders of social functioning with onset specific to childhood

107

537

1.99

9.91

3.0

2.3

19.99

22.91

e6/l

0.10

377

Convergence insufficiency and excess

116

3.35

9.91

1.2

1.4

5.07

9.77

e6/l

0.29

Schizophrenia

247

1600

1.56

9.90

1.3

1.4

39.64

27.71

e6/l

0.17

174

1190

Diseases of middle ear and mastoid

901

5855

1.26

9.90

1.6

1.4

59.31

28.97

e6/l

0.82

677

4325

Convergent concomitant strabismus

107

550

1.99

9.88

1.5

1.9

23.03

19.10

e6/l

0.16

404

Tubulo-interstitial nephritis, not specified as acute or chronic

104

530

2.00

9.79

1.5

1.4

142.28

34.69

e6/l

0.46

396

Gonarthrosis

895

3999

1.27

9.77

1.3

1.4

31.51

34.42

e6/l

0.10

665

2941

Disorders of vitreous body and globe

713

5236

1.29

9.76

1.4

37.87

34.14

e6/l

0.12

529

3860

Obesity, other/unspecified

525

3915

1.35

9.75

1.3

1.4

39.98

28.08

e6/l

0.19

377

2904

Drug-induced polyneuropathy

4.05

9.72

13.3

1.8

361.50

6.91

e6/l

0.49

Early lumbar disc prolapse operation

183

1111

1.67

9.66

1.3

1.4

25.37

18.40

e6/l

0.30

146

816

Decubitus ulcer and pressure area

431

2.10

9.65

2.2

1.4

37.81

46.08

e6/l

0.13

332

Intermittent heterotropia

116

617

1.92

9.64

1.6

2.3

15.04

31.74

e6/l

0.57

447

Use of riluzole

8.23

9.62

1.0

1.2

1.54

2.78

e6/l

0.62

Mental retardation, excluding more controls

267

2.40

9.61

2.0

3.0

29.66

15.67

e6/l

0.33

187

Fracture of foot, except ankle

387

2756

1.42

9.59

1.5

49.52

22.02

e6/l

0.41

282

2031

Other eating disorders

473

2.05

9.57

1.3

1.8

13.47

21.03

e6/l

0.33

349

Solid cancers, including Hilmo

1294

6228

1.22

9.52

1.5

1.4

56.65

30.22

e6/l

0.94

905

4650

Fracture of shoulder and upper arm

506

3760

1.35

9.52

1.6

1.4

28.15

28.20

e6/l

0.00

371

2774

Anomalies of pupillary function

173

2.82

9.49

1.1

1.4

4.91

14.81

e6/l

0.75

125

Sacroiliitis, not elsewhere classified

375

2.18

9.47

1.3

1.5

55.58

20.11

e6/l

0.61

269

Other/unspecified synovitis and tenosynovitis

166

987

1.70

9.46

1.2

1.4

27.34

35.32

e6/l

0.17

114

724

Benign neoplasm: Cranial nerves

244

2.50

9.43

1.7

1.2

95.90

53.09

e6/l

0.27

180

Disorders of vitreous body

692

5118

1.29

9.42

1.4

33.17

34.85

e6/l

0.05

513

3772

Persistent delusional disorders

120

651

1.88

9.40

1.3

1.4

11.81

38.03

e6/l

1.11

479

Sequelae of injuries of neck and trunk

238

2.51

9.40

1.8

1.5

25.63

29.48

e6/l

0.06

172

Other condition

228

1470

1.57

9.37

1.8

1.4

41.98

26.21

e6/l

0.28

184

1081

Senile cataract

845

4065

1.27

9.35

1.4

13.94

40.41

e6/l

3.71

617

3004

Postzoster neuralgia

115

3.26

9.33

1.2

1.3

17.21

11.40

e6/l

0.26

Insulin, fast-acting or short human

527

3956

1.34

9.33

1.5

18.26

26.75

e6/l

0.84

400

2938

Examination and encounter for administrative purposes

104

539

1.96

9.32

1.3

1.4

15.89

47.14

e6/l

1.08

384

Dialysis, with operation codes

189

1171

1.64

9.21

1.7

1.5

12.28

26.70

e6/l

0.94

131

844

Other specified and unspecified disorders of eye and adnexa

290

2.33

9.18

1.4

21.02

13.01

e6/l

0.27

217

Reactive arthropathies

133

751

1.80

9.14

1.2

1.4

86.63

24.76

e6/l

0.71

101

559

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

436

3194

1.38

9.12

1.4

10.67

29.26

e6/l

3.70

328

2337

Emotional disorders starting during childhood or adolescence

101

519

1.97

9.10

3.1

2.2

20.96

22.18

e6/l

0.04

364

Spondylopathies (FG)

209

1332

1.59

9.04

1.4

61.30

22.73

e6/l

0.77

166

981

Other specified/unspecified inflammatory spondylopathies

369

2.16

9.04

1.4

16.08

43.24

e6/l

0.67

275

Tinnitus

338

2379

1.43

8.99

1.3

1.4

55.71

25.86

e6/l

0.35

243

1745

Haemorrhage, not elsewhere classified

183

2.67

8.98

2.4

1.3

46.75

8.47

e6/l

0.42

132

Excessive, frequent and irregular menstruation

565

2270

1.34

8.97

1.4

18.13

28.11

e6/l

0.72

423

1696

Other arrhythmias

979

5934

1.24

8.93

1.3

1.4

34.04

30.53

e6/l

0.14

736

4356

Specific development disorders of scholastic skills

484

1.99

8.87

2.9

2.5

5.38

14.63

e6/l

1.51

341

Cholecystectomy

1001

6936

1.23

8.84

1.3

1.4

34.13

31.86

e6/l

0.06

734

5154

Diabetes medication

1588

7860

1.18

8.83

1.4

32.32

33.61

e6/l

0.05

1162

5817

Endometriosis of pelvic peritoneum

248

1497

1.52

8.80

1.3

15.67

32.00

e6/l

0.92

172

1124

Other and unspecified urticaria

304

2108

1.46

8.80

1.6

13.50

25.66

e6/l

0.99

231

1532

Abnormal reflex

5.16

8.79

1.3

1.2

1.55

18.25

e6/l

0.54

Infections with a predominantly sexual mode of transmission

482

3601

1.35

8.77

1.5

1.3

23.95

31.73

e6/l

0.48

340

2672

Other inflammation of eyelid

212

1366

1.57

8.76

1.6

1.4

5.27

23.78

e6/l

2.80

138

991

Personal history of risk-factors, not elsewhere classified

115

3.17

8.70

2.0

1.6

3.15

19.81

e6/l

1.14

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

292

2015

1.46

8.67

1.2

1.4

37.08

29.91

e6/l

0.12

203

1487

Superficial injury of thorax

219

1427

1.55

8.61

1.3

1.4

37.20

26.09

e6/l

0.19

155

1054

Fracture at wrist and hand level

521

3944

1.33

8.59

1.3

1.5

24.03

33.73

e6/l

0.37

387

2920

Other specified/unspecified systemic involvement of connective tissue

493

1.97

8.59

1.4

1.5

7.33

34.43

e6/l

1.19

355

False labour

479

2208

1.36

8.58

1.3

18.41

37.28

e6/l

1.09

357

1622

Other coagulation defects

122

686

1.81

8.56

1.7

1.5

33.11

36.81

e6/l

0.07

515

Childhood asthma (age<16)

192

942

1.61

8.50

1.5

1.4

13.34

24.60

e6/l

0.88

145

660

Reactive arthropathies, FINNGEN

112

615

1.85

8.49

1.2

1.4

99.00

23.07

e6/l

0.73

461

Cellulitis

328

2323

1.42

8.46

1.7

1.5

68.90

27.64

e6/l

0.57

244

1699

Other female pelvic inflammatory diseases

233

1546

1.52

8.45

1.3

9.22

39.63

e6/l

2.26

180

1135

Striking against or struck by other objects

518

3935

1.32

8.45

1.4

1.5

29.81

24.94

e6/l

0.18

368

2885

Mental and behavioural disorders due to use of other stimulants, including caffeine

276

2.31

8.43

1.5

1.7

36.11

14.91

e6/l

0.73

209

Use of amantadine

128

3.01

8.42

1.1

1.2

5.04

17.31

e6/l

0.85

Other and unspecified mononeuropathies, also in other diseases

220

2.48

8.41

1.4

1.5

7.65

10.92

e6/l

0.24

156

Other disorders of the musculoskeletal system and connective tissue

212

1380

1.55

8.40

1.4

1.3

11.55

31.53

e6/l

1.49

157

1026

Corneal ulcer

278

1913

1.47

8.40

1.3

1.4

53.92

18.70

e6/l

1.03

221

1400

Atrial fibrillation and flutter

379

1757

1.40

8.37

1.4

1.3

52.83

26.03

e6/l

0.55

270

1275

Intentional self-harm by unspecified means

102

3.27

8.36

1.4

1.3

9.10

13.43

e6/l

0.18

Childhood asthma (age<16), excluding more controls

191

940

1.60

8.36

1.5

1.4

13.40

23.90

e6/l

0.79

144

659

Diabetic retinopathy, excluding more controls

335

1313

1.44

8.35

1.5

1.4

18.78

17.53

e6/l

0.07

249

969

Complications of genitourinary prosthetic devices, implants and grafts

197

2.56

8.33

1.4

34.62

57.26

e6/l

0.24

151

Vascular dementia (undefined)

143

2.80

8.29

1.3

2.45

74.54

e6/l

0.99

107

Procreative management

530

3330

1.32

8.27

1.5

1.6

26.91

44.01

e6/l

0.60

374

2399

Suppurative and unspecified otitis media

567

3871

1.30

8.26

1.9

1.4

43.91

22.34

e6/l

0.51

419

2842

Impotence

410

2.04

8.23

1.4

18.63

13.19

e6/l

0.25

302

Episcleritis

494

1.94

8.21

1.1

1.4

25.04

23.76

e6/l

0.02

361

Disorders of tooth development and eruption

244

1329

1.51

8.21

1.6

1.4

11.07

26.02

e6/l

1.99

161

981

Renal failure

605

4008

1.29

8.17

1.4

1.5

14.81

29.05

e6/l

1.71

445

3022

Viral pneumonia (unknown virus, not influenza)

114

638

1.82

8.16

1.5

84.06

32.32

e6/l

0.46

472

Metatarsalgia

140

831

1.71

8.11

1.2

1.5

13.97

41.61

e6/l

1.48

103

603

Glomerular diseases

248

1684

1.49

8.04

1.5

69.94

27.77

e6/l

0.41

181

1226

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

450

3383

1.34

8.02

1.4

1.5

18.98

31.66

e6/l

0.68

324

2497

Fracture of lower leg, including ankle

802

6360

1.24

8.01

1.4

1.5

17.29

36.05

e6/l

2.96

585

4703

Amblyopia ex anopsia

368

2.08

7.98

1.7

2.4

25.23

11.89

e6/l

0.41

267

SLE, ICD10

283

2.25

7.95

1.3

1.4

17.69

36.33

e6/l

0.38

205

SLE, strict definition

283

2.25

7.95

1.3

1.4

17.69

36.33

e6/l

0.38

205

Gonarthrosis [arthrosis of knee](FG)

1046

4961

1.22

7.95

1.4

28.67

32.72

e6/l

0.18

779

3668

Dermatographic urticaria

115

651

1.80

7.93

1.3

1.4

92.99

31.33

e6/l

0.30

482

Causalgia

127

2.94

7.92

1.3

1.5

3.93

8.73

e6/l

0.40

Myositis

190

2.54

7.91

1.3

4.66

87.96

e6/l

1.19

143

Systemic lupus erythematosus

297

2.21

7.88

1.3

1.5

17.06

31.90

e6/l

0.31

218

Otalgia

140

839

1.69

7.86

2.0

1.7

133.96

29.73

e6/l

0.62

105

611

Motor disorders, excluding more controls

124

2.91

7.85

2.3

4.8

8.88

9.21

e6/l

0.01

Use of biperiden

460

1.95

7.83

1.4

23.63

34.38

e6/l

0.23

340

Other symptoms and signs involving the digestive system and abdomen

223

1490

1.51

7.83

1.5

17.61

56.71

e6/l

1.66

161

1077

Chondrocostal junction syndrome [Tietze]

318

2.16

7.79

1.4

1.5

64.23

31.28

e6/l

0.36

238

Gout

337

2080

1.40

7.79

1.5

1.4

62.24

28.25

e6/l

0.41

235

1574

Disease of hard tissues of teeth, NOS

722

2995

1.27

7.78

1.4

24.68

25.39

e6/l

0.03

523

2256

Lesion of radial nerve

305

2.18

7.78

1.2

1.4

10.50

11.85

e6/l

0.09

219

Lateral epicondylitis

185

1190

1.57

7.76

1.3

1.4

26.13

35.69

e6/l

0.39

144

872

Thyroiditis, ILD-related definition

167

1050

1.61

7.74

1.3

1.5

37.74

28.96

e6/l

0.16

132

752

Disorder of lipoprotein metabolism, unspecified

158

980

1.63

7.72

1.2

1.3

29.82

26.63

e6/l

0.05

106

751

Sequelae of other external causes

519

1.88

7.71

1.6

1.4

30.48

34.57

e6/l

0.08

390

Diabetes mellitus

1551

7667

1.17

7.70

1.4

32.87

34.17

e6/l

0.05

1142

5675

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

113

3.05

7.68

1.3

1.5

1.45

12.28

e6/l

1.02

Benign neoplasm: Spinal cord

113

3.04

7.68

1.8

1.2

36.79

18.81

e6/l

0.37

Other/unspecified enthesopathies of lower limb, excluding foot

105

584

1.82

7.67

1.3

1.5

18.14

31.21

e6/l

0.43

422

Behavioural disorders

200

2.48

7.62

1.3

1.9

29.58

14.10

e6/l

0.45

149

Poisoning by narcotics and psychodysleptics [hallucinogens]

130

2.87

7.60

2.9

1.4

55.05

25.40

e6/l

0.51

Acute mastoiditis

3.84

7.59

1.2

1.5

798.21

16.90

e6/l

0.64

Injuries to the elbow and forearm

1064

7611

1.20

7.55

1.4

1.5

24.77

32.55

e6/l

0.68

785

5607

Cholelithiasis, broad definition with cholecystitis

1241

6967

1.19

7.54

1.3

1.4

43.35

30.59

e6/l

0.37

910

5201

Meniscus derangement

760

4057

1.25

7.51

1.4

17.97

35.40

e6/l

1.61

566

2985

Congenital iodine-deficiency syndrome/hypothyroidism

201

2.45

7.51

1.6

1.8

207.34

46.24

e6/l

0.36

145

Hyperfunction of pituitary gland

439

1.95

7.50

1.3

1.6

182.66

20.86

e6/l

0.48

322

Noninfectious colitis NAS

204

1354

1.52

7.45

1.4

1.6

9.47

27.17

e6/l

1.62

150

991

Other neurotic disorders

337

2.09

7.43

1.4

6.56

42.73

e6/l

1.09

248

Other hearing loss

342

2416

1.38

7.41

1.3

1.4

28.57

27.26

e6/l

0.03

263

1810

Impingement syndrome of shoulder

305

2188

1.40

7.37

1.5

1.4

26.72

38.63

e6/l

0.49

252

1600

Anogenital herpesviral [herpes simplex] infection, including avohilmo

184

1198

1.55

7.36

1.4

1.3

31.65

20.61

e6/l

0.50

131

887

Early onset COPD, excluding more controls

237

1622

1.47

7.36

1.5

1.3

53.69

18.29

e6/l

0.39

181

1193

Type 1 diabetes

367

2710

1.36

7.35

1.5

29.00

28.74

e6/l

0.01

284

2029

Solid cancers

1228

6072

1.19

7.35

1.5

1.4

58.63

30.62

e6/l

0.95

856

4536

Ischemic heart diseases

1184

5929

1.19

7.33

1.3

1.5

25.26

37.16

e6/l

0.78

930

4296

Diseases of peritoneum

142

871

1.65

7.31

1.5

1.4

3.98

31.62

e6/l

2.15

645

Other acute viral hepatitis

111

3.01

7.31

1.0

1.3

26.80

14.56

e6/l

0.26

Other/unspecified soft tissue disorders related to use, overuse and pressure

216

2.37

7.30

1.3

1.4

11.78

42.71

e6/l

0.56

161

Tobacco use

500

1.88

7.30

1.3

1.4

65.62

35.81

e6/l

0.21

372

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

300

2.15

7.29

1.3

1.6

10.87

19.66

e6/l

0.30

225

Infection of intervertebral disc (pyogenic)

3.17

7.27

1.7

1.3

2.31

43.86

e6/l

0.64

Benign neoplasm of colon, rectum, anus and anal canal

837

5793

1.23

7.27

1.4

37.53

34.03

e6/l

0.09

623

4308

Orchitis and epididymitis

122

720

1.71

7.26

1.5

61.97

20.25

e6/l

0.39

100

546

Viral pneumonia (known virus, not influenza)

236

2.31

7.25

1.7

2.0

124.18

47.09

e6/l

0.35

175

Cholecystitis

179

1163

1.55

7.20

1.3

12.32

26.34

e6/l

0.94

133

868

Diabetes, varying definitions

1538

7671

1.17

7.20

1.4

33.05

34.07

e6/l

0.04

1131

5679

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

830

6523

1.22

7.17

1.5

1.4

20.78

33.29

e6/l

1.07

577

4822

Type 2 diabetes

1456

7225

1.17

7.14

1.4

32.60

34.78

e6/l

0.08

1068

5345

Mononeuritis multiplex

7.66

7.14

1.4

1.1

429.80

2.79

e6/l

—

Glaucoma

716

4909

1.24

7.12

1.4

21.95

33.39

e6/l

0.74

544

3646

Unspecified misadventure during surgical and medical care

497

1.86

7.12

1.8

1.4

28.97

43.57

e6/l

0.22

372

Event of undetermined intent

109

629

1.76

7.09

1.6

1.5

17.76

29.14

e6/l

0.40

462

Nonsuppurative otitis media, including avohilmo

492

3288

1.30

7.09

1.5

1.4

81.54

20.61

e6/l

1.03

366

2404

Other and unspecified erythematous conditions

264

2.21

7.09

1.4

1.8

192.36

36.89

e6/l

0.38

197

Dipeptidyl peptidase 4 (DPP-4) inhibitors

713

4509

1.25

7.09

1.4

38.73

32.02

e6/l

0.16

533

3361

Other diseases of pleura

561

3831

1.28

7.08

1.5

1.4

16.60

28.88

e6/l

0.99

407

2878

Conduct disorder

201

2.41

7.07

1.3

2.0

30.43

17.13

e6/l

0.35

148

Abnormal serum enzyme levels

384

2774

1.34

7.06

1.3

1.4

57.53

22.79

e6/l

0.51

271

2097

Superficial injury of shoulder and upper arm

182

1194

1.54

7.05

1.3

1.5

91.12

29.94

e6/l

0.39

130

881

Disorder of the sleep-wake schedule

159

2.60

7.04

1.4

2.4

11.55

10.34

e6/l

0.05

118

Acute suppurative otitis media

420

2970

1.33

7.02

2.1

1.4

56.95

22.73

e6/l

0.62

307

2188

Acute myeloid leukaemia, helper endpoint

3.16

7.00

2.8

1.2

13.17

63.36

e6/l

0.46

Acute myeloid leukaemia

3.16

7.00

2.8

1.2

13.17

63.36

e6/l

0.46

Acute myeloid leukaemia, including Hilmo

3.16

7.00

2.8

1.2

13.17

63.36

e6/l

0.46

Paralytic ileus

272

2.17

6.97

1.4

1.6

6.87

43.67

e6/l

0.94

204

Other fall from one level to another

334

2455

1.37

6.97

1.9

1.5

53.00

25.98

e6/l

0.36

258

1788

Other erythematous conditions

299

2.12

6.96

1.3

1.7

173.72

43.96

e6/l

0.34

231

Burns classified according to extent of body surface involved

3.40

6.96

1.3

1.2

1.11

6.67

e6/l

0.77

Other abnormal immunological findings in serum

172

2.52

6.95

1.1

1.9

37.96

12.29

e6/l

0.33

129

Haemorrhage in early pregnancy

402

2953

1.33

6.93

1.2

1.3

10.33

44.76

e6/l

3.30

322

2152

Candidiasis

209

1417

1.49

6.92

1.5

1.4

65.13

32.10

e6/l

0.23

159

1015

Other enthesopathy of foot (+metatarsalgia)

148

931

1.61

6.90

1.2

1.5

13.50

42.46

e6/l

1.74

107

675

Other specified/unspecified hearing loss

125

754

1.68

6.90

1.3

1.5

35.52

26.21

e6/l

0.12

560

Myocarditis

333

2.04

6.89

1.8

1.3

10.84

12.96

e6/l

0.15

240

Heart failure and antihypertensive medication

304

1417

1.40

6.88

1.4

61.87

24.78

e6/l

0.42

231

1043

Other and unspecified syphilis, including avohilmo

7.03

6.85

1.1

11.11

3.76

e6/l

—

Crohn disease

199

1339

1.50

6.85

1.4

1.5

26.09

27.84

e6/l

0.05

143

978

Other retinal disorders

850

5321

1.22

6.85

1.5

1.4

27.36

31.30

e6/l

0.10

606

3992

Malignant neoplasm of digestive organs

283

2991

0.72

6.83

1.3

1.4

15.40

26.15

e6/l

1.06

203

2268

Carrier of infectious disease

192

2.41

6.80

1.4

1.6

19.13

13.92

e6/l

0.24

147

Necrosis of pulp, including avohilmo

889

7303

1.21

6.78

1.3

1.4

12.69

36.84

e6/l

5.42

660

5371

Other diseases of intestine

208

1415

1.48

6.76

1.4

29.75

28.59

e6/l

0.02

146

1039

Fitting and adjustment of other devices

436

2941

1.31

6.75

1.5

1.4

23.55

23.16

e6/l

0.01

372

2166

Cholelithiasis

1182

6850

1.18

6.73

1.3

1.4

45.86

30.72

e6/l

0.44

871

5114

Other diseases of oesophagus

124

752

1.67

6.70

1.3

1.4

49.96

33.59

e6/l

0.20

557

Drug-induced headache, not elsewhere classified

4.07

6.69

1.3

1.1

3.00

2.97

e6/l

0.01

Ulcer of vagina/vulva

251

2.21

6.69

1.1

1.6

49.45

19.19

e6/l

0.51

184

Acute myeloid leukaemia and myelodysplastic syndromes

175

2.46

6.69

2.2

1.3

10.42

56.26

e6/l

0.78

147

Other (not insulin) diabetes medications

1423

7189

1.16

6.67

1.4

32.87

35.04

e6/l

0.08

1041

5328

Personality and behavioural disorders due to brain disease, damage and dysfunction

3.19

6.65

1.8

1.3

22.78

15.93

e6/l

0.18

Scleritis

106

2.94

6.64

1.1

2.32

3.58

e6/l

0.61

Fentanyl

122

738

1.67

6.60

1.4

44.07

26.13

e6/l

0.32

547

Other and unspecified mononeuropathies of upper limb

233

2.24

6.58

1.6

1.3

20.65

10.85

e6/l

0.30

161

Tonsillectomy and adenotomy

889

5137

1.21

6.58

1.4

1.5

19.33

32.78

e6/l

1.32

666

3744

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

6.14

6.57

1.5

2.5

2.45

22.83

e6/l

0.47

Disorders in reading

171

2.49

6.57

4.7

2.6

2.71

16.61

e6/l

1.34

116

Redundant prepuce, phimosis and paraphimosis

274

1939

1.40

6.56

1.4

1.5

26.84

31.25

e6/l

0.11

199

1449

Urolithiasis

412

3154

1.31

6.55

1.4

51.23

27.49

e6/l

0.37

301

2343

Other peripheral vascular diseases

120

727

1.67

6.55

1.1

1.4

14.78

36.13

e6/l

0.83

541

Injury of nerves and spinal cord at neck level

177

2.44

6.55

1.5

1.3

3.25

33.00

e6/l

0.89

129

Testicular dysfunction

348

1.99

6.51

1.3

1.4

11.84

23.06

e6/l

0.42

242

Hernia

1353

7736

1.17

6.51

1.4

32.47

34.70

e6/l

0.07

994

5758

Allergic conjunctivitis

863

6910

1.21

6.50

1.5

21.03

33.17

e6/l

1.08

601

5111

Vitreous haemorrhage

142

899

1.60

6.48

1.5

1.4

10.78

22.14

e6/l

0.64

104

664

Collagenous colitis

137

861

1.61

6.46

1.4

46.63

34.02

e6/l

0.19

109

633

Molar incisor enamel hypoplasia, with caries

102

3.00

6.46

11.2

2.5

6.14

14.67

e6/l

0.47

Hereditary motor and sensory neuropathy

3.61

6.40

1.4

1.8

2.87

12.55

e6/l

0.44

Neuralgic amyotrophy

7.87

6.38

1.1

1.88

3.47

e6/l

—

Inflammatory diseases of prostate (prostatitis)

156

1013

1.55

6.36

1.4

12.44

25.24

e6/l

0.93

114

767

Care involving dialysis

105

619

1.72

6.35

1.5

1.7

11.59

18.53

e6/l

0.35

449

Spasmodic torticollis

270

2.12

6.34

1.2

1.5

2.41

17.53

e6/l

2.25

196

Polyarthrosis

260

1676

1.41

6.33

1.4

26.35

33.51

e6/l

0.24

207

1238

Use of disulfiram, acamprosate or naltrexone

136

858

1.61

6.33

1.4

106.20

23.64

e6/l

0.39

636

Vasomotor and allergic rhinitis

557

4346

1.26

6.31

1.3

1.5

42.46

36.57

e6/l

0.10

430

3160

Diseases of tongue

487

1.81

6.30

1.5

1.4

7.62

33.84

e6/l

1.72

368

Other ill-defined and unspecified causes of mortality

110

658

1.69

6.30

1.3

9.61

34.55

e6/l

1.15

494

Eating disorders

171

1135

1.52

6.29

1.3

1.6

11.99

21.33

e6/l

0.88

131

832

Arthropathies in other diseases classified elsewhere

291

2.07

6.28

1.8

1.4

75.31

33.00

e6/l

0.33

228

Dislocation, sprain and strain of joints and ligaments of thorax

291

2.07

6.27

1.3

1.5

4.30

23.87

e6/l

1.02

220

Disorders of parathyroid gland

243

1708

1.42

6.24

1.3

1.4

29.18

36.03

e6/l

0.20

169

1277

Orthopaedic devices associated with adverse incidents

154

0.00

6.23

0.0

1.2

—

73.75

—

118

Glomerulonephritis

140

893

1.59

6.22

1.5

1.6

26.71

30.69

e6/l

0.07

661

Vestibular neuronitis

126

784

1.63

6.21

1.2

1.3

9.50

33.00

e6/l

1.34

574

Pregnancy examination and test

248

1085

1.43

6.21

1.3

20.51

40.04

e6/l

0.57

189

790

Disorders of pituitary gland, other and/or unspecified

3.83

6.19

1.3

58.33

5.67

e6/l

0.43

Chronic periodontitis, including avohilmo

1449

8026

1.15

6.17

1.3

1.4

33.85

32.14

e6/l

0.05

1033

6009

Rheumatoid arthritis

411

2804

1.30

6.15

1.3

1.4

26.09

35.61

e6/l

0.50

297

2068

Pyogenic arthritis

513

1.78

6.15

1.3

1.4

18.29

21.13

e6/l

0.06

386

Open wound of wrist and hand

658

5185

1.23

6.14

1.3

1.5

34.47

34.33

e6/l

0.00

464

3838

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

328

1.99

6.14

1.3

1.7

19.86

19.87

e6/l

0.00

244

Osteonecrosis

544

1.76

6.12

1.9

1.4

17.06

42.08

e6/l

0.64

399

Injury of eye and orbit

202

1396

1.46

6.11

1.3

1.4

21.69

25.93

e6/l

0.16

154

1045

Testicular hypofunction

315

2.01

6.10

1.3

1.4

12.42

25.13

e6/l

0.43

215

Other diseases of liver

254

1830

1.40

6.09

1.4

25.14

27.05

e6/l

0.08

177

1352

Periodontitis

1450

8031

1.15

6.09

1.4

33.77

32.13

e6/l

0.05

1036

6011

Chondropathies

221

1555

1.43

6.08

1.6

1.4

29.13

26.18

e6/l

0.09

162

1141

Other specified/unspecified dorsopathies

254

2.13

6.08

1.2

1.6

3.84

48.10

e6/l

0.97

184

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1372

7042

1.16

6.07

1.4

29.07

35.27

e6/l

0.28

1013

5219

355

1.93

6.06

1.4

1.2

5.93

46.31

e6/l

1.25

287

Mixed disorders of conduct and emotions, excluding more controls

177

2.37

6.06

1.3

2.1

44.86

19.21

e6/l

0.62

128

Toxic effect of other and unspecified substances

106

2.84

6.05

1.6

1.4

1.20

15.14

e6/l

1.19

Acute lymphadenitis

531

1.76

6.05

2.0

1.6

11.86

22.33

e6/l

0.42

393

Hypogonadotropic hypogonadism

255

2.13

6.04

1.3

1.5

45.49

17.85

e6/l

0.56

178

Other and unspecified coagulation defects

473

1.81

6.02

1.4

1.5

35.77

31.12

e6/l

0.07

353

Eating disorder

146

946

1.56

6.02

1.3

1.6

12.84

22.67

e6/l

0.77

113

695

Vertical strabismus

296

2.04

6.02

2.2

1.7

19.23

33.96

e6/l

0.33

219

Atypical virus infections of central nervous system

3.26

6.00

1.3

1.1

5.13

6.33

e6/l

0.11

Hypercalcemia

373

1.91

5.99

1.2

1.5

18.83

55.77

e6/l

0.70

271

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

3.46

5.99

1.5

1.2

10.15

79.51

e6/l

0.44

Iridocyclitis in diseases classified elsewhere

160

2.45

5.97

1.4

1.6

6.81

8.78

e6/l

0.16

122

Medical abortion

887

4011

1.20

5.97

1.3

1.4

16.42

36.91

e6/l

2.55

643

2950

Cerebral atherosclerosis

3.12

5.96

1.5

1.1

4.93

12.05

e6/l

0.36

Calculus of kidney and ureter

382

2937

1.31

5.94

1.4

52.41

28.26

e6/l

0.35

282

2187

Other and unspecified intracranial injuries

204

2.25

5.94

3.3

1.4

15.52

55.86

e6/l

0.67

153

Pedestrian injured in transport accident

105

632

1.68

5.92

1.2

1.4

8.40

39.68

e6/l

1.50

463

Systemic lupus erythematosus, unspecified

251

2.12

5.90

1.2

1.4

13.09

13.49

e6/l

0.02

181

Superficial injury of forearm

158

1049

1.52

5.88

1.3

1.7

16.38

30.04

e6/l

0.65

125

771

Atypical virus infections of central nervous system, including avohilmo

3.21

5.88

1.3

1.1

5.13

6.33

e6/l

0.11

Excessive attrition of teeth

917

7672

1.19

5.88

1.4

36.58

30.19

e6/l

0.15

662

5637

Abnormal findings on diagnostic imaging of lung

590

4528

1.24

5.86

1.3

1.4

16.12

32.49

e6/l

1.58

436

3395

Benign neoplasm of other and ill-defined parts of digestive system

225

1599

1.42

5.86

1.4

1.3

36.61

34.06

e6/l

0.04

178

1187

Other diseases of anus and rectum

389

2992

1.30

5.85

1.3

1.4

14.36

28.62

e6/l

1.65

280

2232

Other keratitis

168

1131

1.50

5.85

1.5

1.4

16.44

21.61

e6/l

0.25

116

824

Cushing syndrome

2.90

5.84

1.2

2.00

18.36

e6/l

1.00

Follicular lymphoma, hilmo

320

1.98

5.84

1.5

1.3

5.02

57.68

e6/l

1.21

230

Benign neoplasm: Colon

691

5342

1.22

5.83

1.4

21.50

34.21

e6/l

1.09

520

3979

Fibroblastic disorders

269

1970

1.37

5.83

1.4

40.77

33.89

e6/l

0.13

196

1465

Nail disorders

129

821

1.59

5.82

1.5

106.57

34.19

e6/l

0.35

101

583

Retinal detachments and breaks

440

3455

1.28

5.82

1.4

25.57

33.26

e6/l

0.33

315

2590

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

246

2.12

5.80

8.2

1.6

261.86

25.79

e6/l

0.47

185

Neovascular glaucoma

307

1.99

5.78

1.8

1.3

31.39

56.37

e6/l

0.34

234

Chronic iridocyclitis

450

1.81

5.77

1.4

1.5

9.02

23.56

e6/l

0.54

333

Any event in hilmo or specialist outpatient

+∞

5.77

2.1

0.0

1.14

—

e6/l

—

Sicca syndrome [Sjögren]

119

745

1.62

5.76

1.4

1.3

4.07

42.40

e6/l

2.48

544

Nonsuppurative otitis media

348

2297

1.32

5.75

1.8

1.5

104.10

20.54

e6/l

1.05

270

1684

Other disorders involving the immune mechanism, not elsewhere classified

267

2.07

5.75

7.8

1.6

241.24

24.13

e6/l

0.47

201

Gout, FINNGEN

337

2542

1.32

5.74

1.5

1.4

62.24

25.77

e6/l

0.45

235

1911

Sequelae of other accidents

109

2.74

5.74

1.3

1.2

45.08

21.17

e6/l

0.27

Car occupant injured in other and unspecified transport accidents

274

2020

1.37

5.73

1.4

17.92

24.70

e6/l

0.40

206

1486

Dermatitis due to substances taken internally

488

1.77

5.72

1.6

32.31

24.82

e6/l

0.18

357

Gastric ulcer

207

1456

1.43

5.71

1.4

1.3

73.96

27.86

e6/l

0.44

156

1088

Folate deficiency anaemia

3.22

5.70

1.2

500.38

16.14

e6/l

0.48

Budesonide

199

1392

1.44

5.68

1.6

1.3

87.19

24.34

e6/l

0.51

146

1016

Overexertion and strenuous or repetitive movements

148

977

1.53

5.68

1.5

1.4

13.86

31.49

e6/l

1.01

728

Meralgia paraesthetica

289

2.01

5.66

1.3

1.5

7.39

33.47

e6/l

0.63

208

Continuous positive airway pressure

207

1209

1.43

5.66

1.7

1.6

35.63

14.44

e6/l

0.82

149

871

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

221

1576

1.41

5.65

1.8

1.6

26.33

25.60

e6/l

0.02

159

1148

Calcific tendinitis of shoulder

483

1.76

5.62

1.6

1.4

28.04

51.48

e6/l

0.47

354

Toxic effects of substances chiefly nonmedicinal as to source

172

1174

1.48

5.61

1.3

1.6

17.39

27.59

e6/l

0.52

135

856

Other and unspecified disorders of adult personality and behaviour

3.55

5.58

1.5

1.3

4.33

18.47

e6/l

—

Poisoning by medicine, drug-induced

111

2.71

5.58

1.2

2.00

12.62

e6/l

0.94

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

147

2.46

5.56

5.1

2.7

1.28

11.34

e6/l

1.37

116

Astigmatism

104

635

1.66

5.56

2.5

2.1

38.91

37.70

e6/l

0.02

464

Injury of muscle and tendon at shoulder and upper arm level

465

3698

1.26

5.56

1.3

1.4

25.85

27.39

e6/l

0.04

354

2741

Abnormal results of function studies

129

831

1.57

5.54

1.3

1.5

4.50

26.79

e6/l

2.10

620

Other embolism and thrombosis

167

1136

1.48

5.54

1.4

49.33

26.09

e6/l

0.30

126

841

Other maltreatment syndromes

292

2.00

5.52

1.4

18.45

15.52

e6/l

0.12

212

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

243

1769

1.38

5.51

1.7

1.6

23.97

26.64

e6/l

0.11

176

1291

Ill-defined and unknown causes of mortality

114

714

1.61

5.50

1.3

1.4

9.35

32.72

e6/l

1.16

102

534

Other disorders of patella

238

1730

1.39

5.46

1.2

1.4

29.38

41.17

e6/l

0.28

185

1266

Thyrotoxicosis, other and/or unspecified

273

2028

1.36

5.46

1.5

1.4

92.88

35.11

e6/l

0.68

203

1481

Other local infections of skin and subcutaneous tissue

149

994

1.52

5.45

2.5

1.5

27.44

28.70

e6/l

0.03

115

736

Effects of other external causes

266

2.04

5.44

1.2

1.5

17.85

19.35

e6/l

0.04

196

Glaucoma suspect

450

3573

1.27

5.43

1.4

10.55

29.24

e6/l

2.69

351

2649

Other and unspecified local infections of skin and subcutaneous tissue

141

931

1.53

5.42

2.6

1.5

28.78

29.51

e6/l

0.02

109

692

Sulfasalazine

377

2932

1.29

5.42

1.3

49.49

32.18

e6/l

0.45

290

2139

Ganglion

280

2090

1.35

5.42

1.4

41.71

45.28

e6/l

0.07

214

1529

Other and unspecified injuries of lower leg

121

773

1.58

5.41

1.3

1.5

34.71

38.17

e6/l

0.04

572

Otitis media, unspecified

180

1148

1.46

5.39

2.0

1.6

90.83

24.09

e6/l

0.49

130

829

Exposure to excessive heat of man-made origin

3.41

5.39

1.1

1.2

0.79

5.18

e6/l

1.10

Menorrhagia

457

2010

1.27

5.38

1.3

1.4

25.27

29.26

e6/l

0.17

337

1511

Ankylosing spondylitis

111

695

1.61

5.38

1.4

66.90

28.15

e6/l

0.39

502

Other cataract

568

3432

1.23

5.35

1.4

15.76

42.14

e6/l

2.25

426

2532

Injury of muscle and tendon at wrist and hand level

189

1326

1.44

5.35

1.4

15.86

27.69

e6/l

0.60

144

985

Biguanides

1367

7212

1.15

5.34

1.4

34.88

35.15

e6/l

0.01

994

5350

Cerebral palsy

150

2.41

5.33

2.7

2.0

39.50

12.44

e6/l

0.35

Fracture of femur

296

2008

1.33

5.32

1.4

19.17

24.82

e6/l

0.21

232

1494

Hypoplasia of dental enamel

120

2.64

5.31

10.7

4.3

6.05

6.95

e6/l

0.06

Glaucoma secondary to other eye disorders

317

1.92

5.30

1.8

1.3

31.39

58.22

e6/l

0.37

233

Kidney transplant status

500

1.73

5.30

1.5

1.8

22.60

30.20

e6/l

0.17

361

Raynaud syndrome

133

873

1.54

5.28

1.3

1.4

10.16

35.09

e6/l

1.43

100

635

Respiratory insufficiency

520

1.70

5.27

1.7

1.4

5.69

11.02

e6/l

0.93

376

Methotrexate

182

1273

1.44

5.24

1.3

39.68

24.65

e6/l

0.34

139

939

Acute laryngitis and tracheitis

178

1220

1.45

5.24

2.2

1.5

22.09

31.02

e6/l

0.26

135

869

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

177

1225

1.45

5.24

1.7

2.0

11.82

30.96

e6/l

1.48

135

899

Other inflammation of eyelid, including avohilmo

657

5455

1.21

5.24

1.5

1.4

38.97

35.13

e6/l

0.07

448

4021

Disorders of breast

690

5058

1.21

5.22

1.4

21.31

37.64

e6/l

1.25

510

3737

Ingrowing nail

487

1.73

5.21

1.6

1.5

158.31

33.29

e6/l

0.42

354

Divergent concomitant strabismus

110

694

1.61

5.20

1.7

1.6

10.78

38.14

e6/l

1.33

510

Vertigo of central origin

115

2.60

5.20

1.1

1.2

5.35

18.81

e6/l

0.86

Vascular dementia (other)

5.40

5.15

1.4

1.1

53.43

3.50

e6/l

—

Other disorders of white blood cells

474

1.74

5.14

2.8

1.5

7.83

42.06

e6/l

1.18

352

Biomechanical lesions, not elsewhere classified

437

1.77

5.13

1.3

1.4

5.66

46.83

e6/l

1.41

330

Gastroduodenal ulcer

291

2196

1.33

5.12

1.3

1.4

81.53

27.95

e6/l

0.65

215

1645

Disorders of synovium and tendon in diseases classified elsewhere

140

2.41

5.12

1.3

1.2

14.27

8.82

e6/l

0.22

104

Other abnormalities of plasma proteins

110

2.62

5.12

1.4

1.2

11.87

16.75

e6/l

0.15

Vitamin D deficiency

172

2.27

5.11

1.2

1.5

28.91

15.16

e6/l

0.35

128

Dissection of cerebral arteries, nonruptured

3.42

5.11

1.6

1.1

38.67

23.31

e6/l

0.16

Extracorporeal dialysis

505

1.71

5.11

1.5

3.65

30.48

e6/l

1.45

379

Car occupant injured in noncollision transport accident

315

1.91

5.08

1.2

1.4

5.93

26.06

e6/l

1.11

233

Myopia

193

1373

1.42

5.08

1.4

1.6

41.94

27.35

e6/l

0.42

147

993

Vascular dementia (mixed)

2.81

5.07

1.5

1.3

1.72

112.28

e6/l

0.95

Marginal zone B-cell lymphoma, including Hilmo

129

2.48

5.05

1.4

1.2

99.38

34.50

e6/l

0.31

101

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.16

5.03

1.2

1.5

12.00

18.50

e6/l

0.19

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

345

1.86

5.02

1.7

1.5

16.50

18.36

e6/l

0.07

248

Adenomyosis (Endometriosis of uterus)

183

1290

1.43

5.02

1.4

19.19

34.27

e6/l

0.66

129

967

Artrosis, including avohilmo

1204

5732

1.15

5.01

1.3

1.4

28.91

34.35

e6/l

0.30

891

4229

Hyperkalaemia

388

1.80

5.01

1.4

1.3

8.71

32.81

e6/l

0.79

299

Amyloidosis

167

2.27

5.00

1.3

13.22

60.50

e6/l

0.64

131

Other/unspecified reactive arthropathies

608

1.63

4.99

1.2

1.4

108.19

28.52

e6/l

0.63

452

Type 1 diabetes, wide definition, subgroup 1

295

2246

1.32

4.99

1.4

1.5

24.06

27.74

e6/l

0.18

224

1662

Postmenopausal osteoporosis with pathological fracture

463

1.73

4.98

1.3

1.2

46.77

31.29

e6/l

0.14

339

Anogenital herpesviral [herpes simplex] infection

101

633

1.62

4.94

1.4

24.07

25.62

e6/l

0.05

462

Bulimia nervosa (incl. atypical)

304

1.91

4.93

1.2

1.6

16.21

20.86

e6/l

0.18

222

Other congenital malformations of skin

369

1.82

4.93

1.8

1.9

44.13

31.64

e6/l

0.16

265

Other diseases of blood and blood-forming organs

587

1.64

4.92

1.4

1.3

13.51

40.72

e6/l

1.03

427

Hodgkin lymphoma, hilmo

235

2.04

4.91

1.6

1.4

8.35

25.57

e6/l

0.62

175

Familial hypercholesterolemia

160

1107

1.46

4.90

1.4

29.68

23.96

e6/l

0.18

130

851

Recurrent aphthous stomatitis , including avohilmo

203

1467

1.40

4.89

3.0

1.4

24.98

29.80

e6/l

0.18

158

1054

Acute generalized exanthematous pustulosis

392

1.79

4.88

1.7

30.69

15.15

e6/l

0.46

292

Acidosis

169

2.24

4.88

1.1

1.9

2.00

26.52

e6/l

0.68

125

Wegener granulomatosis

113

2.55

4.87

1.4

1.2

381.65

12.96

e6/l

0.48

Burns and corrosions

198

1427

1.40

4.85

1.6

17.23

24.68

e6/l

0.39

153

1050

Periapical abscess

658

5509

1.20

4.84

1.4

32.77

34.80

e6/l

0.04

483

4058

Erosion of teeth , including avohilmo

398

3166

1.26

4.83

1.5

1.4

10.81

24.40

e6/l

2.67

278

2346

Perineal laceration during delivery

145

1696

0.68

4.82

1.3

17.70

27.52

e6/l

0.51

105

1247

Previous suicide attempt

102

2.65

4.81

1.2

1.5

1.42

14.86

e6/l

1.12

Excessive earwax

868

6736

1.17

4.79

1.5

11.17

35.41

e6/l

5.33

660

4996

Fracture of neck

499

1.69

4.79

1.3

1.4

10.10

41.92

e6/l

1.12

373

Other congenital malformations

137

925

1.50

4.79

1.5

2.0

24.10

27.22

e6/l

0.08

667

Other and unspecified iridocyclitis

432

1.74

4.77

1.3

1.5

9.70

25.66

e6/l

0.57

318

Acute peritonitis

515

1.67

4.76

1.6

1.5

4.56

41.46

e6/l

1.51

382

Other Crohn's disease

105

671

1.58

4.75

1.6

1.5

17.94

24.12

e6/l

0.21

489

Patent foramen ovale

218

2.07

4.74

1.2

3.0

16.97

13.23

e6/l

0.12

155

Mental and behavioural disorders due to cannabinoids

295

1.90

4.71

1.7

1.5

37.70

15.97

e6/l

0.84

219

Malignant neoplasm of digestive organs, including Hilmo

342

3199

0.78

4.70

1.3

1.4

13.34

26.48

e6/l

1.74

250

2422

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1364

7607

1.14

4.69

1.4

37.54

33.34

e6/l

0.15

1016

5624

Certain zoonotic bacterial diseases, including avohilmo

246

1.99

4.69

2.8

1.4

21.71

38.01

e6/l

0.26

185

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

115

1728

0.66

4.69

1.2

1.4

14.30

27.58

e6/l

0.75

1301

Diabetes, insulin treatment (Kela reimbursement)

1438

7574

1.13

4.67

1.4

28.59

35.42

e6/l

0.33

1061

5603

Endometriosis ASRM stages 1,2

253

1908

1.34

4.66

1.3

16.51

26.61

e6/l

0.81

177

1399

Congenital malformations and deformations of the musculoskeletal system

145

991

1.47

4.66

1.8

2.1

13.36

18.38

e6/l

0.35

108

718

Amyloidosis, other/unspecified

134

2.37

4.65

1.3

4.13

29.61

e6/l

0.54

101

Open wound of lower leg

201

1463

1.38

4.65

1.5

20.94

26.53

e6/l

0.27

154

1071

Percutaneous Coronary Intervention

1072

5664

1.15

4.64

1.3

1.5

26.24

37.46

e6/l

0.66

856

4100

Thyrotoxicosis

331

2589

1.29

4.64

1.5

1.4

77.29

31.19

e6/l

0.65

246

1900

Inflammatory bowel disease

437

3533

1.24

4.61

1.4

42.48

31.46

e6/l

0.15

318

2603

Explicit fungal Sepsis

4.35

4.59

2.0

1.2

2.30

5.28

e6/l

—

Drug-induced cataract

187

2.13

4.58

1.6

1.5

28.50

14.17

e6/l

0.35

138

Injury of unspecified body region

107

693

1.56

4.57

1.2

1.6

25.73

35.74

e6/l

0.20

509

Vulvovaginal ulceration/inflammation in other diseases

105

678

1.57

4.55

1.2

1.4

18.62

20.99

e6/l

0.09

502

Preterm labour and delivery

348

2746

1.27

4.55

1.3

1.4

9.58

43.03

e6/l

3.48

255

2007

Coronary revascularization (ANGIO or CABG)

1072

5667

1.15

4.54

1.3

1.5

26.30

37.44

e6/l

0.65

854

4103

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

306

1.86

4.53

1.3

1.4

9.05

28.02

e6/l

0.47

228

Type 2 diabetes, strict (exclude DM1)

1351

6945

1.13

4.52

1.4

33.25

35.79

e6/l

0.09

977

5147

Type 2 diabetes, definitions combined

1343

6902

1.13

4.52

1.4

33.42

35.81

e6/l

0.08

972

5117

Intentional self-harm by sharp object

229

2.01

4.50

1.4

7.62

11.40

e6/l

0.32

168

Viral haemorrhagic fevers, not elsewhere classified/unspecified

109

712

1.55

4.49

1.4

23.81

32.42

e6/l

0.22

527

Superficial injury of ankle and foot

189

1371

1.39

4.49

1.7

1.6

84.59

25.85

e6/l

0.40

138

1010

Iron deficiency

307

1.86

4.49

1.2

1.9

9.39

23.70

e6/l

0.83

227

Explicit fungal Sepsis, including avohilmo

4.23

4.48

2.0

1.2

2.30

5.20

e6/l

—

Additional codes for the location of defect, injury or illness

532

1.64

4.48

1.2

1.5

46.52

42.32

e6/l

0.03

393

Cardiodefibrillation

253

3299

0.76

4.46

1.5

1.4

86.58

28.91

e6/l

0.53

177

2481

Discitis, unspecified

118

2.43

4.45

1.2

1.4

128.00

44.05

e6/l

0.29

Hyperprolactinaemia

308

1.85

4.45

1.1

1.5

260.32

13.85

e6/l

0.48

231

Other specified/unspecified soft tissue disorders

344

1.80

4.44

1.4

3.09

60.50

e6/l

1.55

248

Complications of internal orthopaedic prosthetic devices, implants and grafts

257

1957

1.32

4.42

1.5

1.3

67.52

32.03

e6/l

0.34

195

1447

Arthropod-borne viral fevers and viral haemorrhagic fevers

127

860

1.49

4.42

1.4

20.91

30.67

e6/l

0.31

107

635

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

352

1.78

4.42

1.5

1.3

10.35

53.79

e6/l

1.00

257

Presbyopia

109

715

1.54

4.41

1.2

1.3

17.11

36.45

e6/l

0.69

520

Human immunodeficiency virus [HIV] disease

144

2.28

4.40

1.7

1.3

17.04

18.81

e6/l

0.06

101

Injuries to unspecified part of trunk, limb or body region

141

975

1.46

4.40

1.2

1.5

32.39

33.07

e6/l

0.01

710

Achilles tendinitis

127

860

1.49

4.40

1.2

1.4

26.44

24.41

e6/l

0.06

611

Use of interferon beta-1a

197

2.08

4.40

1.4

1.5

11.52

13.52

e6/l

0.12

149

Other skin changes

237

1786

1.34

4.40

1.5

1.4

30.16

33.14

e6/l

0.04

182

1322

Alcohol induced polyneuropathy

2.98

4.40

1.2

1.1

2.86

18.33

e6/l

0.73

Major coronary heart disease event

1141

5982

1.14

4.37

1.3

1.5

24.94

36.45

e6/l

0.74

909

4336

Medicines for HER+ breast cancer

296

3524

0.78

4.36

1.3

1.4

10.73

42.57

e6/l

4.03

192

2608

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

609

1.58

4.36

3.1

2.5

19.76

21.16

e6/l

0.05

437

Specific developmental disorder of motor function

173

2.15

4.34

2.3

4.9

8.88

5.96

e6/l

0.16

111

Bruxism

165

2.18

4.32

1.4

1.5

1.31

10.13

e6/l

1.33

126

Autoimmune hyperthyroidism

483

1.65

4.31

1.6

1.4

41.29

42.37

e6/l

0.01

347

Dislocation, sprain and strain of joints and ligaments of knee

896

7017

1.16

4.31

1.3

1.4

20.42

34.14

e6/l

1.31

655

5164

Generalized epilepsy, mode (most common among epilepsy diagnosis)

254

1.92

4.30

1.2

1.9

5.33

16.37

e6/l

1.28

193

Stomatitis and related lesions

277

2141

1.30

4.30

2.6

1.4

20.86

25.34

e6/l

0.24

216

1562

Horner syndrome

102

2.53

4.29

1.5

1.2

14.60

12.58

e6/l

0.05

Noninflammatory disorders of female genital tract

550

2280

1.22

4.27

1.5

1.4

32.93

27.97

e6/l

0.14

402

1705

Rosacea

179

1299

1.39

4.27

1.3

4.07

32.31

e6/l

3.51

138

941

Unspecified event, undetermined intent

206

2.03

4.27

1.6

1.5

23.41

17.58

e6/l

0.16

151

Other congenital malformations of brain

3.17

4.24

1.5

4.7

2.45

17.02

e6/l

0.61

L02BA Anti-estrogens

105

1569

0.66

4.22

1.3

1.4

25.21

33.68

e6/l

0.24

1167

Congenital malformations of the circulatory system

210

1520

1.35

4.22

1.8

2.0

26.64

25.35

e6/l

0.03

155

1098

Diabetic maculopathy, excluding more controls

139

967

1.45

4.22

1.4

16.88

27.14

e6/l

0.42

104

719

Sequelae of injuries of lower limb

130

894

1.47

4.20

1.3

1.4

119.77

34.11

e6/l

0.46

660

Localized swelling, mass and lump of skin and subcutaneous tissue

406

3296

1.24

4.17

1.7

1.4

50.54

31.16

e6/l

0.39

295

2424

Syphilis, including avohilmo

229

1.96

4.16

1.8

1.3

21.60

39.34

e6/l

0.30

166

Syphilis

229

1.96

4.16

1.8

1.3

21.60

39.34

e6/l

0.30

166

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

3.39

4.16

1.7

1.2

13.43

110.58

e6/l

—

Abnormal findings on antenatal screening of mother

128

880

1.47

4.15

1.4

12.20

21.42

e6/l

1.23

110

655

Special screening examination for neoplasms

434

1.67

4.15

1.3

1.4

46.51

28.67

e6/l

0.24

303

Polyarthritis, unspecified

308

1.82

4.14

1.2

1.5

11.38

29.24

e6/l

0.43

234

Mixed conductive and sensorineural hearing loss

146

1029

1.43

4.13

1.3

1.4

102.23

30.02

e6/l

0.41

116

755

Fissure and fistula of anal and rectal regions

307

2417

1.28

4.13

1.5

1.4

27.18

30.69

e6/l

0.13

228

1784

Hydrocele

127

872

1.47

4.12

1.3

1.6

11.46

24.65

e6/l

0.75

658

Ischaemic heart disease, wide definition

1002

5384

1.15

4.12

1.3

1.4

15.87

37.95

e6/l

3.34

773

3928

Sub-endpoint used in defining T1D endpoints

369

2921

1.25

4.10

1.5

29.11

25.01

e6/l

0.15

286

2153

Medial epicondylitis

287

1.84

4.10

1.3

1.4

11.95

26.38

e6/l

0.50

206

Human immunodeficiency virus [HIV] disease, including avohilmo

149

2.20

4.08

1.7

1.3

17.04

18.01

e6/l

0.03

106

Other disorders of kidney and ureter

162

1166

1.40

4.08

1.3

1.4

36.51

27.25

e6/l

0.24

113

852

Ovarian dysfunction

118

802

1.49

4.07

1.3

1.4

2.92

21.72

e6/l

5.06

593

Atrial fibrillation and flutter with reimbursement

276

1342

1.30

4.06

1.3

61.26

18.60

e6/l

0.72

187

975

Other abnormal findings of blood chemistry

430

1.68

4.06

1.5

1.3

3.16

33.42

e6/l

1.37

323

Superficial injuries involving multiple body regions

217

1.97

4.06

1.4

1.3

5.47

17.74

e6/l

1.16

159

Type 1 diabetes, wide definition

300

2360

1.28

4.04

1.4

1.5

23.66

27.12

e6/l

0.17

228

1750

Other specified and unspecified strabismus

2.50

4.03

2.0

2.4

21.73

14.05

e6/l

0.19

Melanocytic naevi

428

3509

1.23

4.02

1.4

16.87

32.18

e6/l

1.26

318

2584

Other disorders of penis

122

836

1.47

4.00

1.4

1.9

9.53

17.88

e6/l

0.58

624

Coxarthrosis

626

3413

1.19

3.99

1.4

32.11

32.92

e6/l

0.02

468

2532

Infectious mononucleosis

128

888

1.46

3.98

1.5

31.87

17.88

e6/l

0.56

647

Infectious mononucleosis, including avohilmo

128

888

1.46

3.98

1.5

31.87

17.88

e6/l

0.56

647

Dermatophytosis, including avohilmo

934

8006

1.15

3.98

1.3

1.4

41.42

31.70

e6/l

0.25

672

5945

Hyperparathyroidism

199

1470

1.35

3.96

1.4

28.02

37.22

e6/l

0.24

135

1101

Vascular diseases of the intestine

283

1.83

3.95

1.3

121.15

64.18

e6/l

0.28

213

Crushed, pushed or stepped on by crowd or human stampede

115

783

1.48

3.94

1.3

1.8

7.53

18.01

e6/l

1.38

568

Acute pancreatitis

241

1852

1.31

3.94

1.9

1.4

9.84

24.98

e6/l

1.93

170

1391

Other disorders starting during childhood or adolescence

592

1.56

3.93

3.2

2.6

12.39

20.46

e6/l

0.61

420

Ulcer of lower limb, not elsewhere classified

167

1216

1.38

3.92

1.9

1.3

36.16

30.00

e6/l

0.17

120

892

Autoimmune hepatitis, wide definition

358

1.73

3.92

1.2

1.6

7.77

41.43

e6/l

1.07

267

Malignant neoplasm of pancreas, including Hilmo

677

0.51

3.91

1.3

56.43

27.77

e6/l

0.45

514

Complications following infusion, transfusion and therapeutic injection

113

2.36

3.91

1.2

1.1

5.85

18.40

e6/l

0.79

Other and unspecified trigeminal disorders

113

2.36

3.90

1.3

1.2

70.58

10.47

e6/l

0.44

Ulcer of oesophagus

520

1.59

3.90

1.3

1.4

5.35

40.22

e6/l

1.44

391

Exposure to other and unspecified inanimate mechanical forces

116

794

1.48

3.88

1.4

1.6

9.58

35.29

e6/l

1.46

584

Viral conjunctivitis

186

2.03

3.88

1.4

1.7

2.96

15.42

e6/l

1.54

140

Benign neoplasm: Stomach

118

810

1.47

3.88

1.4

41.46

34.50

e6/l

0.07

589

Other diseases of arteries and capillaries

113

769

1.48

3.88

1.3

1.4

17.09

33.24

e6/l

0.55

569

Other and unspecified vaccines and biological substances

2.97

3.87

1.1

1.0

1.40

16.11

e6/l

—

Procedures for purposes other than remedying health state

186

2.03

3.87

1.8

1.4

31.21

16.37

e6/l

0.33

129

Other peripheral vertigo

115

786

1.48

3.87

1.4

1.3

11.87

35.37

e6/l

1.26

577

Rheumatoid arthritis, including avohilmo

468

3889

1.21

3.84

1.3

1.4

26.29

31.89

e6/l

0.31

336

2874

Thiazolidinediones

131

920

1.44

3.82

1.4

1.3

20.06

30.36

e6/l

0.35

682

Malignant neoplasm of breast, HER2-negative

375

2971

0.81

3.80

1.3

1.4

50.97

34.78

e6/l

0.19

233

2232

Other noninflammatory disorders of vulva and perineum

130

913

1.44

3.79

1.6

1.3

35.44

29.18

e6/l

0.11

685

Biological medication for rheuma

253

1969

1.29

3.79

1.4

1.5

84.26

26.94

e6/l

0.62

191

1428

Personal history of malignant neoplasm

119

823

1.46

3.78

3.5

1.4

11.15

33.50

e6/l

1.19

611

Phlebitis and thrombophlebitis (not including DVT)

282

2225

1.27

3.77

1.5

1.4

41.86

35.41

e6/l

0.11

207

1632

Generalized skin eruption due to drugs and medicaments

341

1.73

3.73

1.6

1.7

34.89

15.64

e6/l

0.51

258

140

1000

1.41

3.73

1.2

1.3

16.68

18.39

e6/l

0.08

755

Type 2 diabetes, definitions combined, including avohilmo

1341

6936

1.12

3.73

1.4

34.16

35.72

e6/l

0.05

969

5144

Hepatic failure, not elsewhere classified

304

1.77

3.72

1.4

2.87

40.10

e6/l

1.11

226

Malignant neoplasm of other connective and soft tissue

196

1.98

3.72

1.1

1.2

25.73

54.36

e6/l

0.34

152

Other specified/unspecified disorders of bone/cartilage

210

1.94

3.72

1.2

6.43

9.58

e6/l

0.27

144

Early syphilis

2.44

3.71

1.9

1.4

26.60

24.50

e6/l

0.04

Other and unspecified injuries of wrist and hand

372

1.69

3.71

1.2

1.7

9.10

32.13

e6/l

0.76

280

Allergic urticaria

117

810

1.46

3.71

1.9

1.7

40.69

38.06

e6/l

0.03

581

Sequelae of injuries of upper limb

134

952

1.42

3.69

1.4

16.32

33.19

e6/l

0.84

109

695

Emergency coronary revascularization (for ACS)

1128

6039

1.13

3.68

1.3

1.5

26.20

35.69

e6/l

0.56

900

4383

Malignant neoplasm of breast

377

2973

0.81

3.68

1.3

1.4

50.56

34.77

e6/l

0.19

235

2233

Cardiac murmurs and other cardiac sounds

129

900

1.43

3.67

1.8

15.00

32.79

e6/l

0.85

105

639

Other and unspecified mental retardation

196

1.98

3.66

2.4

4.5

40.19

10.68

e6/l

0.45

130

Other and unspecified rosacea

123

862

1.44

3.66

1.3

3.89

35.65

e6/l

2.47

632

Pregnancy hypertension

570

4324

1.18

3.65

1.3

1.4

19.93

37.09

e6/l

0.85

439

3158

Disorders of multiple cranial nerves

11.76

3.64

1.3

2.50

5.50

e6/l

—

Autoimmune thyroiditis

170

2.05

3.64

1.6

1.5

3.71

6.78

e6/l

0.69

124

Other/unspecified enthesopathies, not elsewhere classified

657

1.50

3.64

1.3

1.4

8.76

42.45

e6/l

1.52

478

Hypertrophic disorders of skin

538

1.56

3.63

1.4

1.5

2.44

40.09

e6/l

1.79

400

Effects of heat and light

3.04

3.63

1.6

1.1

13.10

15.92

e6/l

—

Toxic effect of ethanol

344

1.71

3.62

1.2

1.7

19.33

12.64

e6/l

0.23

248

Other and unspecified disorders of white blood cells

329

1.73

3.62

3.5

1.5

9.90

39.09

e6/l

0.83

243

Open wound of abdomen, lower back and pelvis

270

1.81

3.61

1.9

1.7

30.76

29.43

e6/l

0.02

199

Respiratory disorders in diseases classified elsewhere

111

2.32

3.60

1.3

1.2

15.67

4.21

e6/l

0.74

Fracture of forearm

755

5888

1.15

3.60

1.4

1.5

21.39

33.54

e6/l

1.35

557

4337

Early syphilis, including avohilmo

111

2.31

3.60

1.8

1.4

23.65

21.96

e6/l

0.04

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

626

4647

1.17

3.60

1.3

1.4

19.65

36.39

e6/l

0.92

482

3390

Other and unspecified disorders of vitreous body

524

4328

1.19

3.60

1.4

38.11

38.65

e6/l

0.01

389

3194

Deviated nasal septum

416

3439

1.21

3.59

1.3

1.4

15.40

34.31

e6/l

1.84

318

2496

Other and unspecified epidermal thickening

220

1.90

3.58

1.8

1.7

10.50

30.92

e6/l

0.67

170

Papulosquamous disorders

512

4322

1.19

3.57

1.3

1.4

25.65

36.35

e6/l

0.59

373

3172

Other epidermal thickening

376

1.67

3.57

1.7

1.6

7.63

50.79

e6/l

1.20

283

Residual foreign body in soft tissue

438

1.62

3.56

1.5

1.3

13.76

44.43

e6/l

0.87

324

Later onset COPD

175

1871

0.75

3.55

1.2

1.3

39.50

28.82

e6/l

0.18

128

1423

Exposure to other and unspecified man-made environmental factors

158

2.07

3.55

1.9

1.4

4.04

12.04

e6/l

0.94

119

Gestational [pregnancy-induced] hypertension

352

2865

1.23

3.54

1.3

12.00

37.79

e6/l

2.48

264

2105

Hyperkinetic disorders (excl. ADHD)

211

1.91

3.54

1.4

3.4

53.95

16.19

e6/l

0.60

149

Hypertrophic scar

494

1.58

3.53

1.4

1.6

1.98

31.91

e6/l

1.64

367

Diabetic retinopathy, strict definition

197

1327

1.33

3.53

1.4

16.71

32.01

e6/l

0.74

147

975

Benign neoplasm: Adrenal gland

105

720

1.47

3.52

1.3

1.4

6.18

35.54

e6/l

1.66

522

Coeliac disease

163

1207

1.36

3.51

1.4

1.6

13.78

32.30

e6/l

1.37

123

869

Other diseases of lip and oral mucosa

568

4845

1.18

3.51

1.5

1.4

47.52

34.13

e6/l

0.24

387

3585

Other bursopathies

150

1096

1.38

3.50

1.3

1.4

44.78

32.75

e6/l

0.30

110

803

Dependent personality disorder

166

2.03

3.49

1.2

1.4

6.32

9.82

e6/l

0.23

119

Chronic kidney disease

350

2746

1.23

3.49

1.4

15.84

25.11

e6/l

0.86

263

2069

Malignant neoplasm of breast, including Hilmo

388

3013

0.82

3.49

1.3

1.4

50.16

34.72

e6/l

0.20

245

2263

Malignant neoplasm of breast, HER2-negative, including Hilmo

388

3013

0.82

3.48

1.3

1.4

50.16

34.72

e6/l

0.20

245

2263

Superficial injury of neck

166

2.03

3.48

1.2

1.6

3.64

12.55

e6/l

1.21

126

Caries of enamel

1432

8456

1.11

3.47

1.6

1.4

37.34

31.19

e6/l

0.20

980

6322

Angina pectoris

698

3998

1.16

3.47

1.3

1.4

16.25

33.40

e6/l

2.04

532

2903

Secondary polycythaemia

180

1.98

3.47

1.3

1.2

10.58

14.89

e6/l

0.20

131

Other follicular disorders

107

739

1.46

3.46

1.3

1.4

55.52

30.38

e6/l

0.52

538

Other and unspecified injuries of ankle and foot

395

1.64

3.45

1.5

1.7

2.40

23.44

e6/l

2.63

292

Injuries involving multiple body regions

334

1.70

3.45

1.4

1.5

4.44

23.70

e6/l

1.13

246

Acute pancreatitis (for exclusion)

241

1889

1.28

3.44

1.9

1.3

9.84

24.17

e6/l

2.22

170

1400

Polymyalgia rheumatica

143

1040

1.38

3.44

1.3

1.4

17.73

30.49

e6/l

0.52

773

Hypertrophy of breast in women and men

261

2067

1.27

3.43

1.5

1.3

12.50

41.72

e6/l

2.10

191

1508

Severe visual impairment, monocular

2.58

3.43

3.2

1.1

16.31

3.81

e6/l

0.69

Exophthalmic conditions

2.57

3.43

1.2

20.29

8.57

e6/l

0.28

Mental retardation

408

1.63

3.43

2.0

3.2

29.06

11.56

e6/l

0.46

290

Other articular cartilage disorders

174

1.99

3.42

1.2

1.3

2.44

8.61

e6/l

0.87

130

Diabetic nephropathy, excluding more controls

161

969

1.36

3.41

1.6

1.4

45.39

15.33

e6/l

0.73

127

714

Melanocytic naevi of upper limb, including shoulder

210

1.89

3.40

1.9

1.6

6.48

12.46

e6/l

0.49

157

Other disorders of the genitourinary system

148

1086

1.37

3.39

1.4

1.3

101.64

35.04

e6/l

0.34

108

806

Plantar fascial fibromatosis

120

850

1.42

3.38

1.3

9.39

38.20

e6/l

1.87

628

Insulin, fast-acting (human)

182

1378

1.33

3.38

1.4

24.81

28.54

e6/l

0.14

139

1029

Unspecified nephritic syndrome

168

2.00

3.38

1.2

8.32

13.88

e6/l

0.35

125

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

859

0.60

3.38

1.2

1.3

6.88

23.15

e6/l

1.12

644

Diseases of spleen

134

2.13

3.38

1.5

1.2

5.15

18.53

e6/l

0.95

Recurrent dislocation of patella

476

1.57

3.37

1.1

1.4

33.70

17.39

e6/l

0.37

355

Perioral dermatitis

211

1.88

3.35

1.3

1.4

6.19

7.62

e6/l

0.12

156

Other and unspecified diseases of blood and blood-forming organs

211

1.88

3.35

1.6

1.3

4.24

59.37

e6/l

1.11

153

Recurrent dislocation and subluxation of joint

630

1.49

3.33

1.3

1.5

14.48

23.24

e6/l

0.35

475

Open wound of ankle and foot

141

1031

1.38

3.31

1.4

1.6

24.03

25.52

e6/l

0.04

100

761

Alcoholic liver disease

123

879

1.41

3.31

1.3

1.4

14.74

29.03

e6/l

0.60

648

Radial styloid tenosynovitis [de Quervain]

470

1.57

3.31

1.4

8.69

38.81

e6/l

1.20

338

Diseases of arteries, arterioles and capillaries

816

5250

1.14

3.30

1.4

44.51

30.96

e6/l

0.40

619

3899

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

295

2382

1.25

3.30

1.3

1.4

16.49

30.65

e6/l

1.19

213

1765

Other diseases of pancreas

107

747

1.45

3.29

1.3

1.4

68.36

30.59

e6/l

0.27

551

Ehlers-Danlos syndrome, including avohilmo

116

2.21

3.28

1.3

1.5

1.47

12.24

e6/l

1.12

Other dialysis

264

1.77

3.27

1.6

1.7

20.68

24.68

e6/l

0.07

192

Benign neoplasm of other and unspecified sites

264

1.77

3.27

1.4

1.2

5.85

46.87

e6/l

1.03

196

Dialysis

355

1.66

3.26

1.5

1.8

16.22

19.48

e6/l

0.08

266

Multiple myeloma, including Hilmo

332

1.68

3.25

1.4

1.3

12.55

35.00

e6/l

0.61

256

Abscess of anal and rectal regions

114

807

1.42

3.25

1.4

1.5

33.95

30.40

e6/l

0.06

590

Crohn disease (strict definition, all UC cases excluded)

481

1.56

3.24

1.6

1.5

11.38

36.16

e6/l

0.88

346

Adenocarcinoma and papilloma adenocarcinoma of rectum

824

0.60

3.24

1.2

1.3

7.29

23.64

e6/l

1.06

618

Personal history of other diseases and conditions

168

1261

1.34

3.23

1.7

1.5

25.91

27.71

e6/l

0.05

117

921

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

108

758

1.44

3.23

1.3

1.5

23.75

20.10

e6/l

0.10

562

Dermatophytosis

172

1302

1.33

3.23

1.5

25.79

26.01

e6/l

0.00

134

950

Benign neoplasm: Skin of lower limb, including hip

221

1.84

3.22

1.2

1.5

3.00

32.36

e6/l

1.15

161

Impetigo

434

1.59

3.22

2.8

1.9

6.34

17.09

e6/l

0.93

313

Dermatitis herpetiformis

130

2.12

3.22

1.4

1.3

41.00

16.37

e6/l

0.30

Malignant neoplasm of mesothelium and soft tissue

318

1.69

3.21

1.1

1.3

28.56

36.96

e6/l

0.12

241

Human immunodeficiency virus [HIV] disease resulting in other conditions

137

2.09

3.21

1.8

1.3

17.77

18.24

e6/l

0.01

Benign neoplasm: Spinal meninges

2.43

3.20

1.8

1.1

67.45

15.11

e6/l

0.44

Diseases of external ear

460

3889

1.19

3.20

1.4

1.5

41.66

31.37

e6/l

0.16

334

2883

Other noninflammatory disorders of vagina

101

702

1.45

3.19

1.6

1.4

111.48

26.41

e6/l

0.67

526

Atopic dermatitis

873

6146

1.13

3.19

1.4

1.5

21.84

31.50

e6/l

0.80

632

4495

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

113

788

1.42

3.19

2.0

2.3

113.73

15.86

e6/l

0.42

575

Artificial opening status

491

1.55

3.18

1.8

1.6

48.62

44.97

e6/l

0.04

351

Colorectal adenocarcinoma

130

1748

0.73

3.18

1.3

1.4

10.42

26.37

e6/l

1.45

1329

Anorexia (incl.atypical)

547

1.51

3.17

1.3

1.6

4.05

23.74

e6/l

3.12

403

Other inflammatory liver diseases

580

1.50

3.17

1.2

1.5

6.19

39.70

e6/l

1.54

433

Motor disorders

200

1.89

3.17

2.3

5.0

8.88

6.17

e6/l

0.15

128

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

138

2.07

3.15

1.8

1.3

17.77

18.05

e6/l

0.01

Gonococcal infection

305

1.70

3.15

1.8

1.3

16.78

19.20

e6/l

0.10

215

Intestinal malabsorption

421

1.59

3.15

1.3

1.5

17.11

45.10

e6/l

0.64

308

Endocrine disorders, other/unspecified

145

2.04

3.14

1.3

1.2

20.84

10.43

e6/l

0.37

108

Female genital prolapse

365

1670

1.22

3.13

1.3

1.4

47.92

31.17

e6/l

0.18

257

1250

Mental retardation, wide definition

434

1.58

3.13

2.0

3.1

27.98

11.41

e6/l

0.45

307

Disorders of globe

173

1.94

3.12

1.6

1.4

155.56

21.30

e6/l

0.71

131

Other abortion

2.45

3.12

1.2

1.5

33.00

13.90

e6/l

0.27

Trigger finger

172

1309

1.32

3.11

1.3

1.4

21.50

36.97

e6/l

0.90

126

956

Hordeolum and other deep inflammation of eyelid

575

1.49

3.10

2.2

1.4

13.63

26.99

e6/l

0.44

419

Benign neoplasm of eye and adnexa

128

933

1.38

3.09

1.5

1.4

11.51

31.01

e6/l

1.15

681

Urethral stricture

391

1.60

3.09

1.3

1.4

2.08

34.69

e6/l

1.37

296

Malignant neoplasm of endocrine gland

641

1.46

3.08

1.4

1.3

34.65

30.28

e6/l

0.09

481

Haemorrhoids and perianal venous thrombosis

412

3437

1.19

3.08

1.3

1.4

10.28

28.97

e6/l

3.53

310

2551

Burn and corrosion of hip and lower limb, except ankle and foot

203

1.86

3.07

2.7

1.5

61.96

13.75

e6/l

0.82

145

Injury of other and unspecified intrathoracic organs

552

1.50

3.06

1.3

1.5

9.37

41.97

e6/l

1.36

415

Ménière disease

109

775

1.42

3.05

1.2

1.4

11.99

37.09

e6/l

1.35

566

Pregnancy with abortive outcome

877

4038

1.13

3.05

1.3

1.4

27.44

36.99

e6/l

0.46

661

2970

Torticollis

113

2.16

3.03

1.3

1.4

6.39

17.05

e6/l

0.55

Degenerative macular diseases

128

936

1.38

3.03

1.6

1.4

8.76

33.89

e6/l

1.90

695

Disorders of oesophagus in diseases classified elsewhere

161

1.96

3.03

1.8

1.3

3.90

108.38

e6/l

1.22

116

Chronic hepatitis, not elsewhere classified

278

1.71

3.03

1.4

37.91

36.25

e6/l

0.02

208

Blood alcohol or alcohol intoxication level

204

1.85

3.02

1.3

1.7

6.42

13.22

e6/l

0.80

147

Salpingitis and oophoritis

215

1693

1.28

3.02

1.3

1.4

7.34

38.39

e6/l

2.79

157

1234

Adalimumab

137

1014

1.36

3.02

1.5

1.6

49.34

26.21

e6/l

0.40

101

740

Perforation of tympanic membrane

129

946

1.37

3.02

1.4

26.15

20.79

e6/l

0.11

101

701

Vascular disorders of the intestines

489

1.53

3.01

1.2

1.4

167.26

41.61

e6/l

0.66

369

Pruritus

146

1093

1.34

2.99

1.5

1.4

119.88

29.18

e6/l

0.58

109

792

Fall involving bed

249

1.75

2.98

1.5

1.7

4.66

74.32

e6/l

1.36

188

Viral conjunctivitis, including avohilmo

364

1.61

2.98

1.4

1.5

4.89

12.24

e6/l

1.29

269

Seronegative rheumatoid arthritis

133

982

1.36

2.98

1.2

1.4

33.58

23.05

e6/l

0.37

731

Coxarthrosis [arthrosis of hip](FG)

667

4002

1.15

2.97

1.4

31.91

36.01

e6/l

0.13

500

2976

Effects of foreign body entering through natural orifice

322

2656

1.22

2.97

1.5

36.42

26.46

e6/l

0.32

243

1939

Sequelae of infectious and parasitic diseases, including avohilmo

613

1.46

2.97

1.7

1.4

21.89

37.20

e6/l

0.42

455

Nonalcoholic fatty liver disease

136

1009

1.36

2.96

1.5

1.4

35.48

30.53

e6/l

0.12

742

COPD (mode)

318

2036

1.22

2.96

1.4

27.59

15.10

e6/l

0.46

238

1516

Wide developmental disorders, excluding more controls

258

1.72

2.96

1.5

2.8

7.21

19.59

e6/l

1.15

187

Nummular dermatitis

105

747

1.42

2.95

1.7

1.4

36.83

26.75

e6/l

0.14

553

Campylobacter enteritis

228

1.78

2.94

1.2

1.5

1.79

12.76

e6/l

1.79

170

Infections of genitourinary tract in pregnancy

128

942

1.37

2.94

1.4

1.3

30.38

31.88

e6/l

0.03

102

677

Drug-induced tremor

2.79

2.94

1.1

1.67

3.26

e6/l

—

Crohn disease (strict definition, require KELA)

632

1.45

2.93

1.7

1.5

16.81

32.72

e6/l

0.57

460

Routine general health check-up of defined subpopulation

135

2.03

2.92

4.9

1.6

16.23

21.25

e6/l

0.17

L04AC Interleukin inhibitors

657

1.45

2.92

1.3

1.5

21.43

21.01

e6/l

0.01

475

Outcome of delivery

228

1106

1.27

2.92

1.2

1.3

35.86

39.99

e6/l

0.07

148

810

Other diseases of pericardium

382

1.59

2.91

1.5

4.64

19.15

e6/l

0.97

290

Tularaemia

2.30

2.90

1.7

1.2

2.00

19.70

e6/l

0.93

Pedestrian injured in collision with pedal cycle

259

1.72

2.90

1.2

1.4

9.36

14.10

e6/l

0.33

191

Dislocation, sprain and strain of joint and ligaments of hip

297

1.67

2.89

1.5

1.4

2.67

67.81

e6/l

1.53

217

Tumor necrosis factor alpha inhibitors

224

1784

1.26

2.89

1.4

1.5

93.21

28.30

e6/l

0.62

167

1299

Use of rotigotine

2.35

2.88

1.6

1.3

3.67

17.74

e6/l

0.85

Psoriatic and enteropathic arthropathies

145

1091

1.34

2.88

1.3

1.4

22.92

20.95

e6/l

0.07

115

802

Congenital malformations of the respiratory system

186

1.87

2.88

1.6

3.3

48.58

10.29

e6/l

0.55

132

Striae atrophicae

2.25

2.88

1.3

1.2

3.44

10.38

e6/l

0.52

Pilonidal cyst

117

852

1.38

2.88

1.6

1.5

26.77

25.84

e6/l

0.03

632

Malignant neoplasm of breast, HER-positive

278

2533

0.81

2.88

1.3

1.4

11.13

35.54

e6/l

2.66

179

1903

Retinal detachment with retinal break

147

1109

1.33

2.87

1.5

1.4

4.63

27.94

e6/l

2.35

105

818

Other specified and unspecified retinal disorders

275

1.69

2.86

2.3

1.4

14.89

70.38

e6/l

1.05

202

Systemic sclerosis (FG)

186

1.86

2.86

1.2

1.5

2.50

46.41

e6/l

0.75

137

Other disorders of male genital organs

321

1.64

2.86

1.4

1.5

25.81

14.03

e6/l

0.26

230

Other specified/unspecified bacterial intestinal infections

569

1.47

2.86

1.7

1.4

11.49

39.58

e6/l

1.07

420

Malignant neoplasm of endocrine gland, including Hilmo

103

735

1.41

2.86

1.4

1.3

31.22

28.96

e6/l

0.05

550

Endometriosis of rectovaginal septum and vagina

685

1.43

2.85

1.2

1.3

10.99

35.46

e6/l

1.09

511

!Aliquae complicationes praecoces traumatis

392

1.57

2.85

1.4

24.07

35.77

e6/l

0.24

294

Early complications of trauma

392

1.57

2.85

1.4

24.07

35.77

e6/l

0.24

294

Otitis externa, unspecified

158

1206

1.32

2.85

1.4

1.5

88.70

30.22

e6/l

0.36

115

880

Other contact dermatitis

103

736

1.41

2.84

1.3

1.4

6.27

32.80

e6/l

2.00

545

Haemolytic anaemias

299

1.66

2.83

1.3

1.6

3.65

40.35

e6/l

1.07

222

Colorectal cancer

170

2099

0.77

2.82

1.3

1.4

15.48

25.83

e6/l

0.58

122

1593

Crohn's disease NAS

613

1.45

2.80

1.4

1.6

32.77

38.82

e6/l

0.09

456

Volvulus

202

1.81

2.79

1.1

1.5

2.92

82.50

e6/l

1.23

153

Otitis externa

300

2475

1.22

2.79

1.3

1.5

56.83

25.23

e6/l

0.38

224

1810

Presbycusis

122

887

1.36

2.78

1.3

33.45

26.68

e6/l

0.10

671

Muscle strain

247

1.72

2.78

1.2

1.4

15.64

25.24

e6/l

0.26

186

Bitten or struck by other mammals

158

1211

1.31

2.78

1.2

1.5

12.90

31.54

e6/l

1.03

115

885

Status post-ami

178

1727

0.78

2.76

1.4

18.65

31.94

e6/l

0.56

147

1256

Melanocytic naevi of trunk

159

1221

1.31

2.76

1.3

1.4

13.97

29.05

e6/l

0.94

107

908

Malignant neoplasm of breast, ER-positive, including Hilmo

281

2540

0.82

2.74

1.3

1.4

11.04

35.42

e6/l

2.67

181

1910

Systemic sclerosis

189

1.83

2.74

1.2

1.5

2.50

14.99

e6/l

1.59

139

Charcot foot

139

1.98

2.73

1.7

1.3

167.53

62.68

e6/l

0.35

Crohn disease (strict definition, require KELA, min 2 HDR)

625

1.44

2.72

1.7

1.5

17.34

33.02

e6/l

0.54

455

Atrophic disorders of skin

200

1584

1.27

2.72

1.4

17.70

40.36

e6/l

1.17

138

1165

Erythema multiforme

182

1.84

2.72

1.5

3.85

13.24

e6/l

0.96

136

Malignant melanoma

176

1372

1.29

2.72

1.3

10.52

24.40

e6/l

1.52

128

1036

Hypertrophy of breast

225

1807

1.25

2.72

1.4

1.3

7.27

40.91

e6/l

2.55

164

1316

Unspecified abortion

445

1.52

2.72

1.2

1.3

16.33

27.62

e6/l

0.43

324

Evidence of alcohol involvement determined by level of intoxication

2.23

2.71

1.4

1.8

7.86

16.76

e6/l

0.51

Thyrotoxicosis with diffuse goitre

175

1364

1.29

2.71

1.7

1.3

22.96

27.98

e6/l

0.18

134

988

Problems related to social environment

204

1.79

2.71

1.2

1.4

9.24

12.32

e6/l

0.18

158

Atopic dermatitis, strict definition with reimbursement

427

3501

1.18

2.71

1.4

1.5

14.44

33.83

e6/l

1.74

321

2554

Arteriovenous malformation of cerebral vessels

2.18

2.69

2.0

1.2

9.54

22.24

e6/l

0.52

Hypertensive heart and/or renal disease

262

1556

1.23

2.69

1.3

1.4

74.36

29.70

e6/l

0.43

208

1173

Malignant melanoma, including Hilmo

195

1542

1.27

2.69

1.3

9.69

23.09

e6/l

1.71

144

1159

Osteomyelitis

519

1.48

2.69

1.3

1.4

20.31

41.46

e6/l

0.54

398

Chronic pancreatitis

147

1121

1.32

2.69

1.2

1.4

18.47

26.40

e6/l

0.30

104

819

Bacterial, viral and other infectious agents, including avohilmo

122

906

1.36

2.68

1.3

1.6

5.37

26.28

e6/l

1.99

663

Mixed specific developmental disorders

245

1.69

2.67

2.2

4.1

7.62

7.45

e6/l

0.01

159

Burns and corrosions of external body surface, specified by site

149

1140

1.32

2.67

1.6

1.7

19.80

26.67

e6/l

0.26

114

833

Ovarian dysfunction, other/unspecified

2.64

2.67

1.9

1.1

2.33

15.53

e6/l

—

Other diseases of peritoneum

359

1.58

2.67

1.3

1.4

2.91

59.62

e6/l

1.66

264

Acute nasopharyngitis (common cold)

150

1139

1.31

2.67

1.6

1.4

21.05

38.48

e6/l

0.54

118

827

Asymptomatic human immunodeficiency virus [HIV] infection status

3.04

2.66

2.6

1.4

35.14

26.61

e6/l

—

Hypoparathyroidism

281

1.66

2.66

1.3

1.5

30.24

40.05

e6/l

0.13

206

Gonarthrosis,primary

1147

6267

1.11

2.66

1.4

31.90

33.14

e6/l

0.05

860

4651

Pyoderma gangrenosum

2.53

2.66

1.1

1.57

21.21

e6/l

—

Foreign body in alimentary tract

488

1.49

2.66

1.3

1.7

35.27

30.09

e6/l

0.09

358

Endocarditis

289

1.65

2.65

1.5

1.6

419.50

23.81

e6/l

0.88

219

Dementia due to Parkinson's disease

169

1.86

2.65

1.3

1.74

61.33

e6/l

1.02

133

L02BG Aromatase inhibitors

245

2962

0.81

2.65

1.3

1.4

7.53

41.18

e6/l

4.58

160

2191

Mature T/NK-cell lymphomas, hilmo

2.20

2.64

1.5

1.2

337.33

13.74

e6/l

0.58

Tuberculosis, wide, including avohilmo

488

1.49

2.64

1.4

1.3

17.48

42.59

e6/l

0.67

368

Malignant neoplasm, without specification of site, including Hilmo

320

1.61

2.64

1.4

31.20

34.01

e6/l

0.04

253

Other or ill-defined heart diseases

464

1.50

2.64

2.1

1.4

36.04

21.50

e6/l

0.21

346

Helminthiases, including avohilmo

392

1.55

2.64

1.7

2.1

28.04

23.46

e6/l

0.14

294

Thyrotropin deficiency

100

2.16

2.63

1.9

1.4

13.50

13.56

e6/l

0.00

Diabetic retinopathy

392

2057

1.19

2.63

1.5

1.4

16.80

31.58

e6/l

1.08

293

1532

Coronary artery bypass grafting

175

1652

0.78

2.63

1.2

1.3

19.38

30.31

e6/l

0.47

136

1206

Crohn's disease of small intestine

672

1.41

2.62

1.7

1.5

15.93

40.48

e6/l

0.91

499

Malignant neoplasm of other connective and soft tissue, including Hilmo

345

1.58

2.62

1.1

1.4

23.50

34.88

e6/l

0.19

260

Tuberculosis, wide

481

1.49

2.61

1.4

1.3

17.81

43.12

e6/l

0.66

363

Cutaneous lupus erythematosus

192

1.80

2.61

1.2

1.4

2.71

48.74

e6/l

0.85

144

Congenital malformations of the respiratory system, including avohilmo

200

1.79

2.60

1.6

3.2

48.58

41.44

e6/l

0.06

143

Erythema nodosum

245

1.70

2.59

1.2

1.5

329.29

7.83

e6/l

0.67

179

Tuberculosis, IBD comorbidity

466

1.49

2.58

1.4

1.3

17.81

31.52

e6/l

0.38

354

Chronic ulcer of skin, not elsewhere classified

540

1.46

2.58

1.3

1.4

16.98

41.22

e6/l

0.66

404

Alcohol-induced chronic pancreatitis

557

1.45

2.58

1.2

1.4

17.82

25.34

e6/l

0.19

408

Achalasia of cardia

121

2.02

2.58

1.2

2.81

89.61

e6/l

1.04

Dislocation, sprain and strain of joints and ligaments of head

378

1.55

2.58

1.9

2.1

243.23

20.08

e6/l

0.52

280

Peroneal tendinitis

135

1.96

2.58

1.2

1.8

1.45

11.23

e6/l

1.18

Systemic sclerosis, icd10

193

1.79

2.57

1.2

1.4

2.50

19.30

e6/l

1.66

142

Seropositive rheumatoid arthritis

279

2293

1.21

2.57

1.3

1.4

28.25

37.26

e6/l

0.36

206

1703

Spondylopathies in diseases classified elsewhere

2.27

2.57

1.2

1.3

15.36

54.10

e6/l

0.43

Spinal enthesopathy

107

2.07

2.56

1.2

6.88

42.95

e6/l

0.64

Acute bronchiolitis

578

1.42

2.55

2.3

2.7

3.36

18.36

e6/l

2.72

406

Congenital deformities of feet

239

1.70

2.54

1.6

1.9

3.03

16.06

e6/l

1.64

173

Burns and corrosions of multiple and unspecified body regions

172

1.83

2.53

2.7

1.4

16.59

13.88

e6/l

0.06

125

Presence of other functional implants

733

4458

1.13

2.52

1.4

45.14

34.38

e6/l

0.25

551

3326

Entropion and trichiasis of eyelid

601

1.42

2.52

1.2

1.3

49.33

21.54

e6/l

0.32

452

Gonococcal infection, including avohilmo

341

1.57

2.51

1.9

1.3

16.41

17.89

e6/l

0.06

240

Malignant neoplasm of rectum

831

0.66

2.51

1.2

1.3

8.53

25.20

e6/l

1.10

626

Anaemia in chronic diseases classified elsewhere

180

1.80

2.50

1.3

1.4

42.12

60.24

e6/l

0.18

138

Sexual dysfunction

144

1.91

2.49

1.7

1.3

15.26

15.38

e6/l

0.00

104

Other bullous disorders

218

1.72

2.47

1.3

1.6

31.60

12.78

e6/l

0.30

162

Hypertensive Heart Disease

235

1449

1.23

2.47

1.3

1.4

83.71

28.30

e6/l

0.48

184

1088

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

170

1339

1.28

2.46

1.4

78.99

26.55

e6/l

0.39

124

972

Chronic myeloproliferative disease

2.13

2.46

1.2

64.69

45.55

e6/l

0.10

Inflammatory disorders of breast

647

1.40

2.45

1.2

1.3

4.57

29.17

e6/l

1.70

472

Bullous disorders

464

1.48

2.45

1.3

1.4

18.40

43.26

e6/l

0.55

345

Hydronephrosis

130

989

1.32

2.45

1.4

5.39

26.18

e6/l

1.76

730

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

681

1.39

2.45

1.7

1.5

16.57

32.35

e6/l

0.60

497

Abnormal findings in nipple discharge synovial fluid wound secretions

124

1.98

2.44

1.3

2.73

10.73

e6/l

0.76

Acute gastritis

597

1.42

2.44

1.4

1.5

16.23

38.88

e6/l

0.72

446

Asthma mixed form (mode)

375

1.53

2.43

1.2

1.4

18.89

18.73

e6/l

0.00

274

Other abnormal products of conception

435

2456

1.17

2.41

1.2

1.4

30.45

34.94

e6/l

0.17

315

1812

Injury of nerves at forearm level

2.10

2.40

1.2

1.4

87.09

6.15

e6/l

0.44

Mixed disorders of conduct and emotions

251

1.66

2.40

1.3

2.3

44.86

21.59

e6/l

0.51

174

Tongue abnormality

541

1.44

2.39

1.5

8.16

41.06

e6/l

1.30

396

Prepatellar bursitis

353

1.54

2.39

1.2

1.4

74.31

32.55

e6/l

0.28

267

Intercostal neuropathy

2.57

2.39

1.1

1.3

4.40

3.92

e6/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

475

1.47

2.39

1.6

1.4

28.55

23.15

e6/l

0.14

349

Malignant melanoma of skin, including Hilmo

161

1265

1.28

2.39

1.3

7.92

22.07

e6/l

1.60

118

950

Polycystic ovarian syndrome

575

1.42

2.38

1.1

1.4

3.53

21.54

e6/l

3.24

436

Other and unspecified disorders of skin and subcutaneous tissue

527

0.58

2.37

1.5

1.4

66.05

42.65

e6/l

0.15

381

Other obstructive and reflux uropathy

370

1.53

2.37

1.2

1.6

6.98

33.85

e6/l

0.97

269

Generalized epilepsy, strict definition

191

1.75

2.36

1.7

2.1

1.88

10.21

e6/l

1.38

140

Acne, including avohilmo

325

2220

1.19

2.36

1.4

1.5

18.68

22.76

e6/l

0.28

235

1631

Asthma mixed form (mode), excluding more controls

378

1.52

2.36

1.2

1.4

18.89

18.87

e6/l

0.00

276

Malignant neoplasm of rectum, including Hilmo

1020

0.70

2.35

1.2

1.3

7.20

27.83

e6/l

1.84

763

Other acquired deformities of musculoskeletal system and connective tissue

379

1.52

2.35

1.4

5.83

37.21

e6/l

1.05

278

Congenital deformities of feet, including avohilmo

363

1.53

2.34

1.5

1.8

4.40

15.64

e6/l

1.97

261

Glomerular disorders in diseases classified elsewhere

135

1041

1.30

2.33

1.5

1.4

100.81

29.05

e6/l

0.40

101

771

Malignant neoplasm of bronchus and lung, including Hilmo

147

1564

0.78

2.32

1.2

1.4

25.14

28.67

e6/l

0.06

100

1183

Vitamin B12 deficiency anaemia

107

799

1.35

2.31

1.4

12.31

32.39

e6/l

0.97

599

Nontoxic multinodular goitre

211

1718

1.23

2.30

1.4

37.17

35.71

e6/l

0.02

152

1267

Viral warts, including avohilmo

289

2429

1.19

2.28

1.3

1.6

16.13

21.18

e6/l

0.41

225

1772

Hereditary retinal dystrophy

113

1.99

2.28

1.3

1.7

2.86

13.82

e6/l

0.98

Retinal vascular disorders

120

913

1.32

2.28

1.4

1.3

27.79

33.20

e6/l

0.09

674

Peripheral arterial reconstruction

1280

0.74

2.28

1.3

6.76

29.38

e6/l

2.36

956

Disorder of external ear, unspecified

286

1.59

2.27

1.2

1.3

8.16

40.79

e6/l

0.85

216

Multiple myeloma and malignant plasma cell neoplasms

350

1.53

2.26

1.4

1.3

13.13

52.78

e6/l

0.91

258

Retinal vascular occlusion

119

906

1.32

2.26

1.4

1.3

28.10

33.39

e6/l

0.09

670

Other superficial mycoses, including avohilmo

146

1143

1.29

2.26

1.3

1.5

7.59

30.60

e6/l

2.15

834

Certain zoonotic bacterial diseases

142

1.86

2.26

3.3

1.3

18.85

13.83

e6/l

0.10

105

Follicular cysts of skin and subcutaneous tissue

226

1859

1.22

2.25

1.6

1.4

16.58

26.31

e6/l

0.52

182

1367

Diabetic maculopathy

138

1012

1.30

2.25

1.4

1.3

16.88

24.20

e6/l

0.36

104

735

Allergic rhinitis

433

3715

1.15

2.25

1.3

1.6

21.37

33.09

e6/l

0.55

325

2707

Infections specific to the perinatal period

121

1.95

2.25

4.0

4.8

7.72

10.71

e6/l

0.15

Sequelae of intentional self-harm, assault and events of undetermined intent

2.31

2.22

1.7

1.9

19.63

19.89

e6/l

—

Injury of nerves at lower leg level

2.18

2.22

1.0

1.2

2.44

24.74

e6/l

—

Personal history of certain other diseases

180

1.75

2.21

1.5

1.3

8.14

26.78

e6/l

0.74

136

Pneumonia derived septicemia

288

1.58

2.21

1.5

1.9

394.67

38.52

e6/l

1.24

216

Blepharochalasis

322

2740

1.18

2.21

1.2

1.4

32.10

31.60

e6/l

0.01

230

2035

Other disorders of breast

172

1378

1.26

2.20

1.3

7.02

34.89

e6/l

1.92

122

997

Other endocrine disorders

519

1.42

2.20

2.6

2.8

12.30

13.59

e6/l

0.08

355

Assault by unspecified means

188

1.73

2.20

1.3

1.5

14.88

18.94

e6/l

0.16

141

Other leukaemias of specified cell type

3.89

2.19

8.4

1.1

55.00

2.31

e6/l

—

Atopic dermatitis, strict definition

419

3559

1.15

2.19

1.4

1.6

12.86

31.53

e6/l

2.17

314

2604

Malignant melanoma of skin

134

1042

1.29

2.19

1.3

8.37

23.83

e6/l

1.38

779

Phakomatoses, not elsewhere classified

101

2.03

2.19

1.6

2.4

2.93

12.97

e6/l

0.70

Primary hyperparathyroidism

124

955

1.31

2.18

1.3

1.4

17.75

37.36

e6/l

0.87

698

Oligomenorrhoea

321

1.54

2.18

1.8

1.3

15.03

17.00

e6/l

0.06

236

Malignant neoplasm of thyroid gland, including Hilmo

653

1.37

2.18

1.3

34.89

31.41

e6/l

0.07

486

Alcoholic gastritis

101

2.02

2.18

1.4

1.3

2.40

50.28

e6/l

0.81

Embolic stroke

273

1.59

2.17

1.7

1.3

8.59

64.49

e6/l

1.12

206

Postprocedural musculoskeletal disorders, not elsewhere classified

620

1.38

2.16

1.5

1.3

18.38

37.90

e6/l

0.51

456

Diabetes mellitus in pregnancy

443

2449

1.15

2.15

1.3

23.02

32.68

e6/l

0.46

327

1800

Glucosamine medication

501

3515

1.14

2.15

1.4

23.71

33.26

e6/l

0.49

374

2601

Nasal polyp

220

1815

1.22

2.14

1.3

1.4

25.75

26.11

e6/l

0.01

168

1326

Ehlers-Danlos syndrome

2.05

2.14

1.3

1.6

1.38

13.19

e6/l

0.95

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

323

1.54

2.13

1.2

1.9

31.32

22.65

e6/l

0.19

240

Benign neoplasm: Other/unspecified site

116

1.93

2.13

1.5

1.1

10.13

26.55

e6/l

0.73

Prolonged pregnancy

144

1552

0.79

2.13

1.5

1.3

6.71

35.88

e6/l

1.93

115

1158

Gluteal tendinitis

347

1.51

2.13

1.4

19.26

39.42

e6/l

0.43

257

Suggestive for eosinophilic asthma

110

837

1.32

2.13

1.3

43.55

30.69

e6/l

0.15

618

Female infertility, associated with anovulation

101

759

1.34

2.12

1.4

1.3

14.16

18.60

e6/l

0.22

576

Primary angle-closure glaucoma

315

1.54

2.12

1.4

1.3

20.64

60.75

e6/l

0.67

232

DVT of lower extremities

206

1691

1.22

2.11

1.4

1.3

40.92

28.77

e6/l

0.21

162

1251

Benign neoplasm: Rectum, anus and anal canal

219

1809

1.22

2.11

1.3

35.03

25.37

e6/l

0.20

149

1332

Lichen simplex chronicus

284

1.57

2.10

1.4

1.3

21.47

44.45

e6/l

0.40

214

Contusion of toe(s) without damage to nail

229

1.64

2.10

1.9

1.5

13.04

13.61

e6/l

0.02

171

Hepatomegaly and splenomegaly, not elsewhere classified

2.31

2.10

1.4

1.2

64.89

30.52

e6/l

—

Malignant neoplasm of thyroid gland

598

1.38

2.10

1.4

1.3

37.44

32.26

e6/l

0.10

449

Convalescence

422

1.46

2.10

1.4

49.39

21.90

e6/l

0.33

303

Disorders of orbit

373

1.49

2.09

1.5

47.41

14.96

e6/l

0.88

273

Benign neoplasm: Sigmoid colon

207

1703

1.22

2.08

1.4

1.3

32.87

28.53

e6/l

0.11

152

1257

Burn and corrosion of shoulder and upper limb, except wrist and hand

176

1.73

2.08

2.8

1.5

16.50

15.57

e6/l

0.02

130

Benign neoplasm: Other and unspecified parts of mouth

269

1.58

2.08

1.3

17.09

48.94

e6/l

0.64

200

Ulcerative colitis

309

2637

1.18

2.08

1.3

1.4

53.03

25.11

e6/l

0.32

228

1931

Other diseases of stomach and duodenum

540

1.40

2.07

1.6

1.4

16.60

41.84

e6/l

0.63

397

Tularaemia, including avohilmo

154

1.78

2.06

1.5

1.3

2.63

14.68

e6/l

1.12

112

Helminthiases

132

1.85

2.06

1.3

1.7

52.28

12.81

e6/l

0.96

103

Combinations of oral blood glucose lowering drugs

323

2768

1.17

2.06

1.4

1.3

59.42

31.65

e6/l

0.38

247

2061

Spontaneous abortion

592

3528

1.13

2.06

1.2

1.4

35.07

37.27

e6/l

0.06

438

2595

Ankylosing spondylitis, ICD10

109

833

1.32

2.06

1.4

1.5

68.40

20.83

e6/l

0.51

612

Other congenital malformations, including avohilmo

174

1409

1.24

2.04

1.5

1.9

22.30

27.59

e6/l

0.18

125

1022

Etanercept

627

1.37

2.04

1.2

1.6

21.90

25.60

e6/l

0.08

459

Caught, crushed, jammed or pinched in or between objects

509

1.41

2.03

1.4

1.6

53.56

29.43

e6/l

0.40

373

Primary open-angle glaucoma, strict

262

2204

1.19

2.02

1.4

1.3

19.96

34.92

e6/l

0.81

200

1656

Respiratory tuberculosis, confirmed

111

1.92

2.02

1.4

1.3

23.56

18.32

e6/l

0.12

Postpartum haemorrhage due to anatomy

1161

0.74

2.01

1.2

1.3

18.54

22.40

e6/l

0.15

877

Isolated growth hormone deficiency

2.01

2.2

5.4

8.14

3.92

e6/l

0.28

Disorders of continuity of bone

124

968

1.29

2.00

1.8

1.4

38.01

33.46

e6/l

0.06

709

Multiple myeloma

201

1.66

2.00

1.0

1.3

20.77

48.87

e6/l

0.44

161

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

201

1.66

2.00

1.0

1.3

20.77

48.87

e6/l

0.44

161

Contusion of ankle

394

1.46

1.99

1.8

1.7

259.17

26.72

e6/l

0.48

290

Deep endometriosis

116

899

1.30

1.99

1.2

1.3

10.18

29.43

e6/l

1.23

642

Marginal zone B-cell lymphoma

2.03

1.98

1.6

1.2

205.70

44.73

e6/l

—

Other and unspecified vascular occlusions

690

1.34

1.98

1.4

1.3

33.79

34.23

e6/l

0.01

515

Other (seronegative) rheumatoid arthritis, wide

208

1723

1.21

1.97

1.2

1.4

27.68

27.83

e6/l

0.01

145

1295

Pedestrian injured in collision with car, pick-up truck or van

202

1.66

1.97

1.2

11.17

14.79

e6/l

0.13

150

Heart failure and coronary heart disease

355

2868

0.86

1.97

1.3

1.4

16.56

34.10

e6/l

1.30

281

2101

Cardiomyopathy in other diseases

2.64

1.97

1.2

1.3

5.80

85.79

e6/l

—

Drug-induced osteoporosis with pathological fracture

127

1.84

1.96

2.4

1.4

11.50

6.16

e6/l

0.27

Other benign neoplasms of connective and other soft tissue

114

883

1.30

1.96

1.4

39.29

33.98

e6/l

0.08

646

Late syphilis, including avohilmo

127

1.84

1.96

1.7

1.2

15.31

15.75

e6/l

0.01

ILD, hospital admissions 3, with pneumonia sepsis

614

1.36

1.96

1.3

1.4

21.93

21.28

e6/l

0.02

452

Other and unspecified follicular disorders

379

1.47

1.96

1.4

20.65

37.44

e6/l

0.37

280

Other puerperal infections

109

840

1.31

1.96

1.2

1.3

21.09

19.64

e6/l

0.04

629

Acne

149

1187

1.26

1.95

1.4

1.5

18.45

21.56

e6/l

0.14

115

864

Other sexually transmitted chlamydial diseases

667

1.34

1.94

1.6

1.5

32.60

21.24

e6/l

0.36

491

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

539

1.38

1.93

1.1

1.3

39.80

32.41

e6/l

0.12

404

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

106

1.92

1.93

1.3

3.42

12.75

e6/l

0.68

Tibial collateral bursitis [Pellegrini-Stieda]

2.04

1.93

1.6

1.7

86.73

4.68

e6/l

0.50

5-aminosalicylic acid

261

2213

1.18

1.92

1.4

68.06

24.57

e6/l

0.45

192

1615

Scoliosis

711

1.33

1.92

1.7

1.8

17.42

32.74

e6/l

0.45

518

Follow-up care involving plastic surgery

307

0.52

1.92

1.4

1.33

25.88

e6/l

—

211

Hyperaldosteronism

235

1.59

1.92

1.9

1.4

10.39

26.38

e6/l

0.53

173

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.36

1.92

1.7

1.3

5.29

42.77

e6/l

—

Hip and thigh

3.34

1.92

2.4

1.0

10.43

2.80

e6/l

—

Delayed milestone in childhood

218

1.60

1.91

2.7

5.2

32.39

9.45

e6/l

0.34

140

ILD, hospital admission 2, with pulmonary infections

712

1.33

1.90

1.3

1.4

20.12

13.91

e6/l

0.25

533

Polypectomy (DHB20)

575

1.37

1.90

1.5

1.4

7.63

35.20

e6/l

1.12

431

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

392

3432

1.15

1.90

1.4

17.86

36.08

e6/l

1.52

291

2525

Glucagon-like peptide-1 (GLP-1) analogues

392

3432

1.15

1.90

1.4

17.86

36.08

e6/l

1.52

291

2525

Separation of retinal layers (serosa)

365

1.47

1.90

1.2

1.3

262.68

55.24

e6/l

0.37

267

Other and unspecified injuries of shoulder and upper arm

284

1.53

1.89

1.5

1.4

4.65

12.26

e6/l

1.24

211

Respiratory tuberculosis, confirmed, including avohilmo

114

1.87

1.89

1.4

1.3

23.56

17.91

e6/l

0.13

Colonic or urogenital fistula

323

2791

1.16

1.89

1.5

1.3

30.23

29.29

e6/l

0.03

236

2044

Respiratory tuberculosis, bacteriologically and histologically confirmed

114

1.87

1.88

1.4

1.3

23.56

18.12

e6/l

0.13

Bacterial, viral and other infectious agents

109

845

1.30

1.88

1.4

1.6

5.70

26.65

e6/l

1.80

623

Disorders of porphyrin and bilirubin metabolism

1.97

1.87

2.0

1.3

22.77

18.57

e6/l

0.09

Inflammatory disorders of male genital organs, not elsewhere classified

2.01

1.87

1.2

1.5

0.91

14.92

e6/l

0.97

Other and unspecified abdominal hernia

309

1.50

1.86

1.3

1.4

21.42

38.80

e6/l

0.28

235

Chronic lymphocytic leukaemia, helper endpoint

221

1.60

1.86

1.2

1.3

180.72

45.83

e6/l

0.34

175

Chronic lymphocytic leukaemia

221

1.60

1.86

1.2

1.3

180.72

45.83

e6/l

0.34

175

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

221

1.60

1.86

1.2

1.3

180.72

45.83

e6/l

0.34

175

Post-traumatic wound infection, not elsewhere classified

237

1.58

1.86

1.2

1.3

31.54

26.73

e6/l

0.07

173

Pneumococcal septicemia

277

1.53

1.86

1.5

1.9

391.00

41.91

e6/l

1.11

207

Chronic conjunctivitis

261

1.55

1.86

2.0

1.8

13.76

37.87

e6/l

0.51

198

Chromosomal abnormalities, not elsewhere classified

229

1.59

1.86

1.6

3.5

5.64

13.69

e6/l

0.81

155

Benign mammary dysplasia

155

1256

1.24

1.85

1.5

1.4

60.33

37.93

e6/l

0.37

119

921

Conductive hearing loss, unspecified

760

1.31

1.84

2.2

1.5

159.23

33.21

e6/l

0.57

556

Colorectal cancer, including Hilmo

207

2304

0.83

1.84

1.3

1.4

13.76

23.91

e6/l

0.71

153

1750

Habit and impulse disorders

130

1.80

1.83

2.0

1.9

2.53

16.00

e6/l

1.52

Hernia of abdominal wall

556

4986

1.12

1.83

1.4

18.48

28.72

e6/l

0.79

406

3713

Other predominantly sexually transmitted diseases, not elsewhere classified

228

1921

1.19

1.83

1.4

1.3

18.46

26.78

e6/l

0.60

162

1414

Other specified disorders of kidney and ureter

254

1.55

1.83

1.3

1.5

94.59

38.05

e6/l

0.48

184

Dependence on enabling machines and devices, not elsewhere classified

108

1.88

1.82

3.8

2.0

3.75

39.37

e6/l

0.55

Melanoma in situ

352

1.46

1.82

1.1

1.4

12.22

53.93

e6/l

1.02

262

Acute nephritic syndrome

153

1.72

1.81

1.4

3.29

15.96

e6/l

1.19

114

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

369

1.45

1.81

2.7

2.5

3.95

17.35

e6/l

1.28

269

Persons encountering health services in circumstances related to reproduction

807

4934

1.10

1.81

1.5

19.84

40.97

e6/l

2.14

600

3548

Chronic periodontitis, complicated

714

6325

1.10

1.80

1.4

30.53

32.04

e6/l

0.03

486

4710

Anxious personality disorder

161

1.70

1.80

1.2

1.3

2.53

16.49

e6/l

1.68

118

Pyoderma

146

1.74

1.79

1.3

1.5

1.65

17.88

e6/l

1.60

109

COPD, hospital admissions 1, only main diagnosis

268

2687

0.85

1.79

1.4

28.58

32.15

e6/l

0.08

209

2001

Malignant neoplasm of bronchus and lung

129

1348

0.80

1.79

1.2

1.4

27.82

26.68

e6/l

0.02

1019

Contact with heat and hot substances

513

1.38

1.79

1.4

1.7

4.14

18.44

e6/l

1.33

371

Lichen planus

148

1199

1.24

1.78

1.4

42.98

31.46

e6/l

0.22

113

877

Dysplasia of cervi uteri

299

1809

1.17

1.78

1.2

1.3

82.63

29.69

e6/l

0.60

219

1352

Psoriatic arthropathies

115

905

1.28

1.78

1.3

1.4

27.90

23.70

e6/l

0.12

667

Lactose intolerance, other/unspecified

224

1.58

1.78

1.3

1.8

3.11

10.05

e6/l

1.21

168

Septal defects

672

1.32

1.77

1.4

2.7

9.97

37.05

e6/l

1.17

483

Infective dermatitis

130

1039

1.26

1.77

1.4

39.33

27.05

e6/l

0.20

108

761

Thyroiditis

652

1.33

1.77

1.5

1.3

48.08

34.28

e6/l

0.15

479

Contact with lifting and transmission devices, not elsewhere classified

147

1.73

1.76

1.5

1.3

24.29

38.61

e6/l

0.19

108

Torsion of ovary, ovarian pedicle and fallopian tube

209

1.60

1.76

1.2

1.4

60.18

17.52

e6/l

0.33

162

Intestinal adhesions without obstruction

705

1.31

1.75

1.4

1.5

13.75

35.32

e6/l

0.87

524

Sequelae of infectious and parasitic diseases

601

1.34

1.75

1.6

1.4

23.54

38.00

e6/l

0.36

445

Flat foot [pes planus] (acquired)

109

855

1.28

1.74

1.3

1.4

142.23

35.19

e6/l

0.46

634

Pre-eclampsia or eclampsia

269

2310

1.17

1.74

1.3

25.52

38.70

e6/l

0.26

211

1693

Presence of cardiac and vascular implants and grafts

386

3222

0.88

1.73

1.3

1.4

31.25

30.99

e6/l

0.00

304

2429

Burns and corrosions confined to eye and internal organs

234

1.56

1.72

1.6

12.82

11.80

e6/l

0.05

170

Foreign body in genitourinary tract

1.99

1.72

1.2

66.00

11.77

e6/l

—

Other chondrocalcinosis

1.94

1.72

1.2

1.1

2.73

12.08

e6/l

0.60

Chronic nephritic syndrome

307

1.48

1.72

1.6

1.4

10.26

42.54

e6/l

0.83

226

Benign neoplasm: Rectum

193

1613

1.20

1.72

1.3

39.99

26.43

e6/l

0.25

129

1181

Ulcerative colitis, NAS

171

1413

1.22

1.72

1.3

1.5

20.52

27.16

e6/l

0.22

132

1045

Psoriasis

343

3001

1.15

1.72

1.2

1.4

25.48

32.72

e6/l

0.29

242

2189

Carbimazole or st.post thyroidectomy, condition for graves disease

253

2165

1.17

1.71

1.5

1.3

47.52

31.66

e6/l

0.28

176

1589

Hidradenitis suppurativa

357

1.44

1.71

1.3

97.29

21.55

e6/l

0.96

268

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

187

1.63

1.71

1.3

1.4

26.43

7.10

e6/l

0.56

145

Other pleural conditions

760

1.30

1.71

1.4

34.96

32.20

e6/l

0.03

567

Female infertility, cervical, vaginal, other or unspecified origin

336

1870

1.15

1.71

1.4

1.3

17.64

31.65

e6/l

0.83

237

1397

Other lesions of median nerve

187

1.62

1.70

1.1

1.2

39.94

42.76

e6/l

0.02

138

Endometriosis of ovary

204

1614

1.19

1.70

1.4

34.91

30.13

e6/l

0.08

151

1214

Lactose intolerance

259

1.52

1.69

1.4

1.7

5.44

31.27

e6/l

0.60

198

Other bursitis of hip

141

1.72

1.69

1.6

1.3

4.64

85.21

e6/l

0.98

102

Malignant neoplasm of accessory sinuses

3.31

1.69

1.5

1.1

90.00

2.43

e6/l

—

Spontaneous rupture of synovium and tendon

683

1.31

1.68

1.4

11.51

41.87

e6/l

1.36

502

Disorders resulting from impaired renal tubular function

317

1.47

1.68

1.4

1.7

24.59

38.85

e6/l

0.21

231

Late syphilis

1.89

1.68

1.9

1.1

18.46

13.15

e6/l

0.17

Hypoplasia of dental enamel, prenatal

2.43

1.67

5.7

5.2

1.67

3.92

e6/l

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

220

1.56

1.67

1.2

1.6

9.80

12.57

e6/l

0.14

166

Other orthopaedic follow-up care

460

1.38

1.66

1.2

1.4

8.48

22.81

e6/l

0.85

330

Bronchitis, not specified as acute or chronic

737

1.30

1.66

1.2

1.4

5.96

30.76

e6/l

1.36

543

Sacrococcygeal disorders, not elsewhere classified

228

1.55

1.66

1.2

1.6

15.68

39.09

e6/l

0.40

170

Complications predominantly related to the puerperium

331

2899

1.15

1.65

1.2

1.3

16.69

44.47

e6/l

2.04

236

2135

Habitual aborter

197

1.59

1.64

1.3

29.88

21.75

e6/l

0.20

149

Retinal haemorrhage

189

1.61

1.64

2.5

1.3

5.05

61.42

e6/l

0.98

146

Pediculosis, acariasis and other infestations, including avohilmo

234

1998

1.18

1.64

1.2

1.5

11.84

25.15

e6/l

1.68

174

1466

Carcinoma in situ of breast, intraductal

770

0.72

1.64

1.4

1.3

46.03

28.70

e6/l

0.20

554

Defect, injury or illness of neck

2.13

1.63

1.2

1.6

1.14

13.31

e6/l

—

Nonspecific lymphadenitis

548

1.34

1.63

1.8

1.5

26.84

25.41

e6/l

0.03

407

Sulfonylureas

246

2276

0.86

1.63

1.4

1.3

22.96

31.84

e6/l

0.29

187

1711

Benign neoplasm: Transverse colon

120

962

1.25

1.62

1.6

1.3

7.38

28.08

e6/l

1.54

710

Oesophagitis

437

1.38

1.62

1.3

1.5

3.00

48.14

e6/l

1.57

318

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

1.94

1.62

2.2

1.4

26.00

15.68

e6/l

0.22

Umbilical hernia

326

2858

1.14

1.61

1.4

17.40

26.60

e6/l

0.48

237

2103

Hereditary corneal dystrophies

288

0.55

1.61

3.3

1.4

62.91

34.58

e6/l

0.19

209

Pneumonia due to Streptococcus pneumoniae

320

1.45

1.60

1.5

1.4

36.79

15.40

e6/l

0.42

238

Certain conditions originating in the perinatal period

119

846

1.26

1.60

2.9

2.1

18.65

16.69

e6/l

0.07

606

Myeloproliferative diseases

689

1.30

1.60

1.4

26.83

34.09

e6/l

0.15

505

Benign neoplasm: Ascending colon

149

1225

1.22

1.60

1.3

25.77

27.81

e6/l

0.05

113

894

Sudden idiopathic hearing loss

110

875

1.26

1.59

1.5

1.3

42.48

27.78

e6/l

0.19

648

Other abnormal auditory perceptions

1.85

1.59

1.3

1.6

2.08

15.42

e6/l

1.05

Other factor of the environment

1.85

1.59

1.6

1.2

92.50

16.71

e6/l

—

Postpartum haemorrhage due to retained placenta

109

1363

0.80

1.59

1.4

1.3

32.70

21.48

e6/l

0.38

1024

Acquired haemolytic anaemia

183

1.60

1.59

1.3

5.78

12.19

e6/l

0.62

146

Vasculitis limited to skin, not elsewhere classified

191

1.59

1.58

1.1

1.6

6.68

60.07

e6/l

1.01

150

Primary open-angle glaucoma

312

2625

1.15

1.58

1.4

17.41

32.17

e6/l

1.02

240

1983

IBD patients in KELA-register

293

2554

1.15

1.58

1.5

1.4

56.02

25.47

e6/l

0.34

219

1875

Gout, idiopatic and unspecified

257

2219

1.16

1.57

1.4

1.3

76.10

27.03

e6/l

0.46

176

1675

Malignant neoplasm of corpus uteri, including Hilmo

741

0.72

1.57

1.4

15.44

25.39

e6/l

0.40

558

Other and unspecified vasculitis limited to skin

168

1.63

1.56

1.1

1.6

6.94

32.36

e6/l

0.68

129

Postpartum haemorrhage

267

2538

0.86

1.56

1.3

28.59

34.20

e6/l

0.17

206

1867

Lichen ruber planus, wide definition including periferal and oral lichen planus

259

2240

1.16

1.56

1.3

1.4

31.21

35.56

e6/l

0.11

186

1645

Other and unspecified nail disorders

192

1.58

1.55

1.3

1.4

6.09

10.98

e6/l

0.40

143

Postprocedural disorders of digestive system, not elsewhere classified

273

1.48

1.55

1.7

1.6

102.94

41.40

e6/l

0.28

205

Other and unspecified injuries of thorax

130

1.71

1.54

1.2

1.44

15.67

e6/l

1.20

Complications following myocardial infarction

0.00

1.53

0.0

1.3

—

72.91

—

Open wound of forearm

113

907

1.25

1.53

1.2

1.5

58.36

32.08

e6/l

0.32

669

Endometriosis ASRM stages 3,4

273

2377

1.15

1.51

1.3

26.69

36.96

e6/l

0.26

204

1754

Use of antiglaucoma preparations and miotics

555

1.32

1.51

1.3

60.00

38.53

e6/l

0.14

415

Viral warts

120

972

1.24

1.50

1.5

1.6

19.15

24.66

e6/l

0.18

711

Benign neoplasm of mouth and pharynx

120

972

1.24

1.50

1.2

1.4

21.95

29.05

e6/l

0.27

718

Melanocytic naevi of lower limb, including hip

418

1.38

1.50

1.3

1.5

17.35

40.91

e6/l

0.58

311

Vasomotor rhinitis (mode)

661

1.29

1.50

1.4

148.76

35.75

e6/l

0.43

481

Sequelae of other and unspecified infectious and parasitic diseases

470

1.35

1.49

1.7

1.4

30.38

23.29

e6/l

0.17

346

Benign lipomatous neoplasm

338

2989

1.13

1.49

1.4

1.3

43.23

32.31

e6/l

0.24

261

2204

Benign thyroid growths and nodules

369

3046

1.13

1.49

1.3

1.4

26.52

33.51

e6/l

0.17

266

2234

Female infertility

361

1913

1.13

1.48

1.4

1.3

16.90

31.39

e6/l

0.93

261

1428

Pre-eclampsia or poor fetal growth

389

3454

1.12

1.48

1.3

28.43

37.06

e6/l

0.22

301

2537

Other aneurysm

419

1.37

1.48

2.0

1.4

43.79

47.28

e6/l

0.04

314

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

171

1.60

1.48

1.3

2.2

1.56

15.58

e6/l

1.67

127

Myocardial infarction, strict

421

3325

0.89

1.48

1.3

1.4

18.02

32.60

e6/l

1.08

326

2440

Nontoxic goitre/thyroid nodule

321

2831

1.14

1.47

1.3

1.4

29.69

31.21

e6/l

0.03

234

2087

Corns and callosities

575

1.31

1.47

1.8

1.4

10.25

40.56

e6/l

1.18

425

Uterine polyps

337

1734

1.14

1.47

1.3

1.4

32.77

30.36

e6/l

0.06

240

1303

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

681

1.29

1.46

1.8

1.3

16.38

36.43

e6/l

0.82

508

Toxic liver disease

117

1.73

1.46

1.8

1.3

17.15

12.52

e6/l

0.14

Adjustment and management of implanted device

166

1393

1.20

1.46

1.3

1.4

6.50

17.24

e6/l

2.19

113

1033

Glaucoma secondary to eye inflammation

1.96

1.46

1.2

1.4

1.13

15.61

e6/l

—

Premature rupture of membranes

218

1805

0.86

1.46

1.3

20.85

35.76

e6/l

0.64

167

1329

LSIL lesion of the cervix uteri, vagina or vulva

184

1560

1.18

1.45

1.4

1.3

50.93

26.93

e6/l

0.51

134

1158

Molar incisor enamel hypoplasia

443

1.35

1.45

6.3

2.6

5.09

14.16

e6/l

0.83

305

Benign neoplasm: Choroid

577

1.31

1.44

1.5

1.4

13.93

39.22

e6/l

0.89

432

Palmar fascial fibromatosis [Dupuytren]

139

1149

1.21

1.44

1.4

1.3

67.95

32.87

e6/l

0.44

106

860

Bursitis of shoulder

188

1.56

1.44

2.0

1.3

7.68

28.47

e6/l

0.58

137

Alopecia areata

245

1.48

1.44

1.2

1.7

12.96

7.07

e6/l

0.25

176

Congenital deformities of hip

188

1.56

1.43

2.8

2.7

44.33

8.47

e6/l

0.59

136

Malignant neoplasm of corpus uteri

682

0.73

1.43

1.4

16.12

22.12

e6/l

0.22

512

Gout, unspecified

206

1765

1.17

1.43

1.4

1.3

31.74

23.27

e6/l

0.19

140

1316

Maternal care for known or suspected abnormality of pelvic organs

334

1993

1.13

1.42

1.3

27.91

34.88

e6/l

0.24

248

1467

Unspecified human immunodeficiency virus [HIV] disease

1.89

1.42

2.3

1.4

28.50

15.89

e6/l

—

Foreign body in respiratory tract

457

1.34

1.42

2.4

1.7

22.51

44.95

e6/l

0.40

331

Other melanin hyperpigmentation

165

1.59

1.41

1.0

1.2

10.57

48.83

e6/l

0.53

124

Myocardial infarction, unclassifiable

136

1465

0.83

1.41

1.3

10.64

26.03

e6/l

1.18

107

1099

Congenital deformities of hip, including avohilmo

205

1.53

1.41

2.7

2.6

40.10

9.64

e6/l

0.55

149

Congenital malformations of spine and bony thorax

2.13

1.41

1.2

3.6

1.18

16.29

e6/l

0.59

Pedal cyclist injured in transport accident

277

2429

1.14

1.41

1.3

1.5

15.99

23.66

e6/l

0.49

204

1798

Family history of certain disabilities and chronic diseases leading to disablement

475

1.34

1.40

1.3

1.4

87.35

21.58

e6/l

0.38

346

Congenital dislocation of hip, unilateral

2.05

1.40

1.8

3.0

84.43

4.50

e6/l

—

Papillary adenocarcinoma of thyroid gland

458

1.34

1.40

1.4

1.3

47.71

29.81

e6/l

0.29

339

Single delivery by forceps and vacuum extractor

149

1065

0.83

1.40

1.2

1.4

24.06

29.49

e6/l

0.15

112

764

Mixed connective tissue disease

142

1.64

1.40

2.1

1.1

5.76

15.59

e6/l

0.72

108

Infective bursitis

214

1.51

1.39

1.4

25.29

48.86

e6/l

0.32

162

Dissocial personality disorder

119

1.70

1.39

2.7

1.3

6.50

23.56

e6/l

0.92

Diabetic nephropathy

163

1356

1.19

1.39

1.6

1.4

44.70

21.45

e6/l

0.52

129

990

Malignant neoplasm of small intestine

182

1.56

1.38

1.4

1.2

11.35

58.15

e6/l

0.77

142

Other and specified injuries of hip and thigh

166

1.58

1.38

1.5

1.2

2.24

46.13

e6/l

0.77

128

Abnormal findings on examination of urine, without diagnosis

365

1.38

1.37

1.5

86.27

39.69

e6/l

0.36

269

Lichen sclerosus et atrophicus

129

1065

1.22

1.37

1.4

25.66

41.08

e6/l

0.43

790

Supervision of high-risk pregnancy

267

1400

1.15

1.37

1.2

1.3

28.98

45.64

e6/l

0.46

197

1012

Other disorders of conjunctiva

152

1275

1.20

1.37

1.3

1.5

9.62

28.92

e6/l

1.87

117

948

Crystal arthropathies, rheuma endpoint

135

1.65

1.37

1.3

1.2

2.69

57.59

e6/l

0.66

100

Other mycoses, not elsewhere classified/unspecified, including avohilmo

143

1.63

1.36

1.5

1.3

35.88

17.48

e6/l

0.26

108

Atrioventricular septal defect

0.00

1.36

0.0

4.1

—

26.35

—

Labour and delivery complicated by fetal stress [distress]

263

1953

0.87

1.36

1.2

1.3

17.63

32.79

e6/l

0.86

202

1446

Pre-eclampsia

248

2165

1.15

1.36

1.3

27.48

38.87

e6/l

0.20

195

1593

Neuroendocrine tumor and carcinoma of stomach

0.00

1.36

0.0

1.3

—

3.10

—

Inflammatory bowel disease, strict (require KELA)

293

2587

1.14

1.35

1.5

1.4

56.02

26.52

e6/l

0.33

219

1900

Crohn's disease of large intestine

487

1.32

1.35

1.2

1.5

12.24

24.71

e6/l

0.52

361

Ectropion of eyelid

240

1.47

1.35

1.3

111.26

39.89

e6/l

0.29

186

Contact with sharp glass

367

1.37

1.34

1.5

9.56

17.70

e6/l

0.76

271

Female infertility, tubal origin

427

1.34

1.3

3.98

22.73

e6/l

3.71

316

Myocardial infarction, with ST-elevation

110

1344

0.82

1.34

1.2

1.3

31.31

27.10

e6/l

0.09

993

Other crystal arthropathies

136

1.64

1.34

1.3

1.2

2.69

53.89

e6/l

0.64

105

Disorders of puberty, all

168

1.57

1.33

2.2

3.2

2.55

10.34

e6/l

1.00

120

Pedal cyclist injured in other and unspecified transport accidents

135

1124

1.21

1.33

1.4

1.5

9.04

30.55

e6/l

1.73

103

824

Corneal scars and opacities

233

1.47

1.33

3.4

1.5

56.30

34.51

e6/l

0.23

170

Torsion of testis

160

1.58

1.33

1.4

2.3

71.53

17.94

e6/l

0.38

112

Pituitary-dependent Cushing's disease

2.45

1.32

1.1

2.25

23.71

e6/l

—

Unspecified threat to breathing

1.79

1.31

1.3

1.5

1.45

10.44

e6/l

0.60

Benign neoplasm: Liver/bile ducts

234

1.47

1.30

1.4

1.5

62.76

12.20

e6/l

0.68

181

L02BX Other hormone antagonists and related agents

403

0.67

1.30

1.1

1.4

7.79

31.33

e6/l

0.86

311

Hirsutism in women

177

1.54

1.30

1.2

1.4

28.28

8.94

e6/l

0.53

137

Valvular operations

104

1273

0.81

1.30

1.2

1.6

234.89

18.13

e6/l

0.93

929

Iron deficiency anaemia secondary to blood loss (chronic)

162

1374

1.18

1.30

1.5

1.4

11.65

28.99

e6/l

1.24

120

1026

Unstable angina pectoris

387

2731

1.12

1.30

1.3

1.4

17.19

33.76

e6/l

1.26

303

2009

Idiopathic gout

738

1.25

1.30

1.3

142.50

25.61

e6/l

0.43

560

Psoas tendinitis

2.13

1.30

1.1

1.4

12.20

17.45

e6/l

—

Other disorders of pigmentation

378

1.36

1.29

1.1

1.3

8.28

55.64

e6/l

1.36

283

Contusion of toe(s) with damage to nail

1.74

1.29

2.1

1.5

55.73

15.72

e6/l

0.35

Malignant neoplasm of accessory sinuses, including Hilmo

2.35

1.28

1.6

1.2

68.00

5.48

e6/l

—

Acne vulgaris

113

927

1.22

1.28

1.4

1.5

11.61

21.72

e6/l

1.10

682

Lichen simplex chronicus and prurigo

553

1.29

1.28

1.4

1.3

67.02

30.89

e6/l

0.30

406

Lichen planus, including avohilmo

215

1868

1.15

1.28

1.3

1.4

34.28

35.15

e6/l

0.02

160

1390

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

740

1.25

1.28

1.1

1.4

98.04

27.99

e6/l

0.54

538

Hypertensive Renal Disease

202

1.49

1.27

1.2

1.3

2.56

44.20

e6/l

0.77

147

Congenital malformations of cardiac septa

708

1.25

1.27

1.4

2.6

9.80

38.58

e6/l

1.34

503

Certolizumab pegol

170

1.55

1.27

1.2

29.47

10.41

e6/l

0.33

122

Other menopausal disorders

327

1620

1.13

1.27

1.4

32.95

32.08

e6/l

0.02

239

1214

Open wound of shoulder and upper arm

162

1.56

1.27

1.1

1.4

5.33

11.15

e6/l

0.56

124

Non-small cell lung cancer

805

0.77

1.27

1.2

1.3

5.95

29.03

e6/l

1.81

604

Peritonsillar abscess

257

2262

1.14

1.27

1.4

36.73

24.11

e6/l

0.40

196

1653

Open wound of hip and thigh

286

1.41

1.26

1.3

1.5

124.40

14.86

e6/l

0.62

209

Unspecified jaundice

337

1.37

1.25

1.1

1.5

12.70

60.13

e6/l

1.14

250

Spermatocele

528

1.29

1.25

1.5

1.3

18.87

23.09

e6/l

0.12

394

Retinal breaks without detachment

179

1537

1.17

1.25

1.4

40.07

37.69

e6/l

0.04

121

1126

Postpartum hemorraghe, parous women as controls

267

2525

0.88

1.25

1.3

28.59

33.71

e6/l

0.16

206

1880

Other benign neoplasms of uterus

363

0.66

1.25

1.0

1.2

13.61

30.85

e6/l

0.42

268

Hypertrichosis

212

1.48

1.24

1.2

1.3

24.86

23.59

e6/l

0.02

163

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

262

1.43

1.24

1.5

1.4

11.04

17.89

e6/l

0.43

196

All dysplastic lesions of the vulva

390

1.34

1.24

1.9

1.4

20.11

28.73

e6/l

0.16

282

Other disorders of prostate

212

1.47

1.23

1.4

1.3

24.35

10.81

e6/l

0.29

159

Fall on and from ladder

646

1.26

1.22

1.3

1.4

12.34

32.87

e6/l

0.83

487

Bicipital tendinitis

391

1.34

1.22

1.6

1.4

7.78

48.03

e6/l

1.13

290

Haemangioma, any site

100

818

1.23

1.20

1.4

1.6

19.39

32.78

e6/l

0.38

605

Assault by other specified means

1.77

1.20

1.1

1.3

1.11

17.42

e6/l

—

Other surgical follow-up care

272

1.41

1.20

1.1

1.7

85.36

26.15

e6/l

0.49

195

Benign neoplasm of ovary

181

1562

1.16

1.20

1.3

1.4

11.14

40.55

e6/l

1.94

126

1150

Disorders of eyelid in diseases classified elsewhere

264

1.41

1.19

1.4

6.85

14.65

e6/l

0.71

201

Abnormality of white blood cells, not elsewhere classified

1.91

1.19

1.9

1.4

21.33

13.43

e6/l

—

Ventral hernia

261

2311

1.13

1.19

1.4

14.98

27.26

e6/l

0.84

198

1705

Ankyloglossia

189

1.50

1.19

2.6

3.4

5.55

6.52

e6/l

0.13

129

Localized skin eruption due to drugs and medicaments

1.73

1.19

1.8

1.3

2.55

6.22

e6/l

0.61

Malignant neoplasm of other and unspecified major salivary glands

0.00

1.18

0.0

1.2

—

23.60

—

Other sexually transmitted chlamydial diseases, including avohilmo

132

1113

1.19

1.17

1.4

26.38

20.08

e6/l

0.27

816

Granulomatous disorders of skin and subcutaneous tissue

215

1.45

1.17

1.4

1.2

19.96

17.07

e6/l

0.05

162

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

777

5625

1.07

1.16

1.3

1.4

65.68

29.63

e6/l

0.84

569

4144

Contusion of other and unspecified parts of foot

526

1.28

1.16

1.4

1.7

5.81

21.13

e6/l

2.11

393

Hallux valgus (acquired)

373

2408

1.11

1.16

1.5

1.4

61.53

35.85

e6/l

0.32

289

1763

Early onset COPD

237

2090

1.14

1.16

1.5

1.4

53.69

30.37

e6/l

0.23

181

1531

Colon adenocarcinoma, helper endpoint

1003

0.80

1.16

1.3

12.09

29.05

e6/l

0.93

741

Carcinoma in situ of skin of other and unspecified parts of face

597

1.26

1.16

1.3

22.80

37.87

e6/l

0.39

452

Congenital malformations of spine and bony thorax, including avohilmo

1.89

1.15

1.2

3.2

1.08

21.71

e6/l

1.07

Burn and corrosion of wrist and hand

343

1.35

1.15

1.3

1.6

13.15

15.29

e6/l

0.09

251

Lifestyle-related condition

1.71

1.15

1.7

1.3

102.78

9.68

e6/l

—

Benign neoplasm of major salivary glands

102

841

1.22

1.15

1.3

1.4

19.51

32.38

e6/l

0.47

614

Simple and mucopurulent chronic bronchitis

300

1.37

1.15

1.9

2.94

52.61

e6/l

1.13

230

Hypoplasia of dental enamel , including avohilmo

422

1.31

1.14

6.8

2.6

5.46

14.59

e6/l

0.78

292

Pediculosis, acariasis and other infestations

554

1.27

1.14

1.4

1.6

17.50

28.06

e6/l

0.34

409

Postpartum hemorraghe, all women as controls

267

2922

0.89

1.14

1.3

28.59

34.87

e6/l

0.20

206

2156

Acute epiglottitis

111

1.64

1.13

1.3

1.2

21.27

11.47

e6/l

0.21

Exposure to smoke, fire and flames

200

1.46

1.13

1.2

1.4

5.14

13.32

e6/l

0.71

145

Follow-up examination after treatment for malignant neoplasms

644

1.25

1.13

1.6

1.4

14.93

41.43

e6/l

0.92

456

Other and unspecified psoriasis

609

1.25

1.12

1.3

1.4

9.04

37.40

e6/l

1.22

440

Other osteochondropathies

654

1.25

1.12

1.6

1.5

25.45

36.22

e6/l

0.25

479

Injury of nerves at wrist and hand level

345

1.34

1.12

1.5

35.03

24.79

e6/l

0.19

256

Exposure to other and unspecified animate mechanical forces

285

1.38

1.11

1.2

1.6

36.54

13.79

e6/l

0.31

214

Complications associated with artificial fertilization

168

1.50

1.11

1.3

1.4

13.00

20.64

e6/l

0.34

129

Other vitreous opacities

363

1.33

1.10

1.6

1.4

25.95

36.09

e6/l

0.17

270

Other and unspecified glaucoma

530

1.27

1.10

1.5

1.3

54.98

39.26

e6/l

0.11

392

Gestational diabetes (for exclusion)

491

3100

1.09

1.10

1.3

18.86

33.63

e6/l

1.12

359

2300

Unspecified kidney failure

782

1.22

1.10

1.5

1.4

6.84

31.28

e6/l

1.52

592

185

1.48

1.09

1.3

1.8

21.18

10.86

e6/l

0.35

128

Ectopic pregnancy

205

1800

1.14

1.09

1.4

70.41

49.68

e6/l

0.14

144

1317

AV-block

185

1375

1.15

1.09

1.3

1.5

12.87

17.46

e6/l

0.21

144

1033

Other misadventures during surgical and medical care

210

1.44

1.09

1.4

1.3

5.88

12.50

e6/l

0.60

149

Obstructed labour due to maternal pelvic abnormality

166

1438

1.16

1.08

1.3

84.02

51.63

e6/l

0.19

115

1037

Degeneration of macula and posterior pole

501

3557

1.09

1.08

1.4

37.93

33.36

e6/l

0.07

349

2681

Colectomy operation

168

1457

1.16

1.07

1.4

27.63

29.05

e6/l

0.03

124

1075

Single delivery by caesarean section

193

1259

0.87

1.07

1.6

1.4

41.50

38.18

e6/l

0.06

148

894

LSIL lesion of the cervix uteri

146

1254

1.17

1.06

1.2

1.3

61.53

24.86

e6/l

0.66

105

935

Varicose veins of other sites

578

1.25

1.06

1.2

1.6

146.21

39.28

e6/l

0.36

414

Other inflammation of vagina/vulva

357

1.33

1.06

1.1

1.5

3.21

19.32

e6/l

1.66

267

Dilated cardiomyopathy

968

0.81

1.05

1.4

96.27

26.35

e6/l

0.40

720

Colon adenocarcinoma

990

0.82

1.05

1.3

12.09

28.11

e6/l

0.93

744

Congenital hypothyroidism without goiter

2.00

1.05

1.2

2.1

3.11

17.91

e6/l

—

Normotensive glaucoma

678

1.23

1.05

1.4

1.3

19.75

40.56

e6/l

0.60

496

Marasmic kwashiorkor

2.35

1.05

1.8

1.9

602.80

2.40

e6/l

—

Other disorders of Eustachian tube

263

1.38

1.04

1.2

1.4

8.92

15.15

e6/l

0.42

197

Benign neoplasm: Peripheral nerves and autonomic nervous system

122

1.58

1.03

1.4

1.2

1.62

11.83

e6/l

1.00

Endometriosis diagnosis and infertility diagnosis occurring together

134

1147

1.17

1.03

1.4

1.3

12.03

26.92

e6/l

1.04

858

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

202

1726

1.14

1.03

1.4

1.9

6.77

25.85

e6/l

2.70

156

1252

Other and/or unspecified nontoxic goitre

680

1.23

1.02

1.3

1.4

9.33

35.28

e6/l

1.45

495

Seropositive rheumatoid arthritis, wide

278

2499

1.11

1.02

1.3

1.4

28.24

32.40

e6/l

0.16

205

1854

L02BB Anti-androgens

621

0.77

1.02

1.2

1.3

6.28

30.77

e6/l

1.35

465

Other congenital malformations of skin, including avohilmo

817

1.21

1.02

1.7

1.6

34.89

36.32

e6/l

0.02

588

Benign neoplasm: Colon, unspecified

259

2320

1.12

1.02

1.4

1.3

15.60

31.28

e6/l

1.17

194

1720

Deficiency of other B group vitamins

155

1.50

1.02

1.3

1.5

10.40

14.14

e6/l

0.15

119

Urethritis and urethral syndrome

155

1.50

1.02

1.3

1.5

23.12

22.64

e6/l

0.01

108

Amiodarone users

798

0.80

1.01

1.3

1.4

39.70

28.93

e6/l

0.17

594

Other blood glucose lowering drugs, excl. Insulins

155

1344

1.16

1.01

1.5

1.3

30.33

30.95

e6/l

0.02

116

989

All dysplastic lesions of the cervix uteri, vagina or vulva

376

3351

1.10

1.00

1.3

67.60

28.64

e6/l

0.54

275

2479

Benign neoplasm: Anus and anal canal

214

1.41

1.00

1.5

1.2

5.50

81.06

e6/l

1.16

155

Lesion of sciatic nerve

265

1.37

1.00

1.2

8.00

32.77

e6/l

0.57

202

Exposure to other and unspecified forces of nature

1.84

1.00

1.1

1.80

18.26

e6/l

—

Malignant neoplasm of skin, including Hilmo

614

3826

1.08

1.00

1.3

1.4

45.61

26.19

e6/l

0.41

446

2887

Nephrotic syndrome

274

1.36

1.00

1.7

1.9

92.41

29.20

e6/l

0.32

201

Bronchiectasis

619

1.23

1.00

1.3

1.5

8.87

33.62

e6/l

1.07

459

Contraceptive management

545

3530

1.08

1.00

1.3

1.4

31.43

42.54

e6/l

0.47

428

2536

Carcinoma in situ of skin of scalp and neck

189

1.44

1.00

1.9

1.2

11.21

51.20

e6/l

0.67

148

Malignant neoplasm of colon

110

1298

0.84

0.99

1.3

1.4

19.22

26.92

e6/l

0.26

984

Other infestations, including avohilmo

148

1.50

0.99

1.1

1.7

33.58

15.02

e6/l

0.24

112

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.99

0.0

5.0

—

15.48

—

Haemangioma and lymphangioma, any site

104

875

1.19

0.99

1.4

1.6

19.25

31.34

e6/l

0.35

646

Carcinoma in situ of breast

0.00

0.99

0.0

1.0

—

29.00

—

Postpartum care and examination

178

976

1.15

0.98

1.3

34.50

43.71

e6/l

0.17

141

705

Macular pucker

159

1385

1.15

0.98

1.3

1.4

14.33

35.34

e6/l

1.58

106

1022

Other and unspecified disorders of orbit

1.98

0.98

1.7

1.0

125.00

3.50

e6/l

—

Degenerative myopia

1.88

0.98

1.6

1.0

167.40

15.41

e6/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

354

0.70

0.97

1.2

1.3

2.12

32.18

e6/l

1.10

277

Paget disease

0.00

0.97

0.0

1.1

—

33.96

—

HSIL lesion of the vulva

157

1.48

0.97

1.3

1.4

32.59

15.16

e6/l

0.22

114

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

758

1.21

0.97

1.5

1.3

21.03

21.40

e6/l

0.01

567

Burn and corrosion confined to eye and adnexa

199

1.42

0.96

1.2

1.5

7.50

8.84

e6/l

0.11

148

Benign neoplasm: Descending colon

604

1.23

0.96

1.2

1.4

6.15

37.50

e6/l

1.46

441

Dislocation, sprain and strain of joints and ligaments of elbow

659

1.22

0.96

1.7

1.9

12.30

30.11

e6/l

0.85

470

Contact with sharp object, undetermined intent

225

1.39

0.95

1.6

1.4

6.43

12.88

e6/l

0.54

163

Monoarthritis, not elsewhere classified

355

1.30

0.95

1.2

1.4

4.10

25.92

e6/l

0.75

276

Primary adrenocortical insufficiency

1.64

0.95

1.3

1.2

75.11

13.56

e6/l

—

Evidence of alcohol involvement determined by blood alcohol level

117

1.56

0.94

1.2

4.75

12.63

e6/l

0.56

Placenta praevia

477

0.75

0.94

1.5

1.3

8.63

21.61

e6/l

0.85

352

Cardiomyopathy (excluding other)

1128

0.84

0.94

1.5

84.48

21.25

e6/l

0.45

825

Myeloproliferative diseases (CML excluded)

625

1.22

0.93

1.2

1.4

32.19

37.23

e6/l

0.09

457

Idiopathic thrombocytopenic purpura

252

1.36

0.92

1.7

1.3

22.60

15.23

e6/l

0.14

185

Maternal care for cervical incompetence

348

1.30

0.92

1.4

1.3

4.37

38.89

e6/l

1.14

249

Other/unspecified rheumatoid arthritis

119

1020

1.17

0.92

1.2

1.3

9.80

34.59

e6/l

1.93

755

Other diseases of appendix

1.65

0.92

1.1

65.38

11.13

e6/l

—

Skin changes due to chronic exposure to nonionizing radiation

389

3237

1.09

0.92

1.4

25.08

31.13

e6/l

0.21

276

2449

Other protozoal intestinal diseases

118

1.54

0.92

1.2

1.9

43.00

17.00

e6/l

0.27

Nontoxic diffuse goitre

244

1.36

0.91

1.5

1.4

6.54

36.57

e6/l

0.63

178

Other protozoal intestinal diseases, including avohilmo

176

1.43

0.91

1.2

1.9

61.41

18.63

e6/l

0.50

136

Infliximab

193

1.41

0.91

1.3

1.4

525.14

19.60

e6/l

0.64

141

Benign neoplasm: other/unspecified salivary gland

193

1.41

0.91

1.4

1.2

28.14

40.41

e6/l

0.13

145

Other and unspecified mononeuropathies of lower limb

210

1.39

0.91

1.3

1.5

3.25

43.13

e6/l

0.70

144

Aortic aneurysm

179

1982

0.88

0.91

1.5

1.3

9.88

26.93

e6/l

1.76

137

1483

Benign neoplasm: salivary glands, exclude unknown (D119)

773

1.20

0.91

1.3

1.4

13.94

33.31

e6/l

0.89

563

Other respiratory diseases principally affecting the interstitium

169

1489

1.14

0.90

1.2

1.4

65.03

27.97

e6/l

0.40

117

1098

Viral agents as the cause of diseases classified to other chapters

185

1.42

0.90

1.2

1.7

13.82

13.77

e6/l

0.00

139

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

332

1.30

0.90

1.4

28.07

57.29

e6/l

0.46

242

Graves disease, strict definition

117

1005

1.17

0.89

1.7

1.3

15.57

28.63

e6/l

0.73

730

Respiratory tuberculosis

359

1.29

0.88

1.5

1.3

26.94

52.73

e6/l

0.43

270

Respiratory tuberculosis, confirmed and not-confirmed

359

1.29

0.88

1.5

1.3

26.94

52.73

e6/l

0.43

270

Periodontal disease, other/unspecified

237

1.36

0.88

1.1

1.5

109.62

55.76

e6/l

0.22

177

Assault by blunt object

111

1.55

0.88

2.2

1.4

17.33

21.43

e6/l

0.09

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

147

1286

1.15

0.88

1.3

1.4

16.99

30.13

e6/l

0.58

108

950

416

3457

1.08

0.88

1.4

23.96

31.73

e6/l

0.30

294

2601

conjunctival haemorrhage

666

1.21

0.88

1.3

1.4

3.47

31.07

e6/l

1.59

493

Other congenital malformations of the digestive system

446

1.25

0.87

2.7

13.44

18.61

e6/l

0.15

319

Other endophthalmitis

1.85

0.87

1.3

1.6

3.75

35.32

e6/l

—

Other superficial mycoses

195

1.40

0.87

1.2

1.6

3.17

14.66

e6/l

1.42

143

Other renal tubulo-interstitial diseases

195

1.40

0.87

1.8

1.6

9.73

10.12

e6/l

0.02

152

Calculus of lower urinary tract

396

1.27

0.86

1.5

1.4

52.81

31.69

e6/l

0.27

293

Hallux rigidus

136

1185

1.15

0.86

1.3

1.4

40.44

27.36

e6/l

0.22

109

871

Atrial septal defect

385

1.27

0.86

1.5

3.0

10.13

9.70

e6/l

0.02

284

Seborrhoeic dermatitis

106

907

1.17

0.86

1.4

106.18

24.56

e6/l

0.39

664

Occupational exposure to risk-factors

282

1.32

0.86

1.2

1.3

1.66

41.74

e6/l

1.12

210

Abscess of Bartholin gland

256

1.34

0.85

1.1

1.4

4.50

13.90

e6/l

1.29

187

Benign neoplasm: Ill-defined sites within the digestive system

1.81

0.85

1.3

1.1

1.75

2.37

e6/l

—

Benign neoplasm: Parotid gland

687

1.20

0.85

1.3

1.4

15.07

34.23

e6/l

0.74

502

Tuberculosis

397

1.26

0.85

1.5

1.3

24.75

49.87

e6/l

0.48

302

Coxarthrosis, primary, with hip surgery

428

4275

0.93

0.84

1.4

39.39

30.47

e6/l

0.23

318

3180

Secondary malignant neoplasm of respiratory and digestive organs

138

0.57

0.84

1.3

1.2

1.37

68.39

e6/l

—

112

Hypocalcemia

188

1.39

0.84

2.3

1.6

11.52

31.62

e6/l

0.51

137

LSIL lesion of the vulva

266

1.33

0.83

2.3

1.4

8.08

15.49

e6/l

0.62

193

Chalazion

125

1087

1.15

0.83

1.3

1.5

20.70

22.91

e6/l

0.08

788

Seborrhoeic keratosis

266

2420

1.10

0.83

1.4

50.20

34.94

e6/l

0.35

194

1809

Malignant neoplasm of small intestine, including Hilmo

240

1.34

0.83

1.4

1.2

10.21

45.85

e6/l

0.76

185

Atherosclerosis, excluding cerebral and coronary sclerosis

341

2910

0.92

0.83

1.4

1.3

52.32

32.25

e6/l

0.29

267

2178

Autism spe, excluding more controls

188

1.39

0.82

1.1

2.6

9.89

22.02

e6/l

0.67

134

Other diseases of gallbladder

337

1.28

0.82

1.4

1.3

18.25

54.20

e6/l

0.63

253

Scabies, including avohilmo

191

1709

1.12

0.82

1.2

1.6

10.36

26.50

e6/l

2.03

145

1243

Wet age-related macular degeneration

106

1185

0.86

0.82

1.5

1.3

119.08

32.36

e6/l

0.35

898

Herpesviral keratitis and keratoconjunctivitis

364

1.27

0.81

1.4

1.5

24.24

7.07

e6/l

0.43

273

Acne conglobata

1.73

0.81

1.1

2.1

2.88

9.97

e6/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

147

1.44

0.81

1.2

2.1

1.50

12.41

e6/l

1.39

106

Disorders of iron metabolism

122

1.49

0.81

1.1

1.3

2.22

34.55

e6/l

—

Short stature, not elsewhere classified

256

1.32

0.80

4.1

4.4

9.42

14.99

e6/l

0.35

177

Thyroid crisis or storm

0.00

0.80

0.0

1.2

—

2.18

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.80

0.0

4.4

—

10.65

—

Atopic conjunctivitis

437

1.24

0.80

1.9

1.7

52.90

18.82

e6/l

0.43

322

ILD, hospital admissions

141

1241

1.14

0.79

1.2

1.4

15.29

29.16

e6/l

0.70

920

Intussusception

190

1.38

0.79

1.2

1.6

2.50

43.32

e6/l

0.73

143

Other disorders of choroid

106

1.52

0.79

1.1

1.6

3.33

18.56

e6/l

—

Injury of intra-abdominal organs

216

1.35

0.79

1.6

1.4

1.86

19.26

e6/l

2.27

160

Chronic hepatitis NAS

1.55

0.79

1.1

56.60

10.65

e6/l

—

Struck by thrown, projected or falling objec

501

1.22

0.79

1.5

1.6

1.79

30.27

e6/l

1.54

367

Total colectomy operation

357

1.27

0.79

1.3

1.6

44.89

24.89

e6/l

0.22

261

Total colectomy

357

1.27

0.79

1.3

1.6

44.89

24.89

e6/l

0.22

261

Asthma and opportunity respiratory infection

366

1.26

0.79

1.3

1.4

7.31

50.16

e6/l

1.11

269

Ankylosing spondylitis, strict definition

393

1.25

0.79

1.4

29.76

15.11

e6/l

0.32

286

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

267

2439

1.10

0.78

1.3

1.4

29.31

33.10

e6/l

0.14

197

1809

Synovial cyst of popliteal space [Baker]

584

1.20

0.77

1.2

1.4

65.44

45.49

e6/l

0.25

432

Allergic purpura

243

1.33

0.77

1.4

1.5

1.33

10.20

e6/l

2.07

178

Other chronic obstructive pulmonary disease, including avohilmo

520

4549

0.94

0.77

1.4

63.57

31.90

e6/l

0.51

386

3404

Hair colour and hair shaft abnormalities

2.21

0.77

1.2

1.00

2.86

e6/l

—

Peripheral retinal degeneration

261

1.31

0.77

2.2

1.4

6.74

14.44

e6/l

0.63

197

Prurigo nodularis

183

1.38

0.76

1.7

1.2

166.07

28.78

e6/l

0.38

134

Malignant neoplasm of heart, mediastinum and pleura

1.53

0.76

2.1

1.3

41.11

82.43

e6/l

—

Other and unspecified disorders of psychological development

128

1.46

0.76

2.8

5.0

31.64

10.47

e6/l

0.49

Medical treatment for female infertility

223

2432

0.91

0.76

1.4

1.3

18.61

30.89

e6/l

0.70

165

1823

Melanocytic naevi, other sites/unspecified

807

1.17

0.76

1.2

1.4

19.09

36.54

e6/l

0.44

590

Complications following abortion and ectopic and molar pregnancy

288

1.29

0.76

1.3

9.75

21.55

e6/l

0.77

202

Other/unspecified seropositive rheumatoid arthritis

270

2472

1.09

0.76

1.3

1.4

28.88

32.68

e6/l

0.14

200

1835

Other specified/unspecified spondylopathies

149

1.42

0.76

1.3

12.09

79.70

e6/l

0.81

109

Other disorders of bone density and structure

218

1.34

0.75

1.4

5.21

9.42

e6/l

0.39

159

Other/unspecified postprocedural disorders of ear and mastoid process

2.14

0.75

1.4

1.1

0.80

4.26

e6/l

—

Mental and behavioural disorders due to tobacco

845

1.16

0.75

1.4

38.74

30.08

e6/l

0.15

623

Epiphora

175

1.38

0.75

1.3

1.2

9.39

19.30

e6/l

0.49

134

Contact with nonpowered hand tool

387

1.25

0.75

1.1

1.4

23.56

34.12

e6/l

0.19

282

Malignant neoplasm of colon, including Hilmo

141

1583

0.88

0.74

1.3

1.4

16.78

28.26

e6/l

0.52

104

1206

Smoking dependency

846

1.16

0.74

1.4

38.74

30.39

e6/l

0.14

622

Exposure to other specified electric current

210

1.34

0.74

1.2

1.6

12.00

14.31

e6/l

0.09

152

Use of levodopa decarbox-comt-inhibitor

245

1.31

0.74

1.7

1.3

1.15

67.68

e6/l

1.23

182

Cyst of kidney

606

1.19

0.74

1.3

1.4

36.59

37.87

e6/l

0.02

450

Chondrosarcoma

2.04

0.73

1.8

1.2

353.80

3.35

e6/l

—

Other obstructed labour

754

0.83

0.73

1.4

1.3

6.93

31.07

e6/l

1.72

546

Juvenile osteochondrosis

290

1.28

0.73

2.5

1.6

5.04

12.00

e6/l

1.07

210

Other salmonella infections, including avohilmo

362

1.25

0.72

1.6

1.5

3.30

22.48

e6/l

1.38

272

Eclampsia

1.97

0.71

1.2

1.1

1.00

36.33

e6/l

—

Other salmonella infections

273

1.29

0.71

1.7

1.5

3.50

24.08

e6/l

1.04

208

Anisometropia and aniseikonia

282

1.28

0.71

1.7

1.9

11.48

36.66

e6/l

0.55

199

Other specified/unspecified disorders of ear

1.96

0.71

1.2

1.3

1.40

2.05

e6/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

568

3136

1.06

0.71

1.3

1.4

18.69

40.69

e6/l

1.71

418

2276

Subacute thyroiditis

300

1.27

0.71

1.5

1.4

85.10

33.46

e6/l

0.27

211

Polycystic ovarian syndrome, broad definition

140

1244

1.13

0.71

1.3

6.03

22.45

e6/l

3.99

108

931

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

196

1779

0.90

0.71

1.4

29.93

26.05

e6/l

0.09

136

1346

COPD, early/later onset

411

3689

0.93

0.70

1.4

47.96

34.35

e6/l

0.20

308

2769

Desensitization to allergens

554

0.81

0.70

1.3

1.8

25.88

18.35

e6/l

0.12

411

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.73

0.70

3.3

2.0

28.29

13.21

e6/l

—

Interstitial lung disease

141

1254

1.13

0.70

1.2

1.4

15.29

28.83

e6/l

0.68

931

Interstitial lung disease endpoints

141

1254

1.13

0.70

1.2

1.4

15.29

28.83

e6/l

0.68

931

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

488

0.80

0.70

1.3

1.93

33.74

e6/l

1.52

375

Gout, strict definition

170

1529

1.11

0.70

1.3

107.69

23.94

e6/l

0.55

118

1145

Contact with other hot fluids

283

1.28

0.70

1.4

1.9

5.38

15.55

e6/l

1.22

202

Benign neoplasm: Skin of ear and external auricular canal

301

1.27

0.69

1.5

1.4

20.21

40.77

e6/l

0.39

229

Ovarian hyperstimulation (induction)

178

1.36

0.69

1.3

1.7

13.00

30.18

e6/l

0.57

136

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

135

1.42

0.69

1.9

1.3

34.09

65.78

e6/l

0.26

107

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

1.89

0.69

1.0

1.1

2.00

37.57

e6/l

—

Polycythaemia vera

257

1.29

0.69

1.1

1.3

1.62

43.25

e6/l

1.09

199

Accidental poisoning by and exposure to alcohol

161

1.38

0.69

1.3

1.2

34.73

16.69

e6/l

0.23

115

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

210

1857

1.10

0.68

1.4

1.9

6.92

27.16

e6/l

3.05

161

1340

Non-small cell lung cancer, including Hilmo

110

1174

0.88

0.68

1.2

1.3

5.92

26.59

e6/l

2.39

886

Other interstitial pulmonary diseases

141

1257

1.12

0.68

1.2

1.4

15.29

28.84

e6/l

0.68

931

Injury of muscle and tendon at lower leg level

163

1466

1.11

0.68

1.3

1.4

15.74

32.10

e6/l

0.93

112

1079

Cardiomyopathies, Primary/intrinsic

1080

0.87

0.68

1.5

85.66

18.12

e6/l

0.48

787

Whooping cough, including avohilmo

153

1.38

0.67

2.4

1.3

51.07

12.54

e6/l

0.48

113

Malignant neoplasm of respiratory system and intrathoracic organs

171

1571

0.90

0.67

1.4

33.38

24.19

e6/l

0.22

119

1187

COPD, hospital admissions

407

3660

0.94

0.67

1.4

47.70

34.39

e6/l

0.20

305

2750

Other conjunctival vascular disorders and cysts

179

1.35

0.67

1.2

1.3

26.11

47.70

e6/l

0.26

128

Malignant neoplasm of liver and intrahepatic bile ducts

226

0.70

0.67

1.3

2.73

44.83

e6/l

0.95

179

Other obstetric trauma

561

0.82

0.67

1.2

1.3

48.83

19.46

e6/l

0.32

413

Disorder of carbohydrate metabolism, other/unspecified

1.82

0.67

5.0

1.1

14.20

13.00

e6/l

—

Gingival hyperplasia

348

1.24

0.67

2.5

2.1

4.69

38.49

e6/l

1.13

254

Injury of urinary and pelvic organs

162

1.37

0.66

1.8

1.4

1.65

49.25

e6/l

0.82

123

Contact with other sharp object(s)

697

1.17

0.66

1.2

1.5

21.54

29.52

e6/l

0.24

502

Cysts of oral region, not elsewhere classified

540

1.19

0.66

1.5

1.4

68.76

41.53

e6/l

0.22

400

Burn and corrosion of trunk

250

1.29

0.66

1.2

1.6

3.15

16.42

e6/l

1.88

187

Male infertility

403

1.22

0.66

1.8

1.5

33.73

17.27

e6/l

0.33

295

Allergic colitis

268

1.28

0.65

1.8

3.6

0.74

14.86

e6/l

2.26

190

Congenital malformations of aortic and mitral valves

405

0.79

0.65

1.6

2.2

4.96

36.40

e6/l

1.23

288

Chronic tubulo-interstitial nephritis

286

1.26

0.65

1.4

3.89

36.46

e6/l

0.89

211

Pleural effusion

139

1243

1.12

0.65

1.4

1.3

7.85

28.76

e6/l

1.83

102

913

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

459

1.20

0.64

1.7

1.3

30.29

43.18

e6/l

0.24

334

Henoch-Schönlein purpura nephritis (HSPN)

1.75

0.64

1.2

1.4

2.20

29.22

e6/l

—

Psoriasis vulgaris

207

1892

1.10

0.64

1.3

1.4

30.76

25.39

e6/l

0.14

144

1396

Motorcycle rider injured in noncollision transport accidents

269

1.27

0.64

1.1

1.6

7.89

20.46

e6/l

1.25

196

Squamous cell neoplasms and carcinomas of the skin

708

1.16

0.64

1.4

1.3

2.47

28.20

e6/l

1.94

553

CR(E)ST syndrome

129

1.41

0.64

1.2

2.23

11.82

e6/l

0.68

Antepartum haemorrhage, not elsewhere classified

102

896

1.14

0.64

1.2

1.3

32.68

29.27

e6/l

0.07

665

Pigmented purpuric dermatosis

1.53

0.63

1.3

1.2

7.71

6.97

e6/l

—

Antenatal screening

241

1465

0.92

0.62

1.3

14.26

42.54

e6/l

1.14

173

1056

Other disorders of veins

485

4509

1.06

0.62

1.3

1.4

21.60

33.88

e6/l

0.89

329

3332

Need for immunization against other single viral diseases

156

1.36

0.61

2.1

1.3

15.06

14.15

e6/l

0.02

114

Benign neoplasm: Caecum

104

918

1.14

0.61

1.3

5.47

31.03

e6/l

1.96

669

Malignant neoplasm of prostate

240

1542

0.92

0.61

1.3

40.88

18.91

e6/l

0.33

165

1167

malignant neoplasm of female genital organs

122

1336

0.89

0.61

1.2

1.4

15.64

27.42

e6/l

0.61

1024

Melanocytic naevi of other and unspecified parts of face

554

1.18

0.61

1.5

1.4

20.70

47.29

e6/l

0.80

410

Essential (haemorrhagic) thrombocythaemia

298

1.25

0.61

1.3

1.4

52.00

38.56

e6/l

0.15

228

Major coronary heart disease event excluding revascularizations

682

4287

1.05

0.60

1.3

1.4

15.69

32.09

e6/l

2.00

528

3117

Malignant neoplasm of other and unspecified urinary organs

0.00

0.60

0.0

1.2

—

2.13

—

Major anomalies of jaw size

236

1.28

0.60

1.3

1.8

3.96

9.73

e6/l

0.85

172

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

106

928

1.13

0.60

1.4

1.3

3.68

23.42

e6/l

1.88

716

Lichenoid drug reaction

0.00

0.60

0.0

1.2

—

2.47

—

231

2151

0.92

0.60

1.3

1.4

63.05

36.16

e6/l

0.22

170

1616

Other and unspecified cicatricial alopecia

0.00

0.60

0.0

1.0

—

3.13

—

Carcinoma in situ of skin of upper limb, including shoulder

183

1.32

0.60

1.3

11.68

87.04

e6/l

1.02

144

Acute posthaemorrhagic anaemia

245

1.27

0.60

1.7

1.3

5.20

71.06

e6/l

1.25

188

Coronary atherosclerosis

745

4487

1.05

0.60

1.3

1.4

16.72

32.86

e6/l

1.96

582

3265

Drug-induced gout

0.00

0.60

0.0

1.2

—

1.73

—

Maternal care for known or suspected fetal abnormality and damage

196

1519

1.09

0.59

1.2

1.3

17.50

36.27

e6/l

0.75

126

1130

Corneal degeneration

131

1.38

0.59

1.4

4.00

54.84

e6/l

0.58

Type 1 diabetes, strict definition, subgroup 2

0.00

0.59

0.0

4.4

—

36.20

—

Other otitis externa (chronic)

612

1.16

0.59

1.4

1.5

8.39

37.14

e6/l

1.26

450

Erectile dysfunction, exclusion

0.00

0.59

0.0

1.2

—

3.22

—

Benign neoplasm: Scrotum

0.00

0.59

0.0

1.5

—

18.28

—

Gonarthrosis, primary, with knee surgery

585

4783

0.95

0.59

1.4

28.82

34.44

e6/l

0.22

428

3551

Mild mental retardation

237

1.27

0.58

1.2

2.3

60.23

10.10

e6/l

0.67

168

Postmenopausal bleeding

282

1369

1.08

0.58

1.3

1.4

20.77

34.61

e6/l

0.67

196

1024

Actinic keratosis

367

3133

1.07

0.58

1.4

1.3

25.75

31.81

e6/l

0.20

260

2372

Alcohol-induced acute pancreatitis

300

1.24

0.58

1.2

1.3

12.17

39.37

e6/l

0.68

226

Mucosal proctocolitis

144

1301

1.11

0.58

1.3

1.4

22.74

28.40

e6/l

0.15

105

960

Pemphigoid

193

1.30

0.58

1.2

1.21

55.09

e6/l

1.04

148

Biological medicines for asthma

202

1.30

0.58

1.2

1.5

2.60

9.24

e6/l

1.11

152

Anomalies of dental arch relationship, including avohilmo

249

2086

1.08

0.58

2.1

1.5

16.31

27.07

e6/l

0.72

187

1504

Idiopathic urticaria

202

1.30

0.57

1.2

1.7

30.24

16.08

e6/l

0.20

153

Distal bite

407

1.20

0.57

3.0

2.7

28.35

13.59

e6/l

0.34

301

Abdominal aortic aneurysm (AAA)

599

0.84

0.57

1.4

1.3

5.42

32.09

e6/l

1.49

453

Unspecified lump in breast

165

1504

1.10

0.57

1.3

15.41

35.08

e6/l

0.77

123

1095

Other complications of labour and delivery, not elsewhere classified

129

1268

0.90

0.56

1.2

1.3

39.86

29.83

e6/l

0.23

102

946

Benign neoplasm: Small intestine

329

1.22

0.56

1.6

1.3

16.47

62.28

e6/l

0.93

237

Scar conditions and fibrosis of skin

384

1.20

0.56

1.5

2.86

29.26

e6/l

1.01

284

Serous carcinoma of ovary, including Hilmo

285

0.77

0.56

1.1

1.3

3.73

15.95

e6/l

1.56

214

Other congenital malformations of the digestive system, including avohilmo

528

1.17

0.55

2.5

2.6

12.80

41.92

e6/l

0.82

366

ILD, hospital admissions 1, main diag only

123

1106

1.11

0.55

1.2

1.4

16.72

29.71

e6/l

0.55

815

Hypothermia

133

1.36

0.55

1.2

1.4

0.73

39.61

e6/l

0.89

Psoriatic arthropathies, ICD10

114

1021

1.12

0.55

1.3

1.4

28.21

30.81

e6/l

0.07

748

Hypertrophic cardiomyopathy

340

0.79

0.55

1.1

1.4

22.90

38.24

e6/l

0.30

254

Primary ovarian failure

177

1.31

0.55

1.3

1.6

1.39

14.09

e6/l

1.58

132

Malignant neoplasm of stomach

373

0.80

0.55

1.6

1.3

21.12

29.12

e6/l

0.14

292

Benign neoplasm of middle ear and respiratory system

673

1.15

0.54

1.4

22.47

32.42

e6/l

0.28

490

UC patients in KELA-register (code 208), prior to 1994

367

1.20

0.54

1.2

1.4

1.75

23.25

e6/l

1.51

265

Benign neoplasm of urinary organs

376

1.20

0.54

1.1

1.4

5.67

50.79

e6/l

1.26

277

Complications of the puerperium, not elsewhere classified

404

1.19

0.54

1.3

1.4

10.69

22.42

e6/l

0.53

303

Haemorrhagic and haematological disorders of fetus and newborn

238

1.25

0.54

5.7

4.3

38.48

6.75

e6/l

0.41

159

Chondrosarcoma, including Hilmo

1.56

0.53

1.7

1.3

294.83

3.00

e6/l

—

Diseases caused by chlamydiae, including avohilmo

134

1.35

0.53

1.1

1.5

1.38

9.72

e6/l

1.19

103

Hypoplasia of dental enamel, prenatal , including avohilmo

1.48

0.53

5.3

5.7

1.71

5.44

e6/l

—

Tooth eruption problems

186

1653

1.09

0.53

2.4

1.7

20.90

18.68

e6/l

0.09

137

1206

Other, unspecified and serous retinal detachments

259

1.24

0.53

1.5

1.4

2.17

46.83

e6/l

1.20

199

Other nutritional anaemias

1.53

0.52

2.7

1.3

777.90

16.11

e6/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

100

1.41

0.52

1.4

1.3

199.33

15.78

e6/l

—

malignant neoplasm of female genital organs, including Hilmo

147

1535

0.91

0.52

1.3

1.4

15.54

31.24

e6/l

1.01

112

1173

Rhinophyma

1.51

0.52

1.8

1.2

1.17

4.79

e6/l

—

Injury of muscle and tendon at hip and thigh level

114

1026

1.11

0.52

1.4

16.60

27.87

e6/l

0.54

757

Endometriosis of fallopian tube

1.42

0.52

3.0

1.5

33.00

17.52

e6/l

—

Liveborn infants according to place of birth

1.44

0.51

3.2

4.2

5.75

12.16

e6/l

—

Abnormal spermatozoa

1012

0.89

0.51

1.2

1.3

24.62

22.90

e6/l

0.04

745

All dysplastic lesions of the cervix uteri

321

2972

1.06

0.51

1.2

1.3

76.87

26.11

e6/l

0.63

237

2194

Type1 diabetes, definitions combined, early onset

711

0.87

0.51

1.8

2.3

38.85

17.43

e6/l

0.66

524

Scabies

416

1.18

0.51

1.2

1.5

11.56

20.88

e6/l

0.44

301

Anoxic brain damage

1.48

0.51

1.4

1.2

1.73

19.12

e6/l

1.11

Crowding of teeth, including avohilmo

118

882

1.11

0.50

2.6

2.0

8.08

23.09

e6/l

2.06

642

Complications of labour and delivery

787

4202

1.04

0.50

1.3

1.4

18.24

37.89

e6/l

2.18

573

3078

Maternal care for known or suspected malpresentation of fetus

203

1562

0.92

0.50

1.3

26.55

33.73

e6/l

0.21

144

1159

Malignant neoplasm of prostate, including Hilmo

250

1581

0.93

0.50

1.3

39.71

18.53

e6/l

0.33

170

1197

Foreign body entering into or through eye or natural orifice

783

1.13

0.49

1.7

62.34

23.56

e6/l

0.40

572

D07AA Corticosteroids, weak (group I)

182

1678

1.08

0.49

1.6

1.8

19.37

26.35

e6/l

0.33

145

1224

Myocardial infarction

483

3541

0.95

0.49

1.3

1.4

16.74

31.99

e6/l

1.33

375

2590

Mandibular retrognathia

677

0.87

0.49

2.4

1.8

5.63

18.35

e6/l

1.52

496

Otosclerosis

633

1.14

0.49

1.5

1.4

21.40

39.28

e6/l

0.51

454

Malignant neoplasm of head and neck, including Hilmo

793

1.12

0.49

1.3

22.74

25.39

e6/l

0.08

590

L01XE Protein kinase inhibitors

437

1.17

0.48

3.4

1.4

24.16

49.36

e6/l

0.46

318

Congenital malformations of great arteries

251

0.78

0.48

1.3

4.1

9.14

10.50

e6/l

0.07

172

Mumps, including avohilmo

208

1.26

0.48

1.4

11.82

13.68

e6/l

0.09

152

Unspecified urinary incontinence

766

1.13

0.48

1.5

1.4

10.16

28.68

e6/l

1.10

551

Malignant neoplasm of oesophagus, including Hilmo

267

0.78

0.48

1.0

1.3

16.77

41.75

e6/l

0.43

205

Benign neoplasm of bone and articular cartilage

795

1.12

0.47

1.3

1.4

6.47

33.79

e6/l

1.71

577

Retained placenta and membranes, without haemorrhage

113

1246

0.90

0.47

1.2

1.3

20.29

39.45

e6/l

0.62

896

Left ventricular outflow tract obstruction, narrow definition

484

0.84

0.47

1.6

2.3

4.17

31.35

e6/l

1.26

340

Other psoriatic arthropathies

110

995

1.11

0.47

1.3

1.4

25.14

31.51

e6/l

0.18

729

Malignant neoplasm of stomach, including Hilmo

430

0.83

0.47

1.5

1.3

23.40

26.25

e6/l

0.05

326

Myelodysplastic syndrome, including Hilmo

218

1.24

0.46

1.1

1.3

8.42

47.20

e6/l

0.82

178

Mumps

200

1.26

0.46

1.3

1.4

12.56

14.14

e6/l

0.07

146

Use of selegiline

337

1.19

0.46

1.5

1.3

8.70

57.36

e6/l

1.17

253

Benign neoplasm: Rectosigmoid junction

328

1.19

0.46

1.3

280.50

56.71

e6/l

0.37

242

Femoral hernia

328

1.19

0.46

1.0

1.4

307.74

38.29

e6/l

0.41

244

Benign neoplasm: Short bones of upper limb

129

1.33

0.46

1.4

1.2

3.73

12.81

e6/l

0.92

Colorectal neuroendocrine tumor and carcinoma

120

0.66

0.46

1.4

1.2

7.13

9.98

e6/l

—

Glaucoma-related operations

421

1.17

0.46

1.3

2.84

49.42

e6/l

1.57

309

Malignant neoplasm of oral cavity, including Hilmo

356

1.18

0.46

1.3

1.4

27.84

33.59

e6/l

0.09

266

Oesophageal obstruction

255

1.22

0.46

1.3

85.17

72.43

e6/l

0.05

192

Cyst of Bartholin Gland

347

1.19

0.46

1.3

1.5

7.00

20.66

e6/l

0.99

264

Foreign body on external eye

164

1515

1.08

0.45

1.4

30.55

30.03

e6/l

0.01

124

1110

Use of ropinirole

302

1.20

0.44

1.4

1.3

2.62

63.59

e6/l

1.41

220

Type 1 diabetes, definitions combined

117

1063

1.10

0.44

1.8

1.9

22.07

21.52

e6/l

0.02

786

Other congenital malformations of face and neck

247

1.22

0.44

1.2

1.7

3.05

9.65

e6/l

1.13

187

COPD-related respiratory insufficiency

895

1.11

0.44

1.3

14.00

29.28

e6/l

0.76

658

Polyp of the female genital tract

335

1795

1.06

0.44

1.3

1.4

26.03

29.50

e6/l

0.13

241

1352

Carcinoma in situ, bladder

285

0.80

0.43

1.7

1.3

11.69

37.88

e6/l

0.62

220

Thoracic aortic aneurysm

121

1322

0.91

0.43

1.5

1.3

13.35

28.37

e6/l

0.90

972

Allergic contact dermatitis

147

1356

1.09

0.43

1.3

1.4

12.38

28.43

e6/l

1.26

112

987

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.44

0.43

1.1

3.25

5.87

e6/l

—

Arthropathic psoriasis

120

1098

1.10

0.42

1.3

1.4

28.36

30.69

e6/l

0.06

810

Changes in corneal membranes

1.58

0.42

1.4

1.0

3.20

3.25

e6/l

—

Injury of blood vessels at abdomen, lower back and pelvis level

1.58

0.42

2.4

1.3

1.40

24.17

e6/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

1.42

0.42

1.4

1.3

67.38

18.92

e6/l

—

Congenital malformations of heart and great arteries

150

1345

1.08

0.42

1.5

2.1

8.24

27.27

e6/l

1.80

116

972

Haemolytic disease of fetus and newborn

0.00

0.42

0.0

8.8

—

1.73

—

Left bundle-branch block

627

0.88

0.42

1.4

11.80

18.05

e6/l

0.29

461

Left hemicolectomy

167

1.26

0.42

1.1

1.3

10.31

37.80

e6/l

0.70

127

Benign neoplasm of other and unspecified female genital organs

381

0.84

0.42

1.1

1.4

143.82

36.55

e6/l

0.35

271

Moderate mental retardation

1.39

0.42

2.1

2.9

3.87

5.76

e6/l

—

Cardiomyopathy, other and unspecified

670

1.12

0.42

1.4

93.60

15.45

e6/l

0.47

499

Type 1 diabetes, strict (exclude DM2)

116

1058

1.10

0.42

1.8

1.9

22.30

21.67

e6/l

0.02

781

Folliculitis decalvans

0.00

0.41

0.0

1.1

—

2.20

—

Traumatic amputation of ankle and foot

0.00

0.41

0.0

1.1

—

2.91

—

malignant neoplasm of male genital organs

258

1648

0.94

0.41

1.3

38.13

19.09

e6/l

0.31

180

1242

Malignant neoplasm of skin

557

3621

1.04

0.41

1.3

1.4

71.01

25.81

e6/l

0.78

408

2731

Multiple delivery

847

0.89

0.41

1.7

1.4

95.83

50.04

e6/l

0.26

603

Other disorders of iris and ciliary body

213

1.23

0.41

1.4

1.3

3.21

8.84

e6/l

0.88

156

Congenital malformations of uterus and cervix

204

1.23

0.41

1.2

1.4

4.85

22.80

e6/l

0.88

154

Coxarthrosis, primary

651

5210

1.04

0.41

1.4

31.79

33.68

e6/l

0.06

485

3876

Abnormal findings in secretions and smears from cervix uteri vagina vulva

636

4509

1.04

0.41

1.3

1.4

47.85

31.11

e6/l

0.35

473

3321

Delivery, wide proxy

373

1883

1.05

0.40

1.3

1.4

40.39

32.54

e6/l

0.16

278

1382

Barrett oesophagus

417

1.15

0.40

1.2

1.4

2.12

47.06

e6/l

1.45

302

Malignant neoplasm of tonsil and base of tongue

168

1.26

0.40

1.3

1.2

7.64

58.69

e6/l

0.78

129

Exclusion endpoint for clefts

204

1.23

0.40

1.4

3.6

4.63

18.86

e6/l

1.31

141

In situ neoplasms

433

4145

1.05

0.40

1.3

45.97

29.25

e6/l

0.23

314

3106

Obstructed labour due to malposition and malpresentation of fetus

249

2442

0.94

0.40

1.4

1.3

21.88

31.58

e6/l

0.52

182

1794

Primary biliary cholangitis (PBC)

160

0.75

0.40

1.2

1.5

1.40

43.08

e6/l

—

121

Inflammation of lacrimal passages (chronic)

103

0.68

0.40

1.4

1.2

28.43

15.69

e6/l

—

Chronic laryngitis and laryngotracheitis

119

1294

0.92

0.39

1.4

19.41

24.41

e6/l

0.25

933

Disorders of sphingolipid metabolism and other lipid storage disorders

1.44

0.39

1.2

1.0

1.40

7.39

e6/l

—

Other and unspecified diseases of spleen

1.44

0.39

1.2

1.3

2.00

31.64

e6/l

—

Bicuspidal aortic valve syndrome

335

0.83

0.39

1.7

1.6

5.14

43.00

e6/l

1.22

238

Pacemaker

337

2981

1.05

0.39

1.3

1.4

6.69

28.80

e6/l

3.42

271

2230

Multiple system atrophy (rare forms of Parkinsonism)

0.00

0.39

0.0

1.1

—

2.69

—

Cervical polyps

907

0.90

0.39

1.2

1.4

32.24

42.76

e6/l

0.19

672

Childhood allergy (age < 16)

190

1466

1.07

0.39

1.9

15.82

21.07

e6/l

0.39

147

1062

Malignant neoplasm of tonsil

133

1.29

0.39

1.4

1.2

8.25

73.57

e6/l

0.80

102

Endometriosis of intestine

151

1.27

0.39

1.2

1.4

7.17

21.46

e6/l

0.99

117

Seropositive rheumatoid arthritis, strict definition

151

1404

1.08

0.38

1.3

23.99

28.07

e6/l

0.14

109

1035

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

202

1898

1.07

0.38

1.4

72.24

25.54

e6/l

0.38

155

1398

Foreign body or object entering through skin

599

1.12

0.38

1.8

1.4

14.04

30.47

e6/l

0.49

440

Melanoma in situ of other and unspecified parts of face

1.36

0.38

1.2

10.43

12.01

e6/l

—

Puerperal sepsis

133

1231

1.08

0.38

1.3

1.4

13.07

39.67

e6/l

1.22

885

Duodenal ulcer

799

1.10

0.38

1.3

1.4

99.51

30.91

e6/l

0.37

601

Inguinal or femoral hernia, bilateral

895

1.10

0.38

1.3

1.4

18.97

14.47

e6/l

0.22

660

Malignant neoplasm of tonsil and base of tongue, including Hilmo

188

1.23

0.37

1.3

1.2

7.00

53.56

e6/l

0.79

142

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

581

1.12

0.37

1.7

1.4

16.04

36.99

e6/l

0.61

433

Benign leiomyoma with endometriosis

152

1416

1.08

0.37

1.3

1.4

46.33

34.20

e6/l

0.17

117

1045

Other diseases caused by chlamydiae, including avohilmo

143

1.27

0.37

1.1

1.5

1.38

11.17

e6/l

1.45

110

Labour and delivery complicated by umbilical cord complications

461

0.87

0.37

1.3

2.56

22.88

e6/l

2.93

336

Pedal cyclist injured in noncollision transport accidents

128

1185

1.08

0.37

1.3

1.6

23.16

28.62

e6/l

0.14

869

Other noninfective disorders of lymphatic vessels and lymph nodes

318

1.17

0.37

1.2

1.4

153.00

30.26

e6/l

0.51

237

Other disorders of skin and subcutaneous tissue, not elsewhere classified

139

1291

1.08

0.37

1.3

1.4

25.09

30.82

e6/l

0.14

101

963

Carcinoma in situ of other and unspecified sites

300

0.83

0.37

1.7

1.3

11.18

36.50

e6/l

0.63

229

Right hemicolectomy

440

1.14

0.36

1.5

1.3

40.79

46.91

e6/l

0.07

328

Artificial joint operation, meniscal resection

1129

7035

1.03

0.36

1.3

1.4

34.27

34.66

e6/l

0.01

824

5225

Other congenital malformations of tongue, mouth and pharynx

161

1.24

0.36

4.2

3.7

2.93

7.16

e6/l

1.23

114

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

180

1.23

0.36

1.1

2.3

1.88

10.30

e6/l

1.32

130

Atrial septal defect, secundum type

298

0.83

0.36

1.9

3.0

1.32

7.82

e6/l

1.84

214

Impacted maxillary molar

671

0.89

0.36

1.8

1.6

7.57

23.40

e6/l

1.67

493

Ulcerative colitis (strict definition, all Crohn cases excluded)

138

1483

0.93

0.36

1.3

1.4

89.15

26.85

e6/l

0.35

107

1094

175

1531

1.07

0.36

1.3

80.61

30.16

e6/l

0.33

129

1149

Other and unspecified acute skin changes due to ultraviolet radiation

179

0.78

0.35

2.6

1.2

9.75

31.22

e6/l

—

134

Idiopathic pulmonary fibrosis

544

0.88

0.35

1.2

1.3

8.13

38.51

e6/l

1.16

407

Oral lichen planus, including avohilmo , including avohilmo

660

1.11

0.35

1.2

1.3

49.02

30.95

e6/l

0.22

475

Wide developmental disorders

393

1.14

0.35

1.5

3.0

7.21

15.75

e6/l

0.88

274

Open bite

575

1.12

0.35

1.8

2.3

20.87

20.78

e6/l

0.00

422

Sequelae of burns, corrosions and frostbite

1.38

0.34

8.5

1.6

58.67

2.85

e6/l

—

Hepatocellular carcinoma, including Hilmo

211

0.80

0.34

1.3

1.42

44.14

e6/l

0.88

165

Extreme obesity with alveolar hypoventilation

362

0.85

0.34

1.3

1.4

9.90

43.90

e6/l

0.87

270

Cholangitis (primary sclerosing, PSC), with reimbursement 202

163

1.23

0.34

1.3

2.0

3.11

10.81

e6/l

—

117

Acute alcohol intoxication ICD-9

246

1.18

0.34

1.2

1.3

14.18

47.01

e6/l

0.62

181

Benign neoplasm: Skin of scalp and neck

210

0.81

0.33

1.2

1.5

18.09

26.91

e6/l

0.19

157

Pustulosis palmaris et plantaris

382

0.86

0.33

1.2

1.4

3.26

41.40

e6/l

1.39

277

Pregnancy, childbirth and the puerperium

316

1575

1.05

0.33

1.4

30.23

34.35

e6/l

0.07

228

1149

Malignant neoplasm of bladder, including Hilmo

874

0.91

0.33

1.4

1.3

13.69

23.11

e6/l

0.47

671

Failed induction of labour

666

0.90

0.33

1.3

21.78

19.19

e6/l

0.07

488

Traction detachment of retina

1.36

0.32

1.4

1.2

11.40

16.40

e6/l

—

malignant neoplasm of male genital organs, including Hilmo

267

1683

0.95

0.32

1.3

37.32

18.92

e6/l

0.30

184

1268

Pneumothorax

578

1.11

0.32

1.4

1.3

6.51

36.57

e6/l

1.32

433

Primary coxarthrosis, bilateral

274

2615

1.05

0.32

1.5

1.3

37.28

29.29

e6/l

0.15

205

1955

Contact with machinery

110

1020

1.08

0.32

1.2

1.4

4.79

18.91

e6/l

1.46

740

Other abnormal uterine and vaginal bleeding

245

1673

1.05

0.32

1.2

1.4

83.89

30.66

e6/l

0.45

172

1259

Other disorders of amniotic fluid and membranes

161

1461

1.07

0.32

1.2

1.3

12.71

37.13

e6/l

1.23

119

1085

Ankylosing hyperostosis [Forestier]

1.31

0.32

1.0

1.2

2.33

47.29

e6/l

0.68

Guttate psoriasis

110

1.28

0.32

1.5

1.3

7.11

19.40

e6/l

—

Poor fetal growth

146

1370

1.07

0.31

1.2

1.3

30.68

19.88

e6/l

0.46

112

1024

Other corneal oedema

1.33

0.31

1.1

1.86

15.30

e6/l

—

Embedded and impacted teeth

326

2756

0.96

0.31

1.6

1.5

13.83

24.79

e6/l

1.11

254

2014

Mixed hyperlipidaemia

296

1.15

0.30

1.6

1.3

21.71

39.90

e6/l

0.34

228

Heart failure and bmi 25plus

320

2045

1.04

0.30

1.4

58.98

45.16

e6/l

0.13

239

1530

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

102

1.28

0.30

1.3

2.9

4.38

9.53

e6/l

—

Benign lipomatous neoplasm of other sites/unspecified

714

0.91

0.30

1.8

1.3

40.07

32.19

e6/l

0.13

526

Other hammer toe(s) (acquired)

155

1327

1.06

0.30

1.4

116.45

30.02

e6/l

0.48

112

987

Abrasion of teeth

403

4177

0.96

0.30

1.3

1.4

16.97

36.64

e6/l

1.89

272

3068

Benign neoplasm: Long bones of lower limb

282

0.85

0.30

1.5

1.4

12.75

14.71

e6/l

0.07

207

Delivery

459

2335

1.04

0.30

1.3

1.4

35.21

34.79

e6/l

0.01

335

1681

Abnormalities of forces of labour

1055

0.93

0.29

1.1

1.3

8.20

38.30

e6/l

1.55

765

Malignant neoplasm of oropharynx

139

1.23

0.29

1.4

1.3

8.25

71.49

e6/l

0.79

105

Intrahepatic Cholestasis of Pregnancy (ICP)

717

1.09

0.29

1.2

1.3

5.06

17.99

e6/l

2.24

530

Other deformities of toe(s)

288

1.15

0.29

1.4

1.3

7.46

31.23

e6/l

0.56

213

Erectile dysfunction

566

0.90

0.29

1.3

1.4

10.16

23.85

e6/l

0.56

421

Juvenile rheumatoid arthirtis

176

1.20

0.29

1.4

1.6

38.50

15.66

e6/l

0.35

138

Polycystic kidney disease

204

1.18

0.29

1.3

1.8

6.28

18.50

e6/l

0.93

153

Pustular psoriasis

429

0.88

0.28

1.2

1.4

7.96

36.85

e6/l

1.06

315

Abscess of lung

121

1.25

0.28

4.2

1.6

113.40

13.35

e6/l

—

Inguinal hernia, bilateral

882

1.08

0.28

1.3

1.4

19.24

14.06

e6/l

0.26

649

Mandibular hypoplasia

1.30

0.28

1.1

2.0

1.88

13.59

e6/l

—

Stenosis and insufficiency of lacrimal passages

786

1.08

0.28

1.6

1.4

47.26

22.60

e6/l

0.55

570

Other diseases of biliary tract

741

0.92

0.27

1.4

1.6

10.27

31.34

e6/l

1.03

551

Pterygium

226

0.84

0.27

1.6

1.3

5.43

35.84

e6/l

0.65

165

Impacted teeth

235

2108

0.96

0.27

1.6

1.5

13.18

24.49

e6/l

1.09

181

1548

Familial hypercholesterolemia, with ischemic heart disease

681

1.09

0.27

1.4

1.3

19.92

40.39

e6/l

0.66

484

Cholesteatoma of middle ear

413

1.12

0.27

1.3

86.21

28.63

e6/l

0.41

313

Hypertension, Pulmonary Arterial

1.24

0.27

1.9

1.1

45.63

3.40

e6/l

—

Unspecified chronic bronchitis

247

0.85

0.27

1.2

1.4

9.43

65.19

e6/l

0.97

191

Thyrotoxicosis with toxic multinodular goitre

500

0.90

0.27

1.3

1.4

145.32

36.09

e6/l

0.34

361

Pollen allergy

240

2266

1.05

0.26

1.3

1.7

14.20

25.42

e6/l

0.94

177

1656

Conduction disorders

316

2438

1.04

0.26

1.3

1.5

12.54

24.32

e6/l

0.83

240

1805

Artificial joint re-operation

568

1.09

0.26

1.3

233.52

39.58

e6/l

0.51

414

Aortic valve malfunction, age under 60 years

934

0.93

0.25

1.7

1.6

16.49

28.92

e6/l

0.45

676

Granuloma annulare

123

1.23

0.25

1.3

1.2

1.25

7.95

e6/l

—

Other infective otitis externa

559

1.09

0.25

1.2

1.4

16.51

39.47

e6/l

0.68

416

Other and unspecified nonscarring hair loss

1.22

0.25

1.3

1.1

4.44

11.00

e6/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

540

1.09

0.25

1.3

1.4

11.83

31.93

e6/l

0.79

400

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

237

2203

1.04

0.25

1.3

1.4

41.10

23.87

e6/l

0.47

175

1669

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

206

1.16

0.25

3.7

3.3

3.63

5.94

e6/l

0.60

143

Malignant neoplasm of tonsil, including Hilmo

142

1.20

0.25

1.4

1.2

8.25

70.17

e6/l

0.79

107

Other assisted single delivery

170

1.18

0.24

1.1

1.4

1.91

22.12

e6/l

1.91

121

Congenital malformations of eye, ear, face and neck

676

1.08

0.24

1.3

2.2

9.24

22.29

e6/l

1.02

479

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

860

1.07

0.24

1.2

1.3

5.03

27.01

e6/l

2.12

626

Other other unspecified disorders of the circulatory system

293

1.13

0.24

1.2

1.7

25.91

42.34

e6/l

0.23

219

L01XX Other antineoplastic agents

465

1.10

0.24

1.2

1.3

16.11

46.28

e6/l

0.81

338

Clear cell adenocarcinoma of kidney

389

1.11

0.23

1.4

1.3

100.43

29.27

e6/l

0.44

292

Type 1 diabetes, strict definition

855

0.93

0.23

1.4

2.0

30.46

18.04

e6/l

0.43

636

Pleural plaque without asbestos

237

1.14

0.23

1.4

1.3

2.22

43.66

e6/l

0.98

184

Acquired clawhand, clubhand, clawfoot and clubfoot

1.29

0.23

1.2

4.00

22.87

e6/l

—

Glaucoma, exfoliation

743

0.93

0.23

1.4

1.3

16.80

35.71

e6/l

0.54

553

Pervasive developmental disorders excl. Autism + Asperger

160

1.18

0.23

2.0

4.4

2.29

9.20

e6/l

0.77

103

Macular hole

457

1.10

0.23

1.3

4.28

48.20

e6/l

1.59

333

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

228

1.14

0.23

1.1

1.2

9.24

11.76

e6/l

0.13

169

therapeutic use

247

1.14

0.22

1.5

1.3

3.31

50.88

e6/l

1.07

184

Pedal cyclist injured in collision with motor vehicle

285

1.13

0.22

1.3

15.58

12.92

e6/l

0.08

206

Non-allergic asthma

814

1.07

0.22

1.2

2.0

8.40

31.58

e6/l

1.42

608

Carcinoma in situ of cervix uteri

105

1113

0.94

0.22

1.1

1.3

122.94

23.72

e6/l

0.42

828

Other secondary gonarthrosis

467

1.09

0.22

2.1

1.3

5.51

41.95

e6/l

1.24

339

Benign neoplasm: Bronchus and lung

0.74

0.22

1.1

1.2

1.86

17.99

e6/l

—

Other localized connective tissue disorders

153

1.18

0.22

1.2

1.3

3.17

54.74

e6/l

0.71

113

Secondary right heart disease

295

0.88

0.22

1.4

1.3

63.47

63.45

e6/l

0.00

225

Cardiomyopathy

171

1634

1.05

0.22

1.4

1.5

49.13

18.47

e6/l

0.40

118

1192

Benign neoplasm: Kidney

295

1.12

0.22

1.1

1.3

3.35

62.00

e6/l

1.33

220

709

1.07

0.22

1.3

22.44

22.89

e6/l

0.01

528

Preparatory care for dialysis

362

1.11

0.22

1.3

1.5

6.59

36.65

e6/l

1.02

268

Allergic contact dermatitis due to drugs in contact with skin

178

0.84

0.22

1.6

1.5

24.80

14.18

e6/l

—

132

Use of benzatropine

0.00

0.22

0.0

1.0

—

2.60

—

Ascorbic acid deficiency

0.00

0.22

0.0

2.7

—

12.36

—

Hookworm diseases

0.00

0.22

0.0

1.5

—

0.50

—

All dysplastic lesions of the vagina

252

0.87

0.22

1.3

1.5

57.00

36.33

e6/l

0.20

191

Hookworm diseases, including avohilmo

0.00

0.22

0.0

1.5

—

0.50

—

Carcinoma in situ, other/unspecified

0.00

0.21

0.0

1.0

—

6.00

—

Malignant neoplasm of oropharynx, including Hilmo

163

1.17

0.21

1.3

8.00

59.61

e6/l

0.78

127

Presence of other devices

235

2228

1.04

0.21

1.5

1.3

11.62

31.38

e6/l

1.82

186

1688

Transepidermal elimination disorders

0.00

0.21

0.0

1.1

—

2.18

—

Hirsprung

0.00

0.21

0.0

4.8

—

4.17

—

Carcinoma in situ of oesophagus

0.00

0.21

0.0

1.3

—

6.43

—

Congenital malformations of the urinary system

565

1.08

0.21

1.3

2.1

3.83

38.75

e6/l

1.55

410

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

827

1.07

0.21

1.3

1.2

55.69

25.80

e6/l

0.36

625

Gastrointestinal stromal tumor and sarcoma

104

0.77

0.21

1.1

1.2

104.63

53.30

e6/l

—

Ulcerative rectosigmoiditis

798

1.07

0.21

1.3

1.4

136.96

35.62

e6/l

0.37

586

Iodine-deficiency-related goitre

0.00

0.21

0.0

1.1

—

3.00

—

Later onset COPD, excluding more controls

167

1218

1.05

0.21

1.2

1.4

41.64

9.75

e6/l

0.67

121

925

Inflammatory disease of cervix uteri

508

1.08

0.21

1.3

110.71

19.83

e6/l

0.40

372

Perichondritis of external ear

117

1.20

0.20

1.5

1.3

2.11

12.06

e6/l

—

Ulcerative proctitis

615

0.93

0.20

1.1

1.3

185.48

34.26

e6/l

0.38

458

Obstetric embolism

0.00

0.20

0.0

1.0

—

64.75

—

Kyphoscoliotic heart disease

0.00

0.20

0.0

1.1

—

3.89

—

Juvenile arthritis (FINNGEN)

449

0.91

0.20

1.4

2.2

23.77

15.62

e6/l

0.21

325

Venous complications and haemorrhoids in the puerperium

108

1.21

0.20

1.3

1.2

21.57

9.51

e6/l

—

Fistulae involving female genital tract

136

1.18

0.20

1.4

1.2

27.00

17.47

e6/l

—

100

Benign neoplasm: Conjunctiva

269

1.12

0.20

1.1

1.4

3.00

12.17

e6/l

1.61

202

Non-small cell lung cancer, adenocarcinoma, helper endpoint

500

0.92

0.20

1.2

1.3

6.53

42.06

e6/l

1.40

379

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

733

1.07

0.19

1.2

1.3

5.06

22.43

e6/l

3.04

555

Primary gonarthrosis, bilateral

554

4536

1.02

0.19

1.3

1.4

33.50

35.44

e6/l

0.05

407

3367

Macular cyst

239

0.88

0.19

1.5

1.3

67.23

78.07

e6/l

0.06

174

Mandibular prognathia

146

1.17

0.19

1.4

2.6

3.18

11.81

e6/l

0.97

113

Carcinoma in situ of skin

643

0.93

0.19

1.4

14.35

35.95

e6/l

0.85

477

Other chronic obstructive pulmonary disease

409

3429

0.98

0.18

1.4

48.11

30.66

e6/l

0.28

307

2587

Other specified disorders of external ear

299

1.11

0.18

1.5

1.3

8.04

42.67

e6/l

0.97

226

Malignant neoplasm of kidney, except renal pelvis

725

1.06

0.18

1.3

1.2

60.04

26.01

e6/l

0.36

546

Emphysema

570

1.07

0.18

1.5

1.4

5.72

34.07

e6/l

1.18

423

All-cause Heart Failure

585

4149

0.98

0.18

1.4

35.12

35.07

e6/l

0.00

455

3084

Carcinoma in situ of other and unspecified genital organs

176

1.14

0.17

1.1

1.4

1.00

15.05

e6/l

1.37

126

Golimumab

339

1.09

0.17

1.2

1.6

106.04

11.02

e6/l

0.49

258

ILD-related respiratory insufficiency

247

0.89

0.17

1.2

1.3

6.12

45.82

e6/l

0.92

187

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

407

1.08

0.17

1.4

15.03

36.02

e6/l

0.56

297

Exfoliative dermatitis

1.11

0.17

1.4

1.2

79.43

14.51

e6/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

514

1.07

0.17

1.3

5.68

31.41

e6/l

1.28

363

Ventricular septal defect, a heart condition

256

0.89

0.17

2.0

3.8

5.28

8.33

e6/l

0.25

171

Other appendicitis

778

1.06

0.16

1.4

1.3

19.31

37.93

e6/l

0.61

581

Use of rasagiline

206

1.12

0.16

1.5

1.2

3.00

82.72

e6/l

1.28

157

Varicose veins

653

5013

0.98

0.16

1.4

32.64

33.93

e6/l

0.04

513

3716

278

0.90

0.16

1.8

4.3

47.60

11.01

e6/l

0.41

187

Pathological resorption of teeth

341

1.09

0.16

1.4

1.5

48.27

37.59

e6/l

0.11

250

conjunctival degenerations and deposits

168

1.13

0.16

1.2

11.79

20.68

e6/l

0.34

119

Nonischemic cardiomyopathy

831

0.95

0.15

1.4

1.5

82.73

30.13

e6/l

0.31

598

Congenital malformations of genital organs

105

998

1.05

0.15

1.4

2.0

42.65

24.01

e6/l

0.22

715

Cystic kidney disease, including avohilmo

297

0.91

0.15

1.3

1.7

6.15

44.45

e6/l

1.06

216

Benign neoplasm of breast

106

1107

0.96

0.15

1.5

1.3

136.43

28.19

e6/l

0.44

812

Left ventricular outflow tract obstruction (LVOTO), broad definition

1025

0.95

0.15

1.6

1.8

14.80

27.19

e6/l

0.51

731

Heart failure, strict

596

4212

0.98

0.15

1.4

34.95

34.75

e6/l

0.00

464

3126

Oesophageal varices

338

0.92

0.15

1.2

1.7

12.79

55.38

e6/l

0.90

244

Motorcycle rider injured in other and unspecified transport accidents

546

1.06

0.15

1.2

1.6

12.73

13.10

e6/l

0.02

380

Carcinoma in situ of other and unspecified digestive organs

371

1.08

0.15

1.5

1.3

4.97

52.97

e6/l

1.32

270

Rubella [German measles], including avohilmo

284

1.09

0.15

1.7

1.3

25.67

33.60

e6/l

0.11

215

Other secondary coxarthrosis

284

1.09

0.15

1.3

1.4

29.52

46.13

e6/l

0.19

212

Single spontaneous delivery

450

2329

1.02

0.15

1.2

1.4

31.75

34.87

e6/l

0.07

325

1677

Aggressive periodontitis

192

0.88

0.15

1.2

1.3

648.67

29.31

e6/l

0.44

146

Psoriasis (vulgaris), strict definition

296

0.91

0.15

1.4

48.56

24.58

e6/l

0.22

215

Respiratory distress of newborn

192

1.11

0.15

6.2

4.9

53.38

7.74

e6/l

0.41

126

Deep bite

132

1116

1.04

0.15

2.2

1.9

21.44

33.09

e6/l

0.41

802

Autism

265

1.10

0.14

1.1

2.7

9.00

18.62

e6/l

0.59

184

Ethmoidectomy

126

1308

0.96

0.14

1.4

130.17

27.04

e6/l

0.64

105

964

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

507

3358

1.02

0.14

1.3

1.4

76.65

26.48

e6/l

0.79

372

2531

Deep bite that required surgery

112

1.17

0.14

1.1

1.2

2.15

11.63

e6/l

0.77

Other congenital malformations of peripheral vascular system

131

1.15

0.14

1.3

2.1

29.20

14.15

e6/l

—

Chondromalacia

227

1.10

0.14

1.2

1.5

3.95

14.62

e6/l

1.27

166

Respiratory tuberculosis, not confirmed

256

1.10

0.14

1.6

1.3

25.85

70.85

e6/l

0.56

192

Benign neoplasm: Skin of upper limb, including shoulder

160

1.13

0.14

1.5

1.2

16.50

16.78

e6/l

—

116

Benign neoplasm: Pancreas

237

1.10

0.14

1.3

1.2

23.00

51.37

e6/l

0.47

179

Olecranon bursitis

470

1.07

0.14

1.3

14.69

41.46

e6/l

0.73

349

Congenital malformations of breast, including avohilmo

180

0.89

0.13

1.1

1.5

10.27

27.81

e6/l

0.59

133

Basal cell carcinoma, including Hilmo

488

3247

1.02

0.13

1.3

1.4

77.72

26.68

e6/l

0.78

360

2455

Malignant neoplasm of tongue, including Hilmo

209

1.10

0.13

1.1

1.4

16.24

51.82

e6/l

0.60

162

Ulcerative colitis (strict definition, require KELA)

181

1760

1.03

0.13

1.2

1.4

79.21

24.40

e6/l

0.41

141

1296

Cardiac arrest

375

1.06

0.13

1.2

1.3

5.47

20.42

e6/l

0.74

276

Traumatic amputation of wrist and hand

345

1.07

0.12

1.1

1.3

4.22

21.37

e6/l

1.09

264

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

885

1.04

0.12

1.2

1.3

5.03

31.21

e6/l

2.49

652

Calcific aortic valvular stenosis

235

2313

0.98

0.12

1.4

10.63

26.09

e6/l

1.68

186

1747

Calcific aortic valvular stenosis, operated

235

2313

0.98

0.12

1.4

10.63

26.09

e6/l

1.68

186

1747

Neuroendocrine tumor and carcinoma of small intestine

116

0.86

0.12

1.0

1.2

7.00

82.49

e6/l

—

Malignant neoplasm of tongue

162

1.11

0.12

1.1

1.4

7.77

64.13

e6/l

0.88

128

Respiratory tuberculosis, not confirmed, including avohilmo

259

1.08

0.11

1.6

1.3

25.85

70.14

e6/l

0.55

194

Benign neoplasm: Skin of eyelid, including canthus

134

1381

0.97

0.11

1.3

17.98

28.17

e6/l

0.55

1016

Pleural plaque with presence of asbestos

466

0.94

0.11

1.2

1.3

37.94

36.56

e6/l

0.02

355

COPD

433

3570

0.98

0.11

1.4

46.27

30.24

e6/l

0.26

322

2690

Malignant neoplasm of urinary organs, including Hilmo

936

1.04

0.11

1.3

50.81

26.04

e6/l

0.32

712

Venous complications and haemorrhoids in pregnancy

153

1.11

0.11

1.1

1.7

33.64

22.26

e6/l

0.21

114

Benign neoplasm: Lip

157

0.89

0.11

1.1

1.2

28.38

50.09

e6/l

—

114

Calcific aortic valvular stenosis, including rheumatic fever

236

2317

0.98

0.11

1.4

10.75

26.03

e6/l

1.66

187

1750

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

176

1718

1.03

0.10

1.2

1.4

80.91

24.79

e6/l

0.41

138

1263

Peripheral artery disease

395

3167

0.98

0.10

1.5

1.4

47.85

36.62

e6/l

0.17

310

2368

Toxic effect of contact with venomous animals

378

1.06

0.10

1.3

1.7

40.39

30.80

e6/l

0.15

272

Calcific aortic valvular stenosis, diagnosis (helper)

235

2306

0.98

0.10

1.4

10.63

26.13

e6/l

1.68

186

1742

Operations 2 for CAVS

235

2306

0.98

0.10

1.4

10.63

26.13

e6/l

1.68

186

1742

Congenital malformations of the urinary system, including avohilmo

604

1.04

0.10

1.3

2.1

3.76

38.10

e6/l

1.62

430

HSIL lesion of the cervix uteri

203

2073

0.98

0.10

1.2

1.3

77.93

32.42

e6/l

0.33

152

1550

Eustachian salpingitis and obstruction

821

1.04

0.10

1.4

1.5

12.06

25.95

e6/l

1.04

607

Acute appendicitis, with complications

191

1869

1.02

0.10

1.4

17.52

30.78

e6/l

0.71

130

1368

Infections of breast associated with childbirth

359

1.06

0.10

1.2

1.4

10.81

21.26

e6/l

0.56

270

Other noninflammatory disorders of cervix uteri

412

0.95

0.09

1.2

1.3

119.45

23.85

e6/l

0.53

308

Arthropathy in Crohn disease

1.15

0.09

1.1

1.2

1.40

10.94

e6/l

—

Heart failure,strict

556

3832

1.01

0.09

1.5

1.4

37.24

33.49

e6/l

0.06

432

2840

Type 1 diabetes, strict definition, subgroup 1

816

0.96

0.09

1.4

1.9

30.95

18.20

e6/l

0.43

610

Laparoscopic right hemicolectomy

442

0.95

0.09

1.8

1.3

7.37

48.06

e6/l

1.35

325

Congenital aortic valve stenosis

1.04

0.09

1.0

4.2

1.40

6.59

e6/l

—

Respiratory conditions due to other external agents

145

1.11

0.09

1.3

1.2

7.36

38.14

e6/l

0.69

107

FESS (DNB20)

123

1263

0.97

0.09

1.4

132.66

27.61

e6/l

0.64

103

928

Primary Sclerosing Cholangitis, IBD and UDCA required

184

1.09

0.09

1.1

2.3

3.67

9.68

e6/l

—

130

Asymmetry of jaw

126

1.11

0.09

1.1

1.7

2.78

15.68

e6/l

—

Benign neoplasm: Larynx

233

1.07

0.09

1.4

22.20

46.57

e6/l

0.40

173

Other acquired deformities of ankle and foot

1.11

0.09

1.3

1.1

1.33

17.00

e6/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

203

1935

0.98

0.09

1.4

85.44

31.44

e6/l

0.41

127

1466

Postmenopausal atrophic vaginitis

267

1430

1.02

0.08

1.3

1.4

14.03

34.07

e6/l

1.07

192

1066

Maxillary retrognathism

175

1.09

0.08

1.3

2.6

9.77

11.47

e6/l

0.08

125

Malignant neoplasm of head and neck

656

1.04

0.08

1.3

12.65

28.13

e6/l

0.64

490

Supervision of normal pregnancy

253

1419

1.02

0.08

1.4

1.3

19.31

43.80

e6/l

0.86

174

1023

Other and unspecified disease of Bartholin gland

224

1.07

0.08

1.5

1.4

262.47

19.12

e6/l

0.45

164

Lesion of plantar nerve

489

1.04

0.08

1.2

1.3

10.59

30.94

e6/l

0.81

341

Other and unspecified disorders of pigmentation

0.77

0.08

1.4

1.1

2.60

12.69

e6/l

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

181

0.92

0.08

3.1

5.0

11.90

7.57

e6/l

—

124

Isolated proteinuria with specified morphological lesion

1.14

0.08

1.2

1.3

3.80

23.49

e6/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

815

0.97

0.08

1.3

36.39

33.56

e6/l

0.03

595

Leiomyoma of uterus

730

4130

0.99

0.08

1.3

1.4

22.32

39.95

e6/l

1.45

532

3052

Inguinal hernia

681

4482

1.01

0.08

1.4

1.5

33.36

30.43

e6/l

0.10

510

3343

Overjet

285

0.94

0.08

4.2

3.0

3.83

12.90

e6/l

1.11

214

Other noninflammatory disorders of uterus, except cervix

211

1383

1.02

0.08

1.5

1.4

71.08

35.10

e6/l

0.26

162

1043

Benign neoplasm: Oesophagus

1.13

0.07

1.1

1.4

1.45

14.73

e6/l

1.00

Benign neoplasm: Appendix

1.08

0.07

1.8

1.2

14.25

25.87

e6/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

322

1.05

0.07

1.0

3.2

9.87

13.85

e6/l

0.22

227

Malignant neoplasm of breast, HER-negative

184

1798

0.98

0.07

1.4

93.75

32.76

e6/l

0.41

111

1361

Rubella [German measles]

284

1.06

0.07

1.7

1.3

25.67

33.60

e6/l

0.11

215

Isolated proteinuria

235

0.93

0.07

1.2

1.4

139.69

31.23

e6/l

0.43

177

Malignant neoplasm of ovary

408

0.95

0.07

1.1

1.3

6.84

14.62

e6/l

0.70

307

Tooth agenesis EXCLUDE clefts and syndromes

397

0.95

0.07

2.7

2.4

8.36

12.72

e6/l

0.41

281

Other congenital malformations of female genitalia

1.07

0.07

1.3

1.4

2.33

13.56

e6/l

—

Benign neoplasm: Skin of trunk

367

0.95

0.07

1.3

1.4

63.24

38.53

e6/l

0.23

271

HSIL lesion of the cervix uteri, vagina or vulva

228

2246

1.02

0.07

1.2

1.3

73.33

31.49

e6/l

0.33

169

1669

Family history of malignant neoplasm

114

1166

0.98

0.07

1.2

1.3

10.33

37.46

e6/l

2.38

853

Ulcerative enterocolitis

255

0.94

0.07

1.0

1.5

14.22

25.01

e6/l

0.25

191

Carcinoma in situ of skin of lower limb, including hip

157

1.08

0.07

1.1

1.3

7.90

79.46

e6/l

—

118

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.05

0.07

1.0

1.2

1.89

10.72

e6/l

—

Non-ischemic cardiomyopathy

307

2405

1.01

0.06

1.6

1.4

55.31

39.32

e6/l

0.15

231

1741

Suppurative and necrotic conditions of lower respiratory tract

453

1.04

0.06

2.5

1.4

59.60

40.30

e6/l

0.25

338

Crossbite

754

1.03

0.06

3.5

2.2

6.48

17.25

e6/l

1.72

535

Congenital malformations of breast

162

0.92

0.06

1.1

1.2

11.10

16.58

e6/l

—

120

Malignant neoplasm of urinary organs

800

1.03

0.06

1.3

59.28

24.62

e6/l

0.40

608

COPD, hospital admissions 3, with asthma pneumonia sepsis

235

1987

1.01

0.06

1.4

1.3

11.15

27.09

e6/l

2.04

177

1489

Malignant neoplasm of oral cavity

276

1.05

0.06

1.1

1.4

5.35

41.17

e6/l

0.93

210

Pleural plaque

678

0.97

0.05

1.3

25.29

37.03

e6/l

0.26

514

Maternal care for known or suspected disproportion

405

0.96

0.05

1.4

25.19

21.26

e6/l

0.08

300

Graves ophthalmopathy

212

0.94

0.05

1.4

10.62

16.42

e6/l

0.25

159

Lung cancer and mesothelioma

151

1300

0.98

0.05

1.2

1.3

27.54

11.76

e6/l

0.40

103

982

Pericarditis

297

1.04

0.05

1.2

1.6

6.33

21.55

e6/l

0.71

219

Graves ophthalmopathy, strict

189

1.06

0.04

1.4

10.62

14.20

e6/l

0.14

145

Long labour

285

2435

0.99

0.04

1.4

1.3

41.57

35.06

e6/l

0.11

196

1779

Cholangitis (primary sclerosing, PSC)

507

1.03

0.04

1.2

1.7

15.45

37.61

e6/l

0.63

381

Amputation of toe

543

0.98

0.04

2.1

1.4

10.80

39.64

e6/l

0.95

403

Maternal care for other known or suspected fetal problems

288

1791

1.01

0.04

1.2

1.3

24.37

32.26

e6/l

0.28

226

1326

Basal cell carcinoma

461

3123

1.01

0.03

1.3

1.4

81.43

26.71

e6/l

0.79

341

2361

Ascites

577

1.02

0.03

1.5

1.4

2.90

51.88

e6/l

2.49

425

Other specified congenital malformation syndromes affecting multiple systems

169

0.94

0.03

1.1

4.1

3.27

15.14

e6/l

1.15

117

Autism spe

270

0.96

0.03

1.1

2.5

9.89

19.20

e6/l

0.52

191

Primary biliary cholangitis, wide definition

169

0.95

0.03

1.2

1.9

1.63

41.36

e6/l

—

126

Foreign body in ear

171

1.05

0.03

1.7

1.9

112.08

10.43

e6/l

0.73

120

Impacted cerumen

105

1036

1.01

0.03

1.8

1.5

7.97

28.14

e6/l

1.56

767

Non-small cell lung cancer, adenocarcinoma

471

0.98

0.03

1.2

1.3

6.53

35.33

e6/l

1.19

356

COPD, hospital admission 2, with asthma infections

292

2496

1.01

0.03

1.4

10.01

32.96

e6/l

2.68

220

1865

Multiple gestation

963

0.99

0.03

1.7

1.3

76.57

42.12

e6/l

0.23

717

Oral lichen planus

241

1.04

0.02

1.5

1.4

106.25

42.14

e6/l

0.32

174

Cystic kidney disease

269

0.97

0.02

1.3

1.8

6.26

48.10

e6/l

1.06

198

Twin gestation

932

0.99

0.02

1.7

1.3

79.64

42.06

e6/l

0.24

697

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

349

0.97

0.02

1.2

1.3

2.00

32.68

e6/l

1.10

271

Other malignant neoplasms of skin (=non-melanoma skin cancer)

472

3214

1.00

0.02

1.3

1.4

81.56

26.69

e6/l

0.82

347

2431

Benign neoplasm: Tongue

222

1.04

0.02

1.3

1.4

15.15

31.19

e6/l

0.35

165

Carcinoma in situ of skin of trunk

228

0.96

0.02

1.3

1.17

72.30

e6/l

1.30

178

Acute poliomyelitis

1.08

0.02

1.4

1.1

6.80

2.24

e6/l

—

Acute poliomyelitis, including avohilmo

1.08

0.02

1.4

1.1

6.80

2.24

e6/l

—

Other disorders of cornea

900

1.01

0.02

1.6

1.4

26.63

22.42

e6/l

0.10

647

Other benign neoplasms of skin

390

3886

1.00

0.01

1.3

1.4

19.16

29.69

e6/l

0.91

285

2886

Transitory endocrine and metabolic disorders specific to fetus and newborn

183

0.96

0.01

3.0

5.0

11.45

7.45

e6/l

0.15

126

Non-rheumatic valve diseases

515

3663

1.00

0.01

1.4

1.5

55.27

27.06

e6/l

0.54

405

2702

IgA nephropathy (IgA glomerulonephritis)

197

0.96

0.01

1.3

829.18

34.63

e6/l

0.49

147

Other ulcerative colitis

552

1.01

0.01

1.5

1.4

44.98

36.75

e6/l

0.10

410

Inguinal hernia, unilateral

203

1.04

0.01

1.0

1.3

1.38

22.73

e6/l

0.75

156

Femoral hernia, unilateral

203

1.04

0.01

1.0

1.3

1.38

22.73

e6/l

0.75

156

Inguinal of femoral hernia, unilateral

203

1.04

0.01

1.0

1.3

1.38

22.73

e6/l

0.75

156

Other acute skin changes due to ultraviolet radiation

267

0.97

0.01

2.1

1.4

7.44

47.77

e6/l

0.94

203

Malignant neoplasm of bladder

447

0.98

0.01

1.4

1.3

17.48

35.50

e6/l

0.49

345

Amputation

752

1.01

0.01

1.9

1.4

19.58

32.25

e6/l

0.36

566

Other juvenile arthritis

377

0.98

0.01

1.5

2.3

25.25

16.27

e6/l

0.22

282

Chronic suppurative otitis media

607

0.99

0.01

1.6

1.7

44.71

25.06

e6/l

0.20

454

Polyhydramnios

487

0.99

0.01

1.4

1.3

9.19

20.93

e6/l

1.05

359

Peripheral artery operations in Hilmo

937

0.99

0.01

1.8

1.3

16.29

31.44

e6/l

0.58

694

Chronic suppurative otitis media, including avohilmo

727

0.99

0.01

1.6

1.9

85.75

34.10

e6/l

0.42

541

Prominent ears

1.07

0.01

1.4

1.3

8.20

13.96

e6/l

—

Retinoschisis and retinal cysts

184

1.03

0.00

1.2

1.4

8.09

66.21

e6/l

0.97

135

Injury of muscle and tendon at ankle and foot level

214

1.03

0.00

1.2

1.4

2.79

12.37

e6/l

1.28

158

Embedded teeth, including avohilmo

100

1006

0.99

0.00

1.7

1.6

14.73

20.67

e6/l

0.24

739

Myocardial infarction, without ST-elevation

362

3264

1.00

0.00

1.3

1.4

14.99

29.78

e6/l

1.30

281

2452

COPD related to multimorbidity

367

3099

1.00

0.00

1.4

51.54

31.30

e6/l

0.29

276

2332

Valvular heart disease excluding rheumatic fever

519

3703

1.00

0.00

1.4

1.5

54.92

26.89

e6/l

0.54

408

2732

Other pulmonary heart/vessel disease

325

0.98

0.00

1.5

1.4

52.08

58.00

e6/l

0.05

247

Malignant neoplasm of ovary, including Hilmo

531

1.00

0.00

1.2

1.3

5.24

23.55

e6/l

1.69

397

Prolapse and hernia of ovary and fallopian tube

196

1.01

0.00

1.0

1.2

26.50

16.62

e6/l

0.16

154

Scissor bite

299

0.99

0.00

3.4

2.6

9.43

16.38

e6/l

0.37

215

Premenstrual syndrome

145

1.04

0.00

1.3

1.4

1.43

21.85

e6/l

—

112

Benign neoplasm: Vulva

165

1.03

0.00

1.1

1.5

261.92

16.58

e6/l

0.46

117

Other nonscarring hair loss

106

1.04

0.00

1.3

1.2

3.64

9.54

e6/l

0.43

Operations for atrial fibrillation

106

1.04

0.00

1.1

1.2

0.83

43.67

e6/l

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

103

0.97

0.00

4.0

1.2

17.70

60.61

e6/l

—

Carcinoma in situ of cervix uteri, endocervix

113

0.97

0.00

1.0

1.3

0.33

11.53

e6/l

—

Oral lichen planus and hypothyroidism or thyroxine medication

163

0.98

0.00

1.5

1.2

15.64

53.40

e6/l

0.46

118

Right bundle-branch block

296

1.01

0.00

1.5

1.3

2.85

21.05

e6/l

0.96

222

LeFortI or BSSO operation

396

1.01

0.00

1.1

1.4

7.13

13.26

e6/l

0.56

297

Neonatal jaundice from other and unspecified causes

192

1.01

0.00

7.0

4.9

2.50

7.91

e6/l

0.70

129

Respiratory and cardiovascular disorders specific to the perinatal period

282

1.01

0.00

5.6

3.9

37.78

8.84

e6/l

0.37

191

Nontoxic single thyroid nodule

624

0.99

0.00

1.3

1.4

15.65

37.82

e6/l

0.82

454

Burn and corrosion of head and neck

178

1.01

0.00

1.1

1.5

1.08

17.40

e6/l

1.84

128

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

182

0.99

0.00

1.2

1.4

24.50

19.35

e6/l

0.11

133

Dermatitis due to ingested food

397

1.01

0.00

1.8

3.0

32.97

17.20

e6/l

0.28

275

Noise effects on inner ear

322

0.99

0.00

1.5

1.3

27.88

38.17

e6/l

0.16

236

Ulcerative ileocolitis

352

0.99

0.00

1.0

1.4

19.92

20.18

e6/l

0.01

257

Benign neoplasm: Skin of other and unspecified parts of face

893

1.00

0.00

1.4

9.43

30.41

e6/l

1.24

661

Other congenital malformations of ear

129

1.01

0.00

1.3

2.1

10.25

15.11

e6/l

—

Other and unspecified corneal deformities and disorders

271

1.00

0.00

2.1

1.5

5.27

32.95

e6/l

0.65

197

Embolic stroke with flimmer

167

1.02

0.00

1.5

1.3

2.27

34.63

e6/l

1.02

132

Pyothorax

342

0.99

0.00

1.7

1.3

36.81

34.06

e6/l

0.04

258

Arterial embolism and thrombosis

405

0.99

0.00

1.3

15.82

48.34

e6/l

0.82

301

Carcinoma in situ of colon

233

0.99

0.00

1.7

1.2

7.82

30.61

e6/l

0.76

166

Cirrhosis of liver, NAS

457

1.01

0.00

1.5

1.4

236.88

45.25

e6/l

0.39

335

Congenital ovarian cysts

427

1.01

0.00

1.2

1.4

15.59

19.50

e6/l

0.13

322

Fibrosis and cirrhosis of liver

673

1.00

0.00

1.4

1.5

188.34

36.06

e6/l

0.40

492

Disorders of lacrimal system and orbit in diseases classified elsewhere

205

0.98

0.00

1.4

1.5

10.62

17.33

e6/l

0.29

154

307

0.99

0.00

2.3

4.0

39.20

13.95

e6/l

0.34

204

Myxoedema coma

0.00

-0.00

0.0

1.0

—

2.67

—

Other specified/unspecified nutritional deficiencies

0.95

-0.00

1.2

0.67

13.72

e6/l

—

Deficiency of other/unspecified nutrient elements

0.00

-0.00

0.0

1.0

—

3.60

—

Brucellosis, including avohilmo

0.00

-0.00

0.0

1.0

—

3.80

—

Carcinoma in situ of bronchus and lung

0.00

-0.00

0.0

1.0

—

2.83

—

Pediculosis and phthiriasis, including avohilmo

0.97

-0.00

1.7

1.4

23.17

13.06

e6/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

840

1.00

-0.00

1.3

19.64

34.82

e6/l

0.58

601

Myelofibrosis

0.00

-0.00

0.0

1.0

—

1.40

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

1.50

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.0

—

2.20

—

Choroidal degeneration

0.00

-0.00

0.0

1.0

—

3.00

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

2.5

—

1.13

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS